KR820000476B1 - Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives - Google Patents

Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives Download PDF

Info

Publication number
KR820000476B1
KR820000476B1 KR7803502A KR780003502A KR820000476B1 KR 820000476 B1 KR820000476 B1 KR 820000476B1 KR 7803502 A KR7803502 A KR 7803502A KR 780003502 A KR780003502 A KR 780003502A KR 820000476 B1 KR820000476 B1 KR 820000476B1
Authority
KR
South Korea
Prior art keywords
mixture
chloro
added
melting point
water
Prior art date
Application number
KR7803502A
Other languages
Korean (ko)
Inventor
미첼 슈츠케 그레고리
루이스 세테스카크 린다
챨스 알렌 리챠드
Original Assignee
한스 디터 스탬머
훽스트 아크티엔 게젤샤프트
한스 하인쯔 로이터
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한스 디터 스탬머, 훽스트 아크티엔 게젤샤프트, 한스 하인쯔 로이터 filed Critical 한스 디터 스탬머
Priority to KR7803502A priority Critical patent/KR820000476B1/en
Priority to KR8200779A priority patent/KR820000562B1/en
Application granted granted Critical
Publication of KR820000476B1 publication Critical patent/KR820000476B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Titla compds. (I; R = H, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, tricycloalkyl, cycloalkyl lower alkyl, cycloalkenyl lower alkyl, boxyl, -COZ, -CH2OH, -CHO, -CH; R2, R3, R4 = H, halogen, lower alkyl; R5, R6 = H, lower alkyl; A, A' = O, S; Z = Cl, Br, F; M, n = 1,2,3), useful as diuretic, were prepd. by reacting compd.(II) with compd.(III) followed by treatment. The treatment comprise hydrolysis, oxidn., N(R7)(R8) or NH2OH treatment, NHO3 treatment in glacial acetic acid, and dealkylation.

Description

1,2-벤즈이소옥사졸옥시아세트산 유도체의 제조방법Method for producing 1,2-benzisoxazoleoxyacetic acid derivative

본 발명은 이뇨제, 뇨산배설제, 항고혈압제로 유효한 다음 일반식(I)의 1,2-벤즈이소옥사졸 옥시아세트산 및 관련 화합물의 제조방법에 관한 것이다.The present invention relates to a method for preparing 1,2-benzisoxazole oxyacetic acid of the following general formula (I) and related compounds effective as a diuretic, uric acid excretion agent, and antihypertensive agent.

Figure kpo00001
Figure kpo00001

상기 일반식에서 R은 수소, 저급알킬, 저급알케닐, 저급알키닐, 시클로알킬, 시클로알케닐, 비시클로알킬, 트리시클로알킬, 시클로알킬저급알킬, 시클로알케닐저급알킬, 나프틸In the above formula, R is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, tricycloalkyl, cycloalkyl lower alkyl, cycloalkenyl lower alkyl, naphthyl

Figure kpo00002
Figure kpo00002

티에닐, 푸릴, 피릴, 피리딜 또는 피리딜 N-옥사이드이고 R1은 탄소수가 1 내지 8인 유리 또는 에스테르화된 카복실그룹,

Figure kpo00003
Figure kpo00004
이며, R2, R3및 R4는 동일하거나 상이하고 각각은 수소, 할로겐 또는 저급알킬이 될 수 있고, X는 수소, 할로겐, 저급알킬, 저급알킬티오, 저급알콕시, 히드록시, 트리플루오로메틸, 니트로, 아미노 또는 아실아미노이며, R5, R6, R7, R8및 R9은 동일하거나 상이하고 수소 또는 저급알킬이 될수 있고; A 및 A'는 동일하거나 상이하고 0 또는 S이며; Z는 염소, 브롬 또는 불소이고; m 및 n은 동일하거나 상이하고 각기 1, 2 또는 3의 정수이다. 또한 본 발명의 범위내에는 생리적으로 무독한 염도 포함된다.Thienyl, furyl, pyryl, pyridyl or pyridyl N-oxide and R 1 is a free or esterified carboxyl group having 1 to 8 carbon atoms,
Figure kpo00003
Figure kpo00004
R 2 , R 3 and R 4 are the same or different and each can be hydrogen, halogen or lower alkyl, X is hydrogen, halogen, lower alkyl, lower alkylthio, lower alkoxy, hydroxy, trifluoro Methyl, nitro, amino or acylamino, and R 5 , R 6 , R 7 , R 8 and R 9 are the same or different and can be hydrogen or lower alkyl; A and A 'are the same or different and are 0 or S; Z is chlorine, bromine or fluorine; m and n are the same or different and are integers of 1, 2 or 3, respectively. Also included within the scope of the present invention are physiologically toxic salts.

본 발명의 범위내에 있는 몇 몇 화합물은 다른 화합물보다도 약학적인 활성이 더욱 크다. 후자의 화합물 중에서 R1이 에스테르화된 카복실그룹, CN, CH2OH 또는 CHO인 화합물은 보다 활성이 큰 화합물의 제조시 중간물질로서 바람직하게 사용된다.Some compounds within the scope of the present invention have greater pharmaceutical activity than others. Of the latter compounds, compounds in which R 1 is an esterified carboxyl group, CN, CH 2 OH or CHO are preferably used as intermediates in the preparation of more active compounds.

상술한 바와 같이, R은 티에닐, 푸릴, 피릴 또는 피리딜과 같은 헤테로사이클 그룹은 물론 지방족 또는 카복실 그룹이 될 수 있다.As mentioned above, R can be an aliphatic or carboxyl group as well as a heterocycle group such as thienyl, furyl, pyryl or pyridyl.

바람직한 화합물그룹은 R이 오르토 치환체 특히 할로겐원자, 바람직하게는 불소를 가지는 (부착위치는 환상구조 어느 곳이나 가능) 방향족 환인 화합물이다. 또한 바람직한 본 발명의 화합물 그룹은 R이 저급알콕시 또는 벤질그룹으로 에스테르화 될 수 있는 카복실그룹인 화합물이다. 또한 바람직한 화합물은 A 및 A'가 각각 산소인 것이다.Preferred compound groups are those in which R is an aromatic ring having an ortho substituent, in particular a halogen atom, preferably fluorine (where the attachment position can be anywhere in the ring). Also preferred are compound groups of the invention wherein R is a carboxyl group which may be esterified with lower alkoxy or benzyl groups. Further preferred compounds are those in which A and A 'are each oxygen.

본 명세서에서 다음용어는 다음의 의미를 가진다.In the present specification, the following terms have the following meanings.

"티에닐, 푸릴, 피릴 또는 피리딜"은 치환체가 할로겐 또는 저급알킬인 비치환 및 치환된 잔기이다."Tienyl, furyl, pyryl or pyridyl" is an unsubstituted and substituted moiety wherein the substituent is halogen or lower alkyl.

"저급"은 1 내지 4의 탄소원자를 의미한다."Lower" means 1 to 4 carbon atoms.

"시클로알킬"은 탄소수가 3 내지 8인 포화된 카보사이클 환이다."Cycloalkyl" is a saturated carbocycle ring having 3 to 8 carbon atoms.

"비시클로 및 트리시클로알킬"은 탄소수 7 내지 10인 비-및 트리 카보사이클 환상계이다."Bicyclo and tricycloalkyl" are non- and tricarbocyclic cyclic systems having 7 to 10 carbon atoms.

"사이클로알케닐"은 탄소수가 5 내지 8인 비치환된 카보사이클 환이다."Cycloalkenyl" is an unsubstituted carbocycle ring having 5 to 8 carbon atoms.

본 발명의 생리학적으로 무독한 염은 알카리 또는 알카리토금속염기 또는 에탄올아민, 디에탄올아민 또는 N-메틸글루카민과 같은 무독성 유기염기와의 염이다.The physiologically nontoxic salts of the present invention are salts with alkali or alkaline earth metal bases or nontoxic organic bases such as ethanolamine, diethanolamine or N-methylglucamine.

본 발명 화합물은 다음 반응의 여러단계중 하나에 의해 제조될 수 있으며 이때 달리 표시된 바가 없다면 R, R1내지 R8, x, m 및 n은 전술한 바와 같고 Y는 염소 또는 불소이며 주위온도는 20 내지 25℃이다.The compounds of the present invention may be prepared by one of several steps of the following reactions where R, R 1 to R 8 , x, m and n are as described above and Y is chlorine or fluorine and the ambient temperature is 20 unless otherwise indicated. To 25 ° C.

a1) 다음 일반식의(II)의 페놀 또는 알콕시벤젠을 프리델-크레프트 조건하에서 RCOZ의 산할라이드와 반응시켜서 다음 일반식(III)의 화합물을 얻는다.a 1 ) The phenol or alkoxybenzene of the following general formula (II) is reacted with an acid halide of RCOZ under Friedel-Craft conditions to obtain a compound of the following general formula (III).

Figure kpo00005
Figure kpo00005

상기식중 R10은 수소 또는 저급알킬이고 R은 전술한 바와 같고 Z는 염소, 브롬 또는 불소이다.Wherein R 10 is hydrogen or lower alkyl and R is as described above and Z is chlorine, bromine or fluorine.

바람직한 방법에서는 용매로서 1, 2-디클로로에탄을 사용하고 프리델 크레프트 촉매로서 염화알루미늄을 사용한다.In a preferred method, 1, 2-dichloroethane is used as solvent and aluminum chloride is used as Friedel Creft catalyst.

a2) 일반식 R-H 화합물을 프리델-크래프트 조건하에서 일반식(IV)의 산할라이드와 반응시켜 일반식(IIIa) 화합물을 얻는다.a 2 ) The general formula RH compound is reacted with an acid halide of general formula (IV) under Friedel-Craft conditions to give a general formula (IIIa) compound.

Figure kpo00006
Figure kpo00006

상기식중 R은

Figure kpo00007
, 티에닐, 피릴 또는 푸릴이고, Y, Z 및 R10은 A에서 정의한 바와 같다.Where R is
Figure kpo00007
, Thienyl, pyryl or furyl, and Y, Z and R 10 are as defined for A.

바람직한 방법에서는 용매로서 1, 2-디클로로에탄을 사용하고 프리델-크레프트 촉매로서 염화알루미늄을 사용한다.In a preferred method, 1, 2-dichloroethane is used as solvent and aluminum chloride is used as Friedel-Craft catalyst.

a3) 일반식(IV) 화합물을 일반식 R-MgZ 또는 R-Li의 화합물과 반응시킨 후 가수분해하여 일반식(IIIa)의 화합물을 얻는다.a 3 ) The compound of formula (IV) is reacted with a compound of formula R-MgZ or R-Li and then hydrolyzed to obtain a compound of formula (IIIa).

Figure kpo00008
Figure kpo00008

상기식중 R10은 저급알킬이고 R은 수소가 아니다.Wherein R 10 is lower alkyl and R is not hydrogen.

바람직한 조건은 -70℃ 내지 주위온도에서 용매로서 테트라히드로푸란을 사용하는 것이다.Preferred conditions are the use of tetrahydrofuran as solvent at −70 ° C. to ambient temperature.

a4) R이 수소이고 R이 저급알킬인 일반식(IIIa) 화합물을 a3)의 방법에 따라 반응시켜 일반식(V)의 화합물을 얻는다.a 4 ) A compound of formula (IIIa) wherein R is hydrogen and R is lower alkyl is reacted according to the method of a 3 ) to obtain a compound of formula (V).

Figure kpo00009
Figure kpo00009

상기식중 R은 수소가 아니다.Wherein R is not hydrogen.

a5) 공정 a4)에서 제조된 화합물을 산화시켜 R 이 수소가 아닌 일반식(IIIa) 화합물을 얻는다. 하나의 방법으로 빙초산중의 크로미움 삼산화물을 사용한다.a 5 ) The compound prepared in step a 4 ) is oxidized to obtain a compound of formula (IIIa) in which R is not hydrogen. One method uses chromium trioxide in glacial acetic acid.

a6) R10이 저급알킬인 일반식(III) 또는 (IIIa) 화합물을 탈알킬화하여 R10이 수소인 상응하는 화합물(III) 또는 (IIIa)를 얻는다. 하나의 방법으로 벤젠중의 염화알루미늄을 사용한다.a 6 ) Dealkylation of the compound of general formula (III) or (IIIa) wherein R 10 is lower alkyl gives the corresponding compound (III) or (IIIa) wherein R 10 is hydrogen. One method uses aluminum chloride in benzene.

a7) 일반식(III) 또는 (IIIa) 화합물을 피리딘과 같은 용매중의 히드록실아민 하이드로클로라이드로 처리하여 상응하는 일반식(VI)의 화합물을 얻는다.a 7 ) The compounds of formula (III) or (IIIa) are treated with hydroxylamine hydrochloride in a solvent such as pyridine to give the corresponding compound of formula (VI).

a8) 일반식(VI) 화합물을 용매 존재하에 주위온도 내지 반응매질의 환류온도에서 염기로 처리하여 환화시켜 일반식(VII)의 상응하는 비사이클화합물을 얻는다.a 8 ) The compound of formula (VI) is cyclized by treatment with a base at ambient temperature to the reflux temperature of the reaction medium in the presence of a solvent to obtain the corresponding bicyclic compound of formula (VII).

Figure kpo00010
Figure kpo00010

바람직한 환화법은 환류온도에서 디메틸 포름아미드-벤젠 혼합물의 용매중에서 나트륨 히드라이드 염기를 사용하는 것이다.Preferred cyclization is the use of sodium hydride base in the solvent of the dimethyl formamide-benzene mixture at reflux.

a9) 일반식(VIII)의 디페놀 또는 디알콕시벤젠을 공정 a1)에 따라 반응시켜 일반식(IX) 화합물을 얻는다.a 9 ) The diphenol or dialkoxybenzene of the general formula (VIII) is reacted according to the step a 1 ) to obtain the general formula (IX) compound.

Figure kpo00011
Figure kpo00011

a10) 일반식 R-H인 화합물을 프리델-크레프트 조건하에서 일반식(R)의 산할라이드와 반응시켜서 일반식(XI) 화합물을 얻는다.a 10 ) A compound of the general formula RH is reacted with an acid halide of the general formula (R) under Friedel-Craft conditions to give a compound of the general formula (XI).

Figure kpo00012
Figure kpo00012

상기식중 R은

Figure kpo00013
, 티에닐, 피릴 또는 푸릴이고, Z, R2, R3, R3및 R10은 전술한 바와 같다.Where R is
Figure kpo00013
, Thienyl, pyryl or furyl, and Z, R 2 , R 3 , R 3 and R 10 are as described above.

a11) 일반식(XII)화합물을 공정 a3)에 따라 처리하여 상응하는 일반식(XI)의 화합물을 얻는다.a 11 ) The compound of formula (XII) is treated according to step a 3 ) to afford the corresponding compound of formula (XI).

Figure kpo00014
Figure kpo00014

상기식중 R10은 저급알킬이다.Wherein R 10 is lower alkyl.

a12) R이 수소이고 R10이 저급알킬일 일반식(XI) 화합물을 공정 a3)에 따라 반응시켜 일반식(XI) 화합물을 얻는다.a 12 ) A compound of formula (XI) wherein R is hydrogen and R 10 is lower alkylyl is reacted according to step a 3 ) to afford a compound of formula (XI).

Figure kpo00015
Figure kpo00015

상기식중 R은 수소가 아니다.Wherein R is not hydrogen.

a13) 공정 a12)에서 제조된 화합물을 산화시켜 R이 수소가 아닌 일반식(XI) 화합물을 얻는다. 하나의 방법은 빙초산중의 크로미움 삼산화물을 사용하는 것이다.a 13) a step 12) is oxidized to the compound R is obtained from the formula (XI) compounds other than hydrogen. One method is to use chromium trioxide in glacial acetic acid.

a14) R10이 저급알킬일 일반식(XI) 화합물을 선택적으로 탈알킬화시켜 카보닐그룹에 대해 오르토위치인 R10이 수소인 상응하는 화합물(V)를 얻거나 완전히 탈 알킬화시켜 두 R10이 모두 수소인 일반식(XI)화합물을 얻는다. 전술한 공정은 염화알루미늄 1당량을, 후자 공정은 2당량을 사용하고 벤젠과 같은 용매중에서 수행할 수 있다.a 14) R 10 is selectively alkylated ride in the general formula (XI) compound one lower alkyl by the R 10 is an equivalent to obtain the compound (V) or completely de-alkylation to the hydrogen ortho to the carbonyl group, the two R 10 All of them obtain a general formula (XI) compound which is hydrogen. The above process can be carried out in a solvent such as benzene, using 1 equivalent of aluminum chloride and the latter 2 equivalents.

a15) 적어도 카보닐그룹에 대해 오르토 위치인 R10이 수소인 일반식(XI)화합물을 공정 a7)에 따라 처리하여 일반식(XIV)화합물을 얻는다.a 15 ) The general formula (XI) compound wherein at least the ortho position R 10 is hydrogen for at least the carbonyl group is treated according to step a 7 ) to obtain the general formula (XIV) compound.

Figure kpo00016
Figure kpo00016

a16) 일반식(XIV) 화합물을 아세틸화시켜 일반식(XV) 화합물을 얻는다.a 16 ) Acetylating a compound of formula (XIV) yields a compound of formula (XV).

Figure kpo00017
Figure kpo00017

여기서 R11은 수소, 저급알킬 또는 아세틸이다.Wherein R 11 is hydrogen, lower alkyl or acetyl.

바람직한 방법은 반응물질 및 용매로서 무수 아세트산을 사용하는 것이다.The preferred method is to use acetic anhydride as reactant and solvent.

a17) 일반식(XV) 화합물을 주위온도 내지 반응혼합물의 환류온도에서 용매 존재하에 염기로 처리하여 환화시켜 일반식(VII)의 비사이클 화합물을 얻는다.a 17 ) The compound of formula (XV) is cyclized by treatment with a base in the presence of a solvent at ambient temperature to the reflux temperature of the reaction mixture to obtain a bicyclic compound of formula (VII).

Figure kpo00018
Figure kpo00018

a18) R10이 저급알킬일 일반식(VII) 화합물을 탈알킬화하여 R10이 수소인 상응하는 화합물을 얻는다.a 18) R 10 is de-alkylated to the formula (VII) compound one lower alkyl to obtain the corresponding compound of R 10 is hydrogen.

바람직한 방법은 170 내지 200℃에서 피리딘 하이드로클로라이드로 처리하는 것이다.The preferred method is to treat with pyridine hydrochloride at 170-200 ° C.

a19) R10이 수소인 일반식(VII) 화합물을 염기와 용매 존재하에서

Figure kpo00019
화합물과 반응시켜 일반식(Ia) 화합물을 얻는다.a 19 ) A compound of formula (VII), wherein R 10 is hydrogen, in the presence of a base and a solvent
Figure kpo00019
Reaction with a compound yields a compound of formula (Ia).

Figure kpo00020
Figure kpo00020

상기식중 R1은 유리 또는 에스테르화된 카복실그룹, CN, CH2OH 또는 CH(OR9)2이고 R9은 저급알킬이다.Wherein R 1 is a free or esterified carboxyl group, CN, CH 2 OH or CH (OR 9 ) 2 and R 9 is lower alkyl.

바람직한 방법은 용매로서 디메틸포름아미드를 사용하고 염기로서 나트륨 수화물을 사용하는 것이다.The preferred method is to use dimethylformamide as solvent and sodium hydrate as base.

b1) R10이 H인 일반식(IX) 화합물을 공정 a19)에 따라 처리하여 일반식(XX)화합물을 얻는다.b 1 ) The compound of formula (IX) wherein R 10 is H is treated according to step a 19 ) to obtain a compound of formula (XX).

Figure kpo00021
Figure kpo00021

b2) 일반식(XX)화합물을 공정 a7)에 따라 처리하여 일반식(XXI)화합물을 얻는다.b 2 ) The compound of formula (XX) is treated according to step a 7 ) to obtain a compound of formula (XXI).

Figure kpo00022
Figure kpo00022

b3) 일반식(XXI) 화합물을 공정 a16)에 따라 처리하여 일반식(XXII)화합물을 얻는다.b 3 ) The compound of formula (XXI) is treated according to step a 16 ) to afford a compound of formula (XXII).

Figure kpo00023
Figure kpo00023

b4) 일반식(XXII) 화합물을 공정 a17)에 따라 폐환하여 본 발명의(Ia) 화합물을 얻는다.b 4 ) The compound of general formula (XXII) is closed according to step a 17 ) to obtain a compound (Ia) of the present invention.

c1) 공정 a14)에 의해 제조된 R이 수소인 일반식(XI) 화합물을 물과 같은 용매중의 히드록실아민-0-설폰산으로 처리하여 일반식(VII) 화합물을 얻는다.c 1) a step 14) and R is a hydrogen treatment of the formula (XI) compound with a hydroxylamine-0-sulfonic acid in a solvent such as water, prepared by the obtained formula (VII) compound.

c2) R이 수소인 일반식(XX) 화합물을 환화시켜 본 발명의(Ia) 화합물을 제조한다.c 2 ) The compound of formula (Ia) of the present invention is prepared by cyclizing a compound of formula (XX) wherein R is hydrogen.

d1) R10이 수소이고 X가 히드록시 또는 아미노가 아닌 일반식(VII) 화합물을 염기 존재하에 디알킬티오카바모일 할라이드로 처리하여 일반식(XXIII) 화합물을 얻는다.d 1 ) A compound of formula (VII) wherein R 10 is hydrogen and X is not hydroxy or amino is treated with a dialkylthiocarbamoyl halide in the presence of a base to give a compound of formula (XXIII).

Figure kpo00024
Figure kpo00024

상기식중 R7및 R8은 저급알킬이다.Wherein R 7 and R 8 are lower alkyl.

바람직한 방법은 용매로서 디메틸포름아미드중의 디메틸티오카바모일 클로라이드를 사용하고 염기로서 나트륨 히드라이드를 사용하는 것이다.The preferred method is to use dimethylthiocarbamoyl chloride in dimethylformamide as solvent and sodium hydride as base.

d2) 일반식(XXIII) 화합물을 용융 가열하여 일반식(XXIV) 화합물을 열전위시킨다.d 2 ) Thermally dissolving the compound of formula (XXIV) by melting and heating the compound of formula (XXIII).

Figure kpo00025
Figure kpo00025

d3) 일반식(XXIV) 화합물을 통상적인 방법으로 가수분해 하여 일반식(XXV) 화합물을 얻는다.d 3 ) The compound of formula (XXIV) is hydrolyzed in a conventional manner to obtain a compound of formula (XXV).

Figure kpo00026
Figure kpo00026

하나의 방법은 가수분해제로서 회수산화나트륨을 사용하는 것이다.One method is to use recovered sodium oxide as the hydrolysis agent.

d4) 일반식(XXV) 화합물을 공정 a19)에 따라서 처리하여 일반식(Ib) 화합물을 얻는다.d 4 ) The compound of formula (XXV) is treated according to step a 19 ) to obtain a compound of formula (lb).

Figure kpo00027
Figure kpo00027

e1) 공정 a14)에 기술된 R10이 저급알킬이고 X가 아미노 또는 히드록실이 아닌 일반식(XXVI) 화합물을 공정 d1), d2) 및 d3)에 따라 처리하여 일반식(XXVII) 화합물을 얻는다.e 1 ) A compound of formula (XXVI) in which R 10 described in process a 14 ) is lower alkyl and X is not amino or hydroxyl is treated according to processes d 1 ), d 2 ) and d 3 ) XXVII) A compound is obtained.

Figure kpo00028
Figure kpo00028

e2) 일반식(XXVII) 화합물을 공정 a7), a16), a17) 및 a18)에 따라 처리하여 일반식(XXVIII) 화합물을 얻는다.e 2 ) The compound of formula (XXVII) is treated according to steps a 7 ), a 16 ), a 17 ) and a 18 ) to obtain a compound of formula (XXVIII).

Figure kpo00029
Figure kpo00029

e3) 일반식(XXVIII)화합물을 공정 a19) 따라 처리하여 일반식(Ic) 화합물을 얻는다.e 3 ) The compound of formula (XXVIII) is treated according to step a 19 ) to obtain a compound of formula (Ic).

Figure kpo00030
Figure kpo00030

f1) 일반식(XXVIII) 화합물을 공정 d1), d2) 및 d3)에 따라 처리하여 일반식(XXIX) 화합물을 얻는다.f 1 ) The compound of formula (XXVIII) is treated according to the processes d 1 ), d 2 ) and d 3 ) to obtain a compound of formula (XXIX).

Figure kpo00031
Figure kpo00031

f2) 일반식(XXIX) 화합물을 공정 a19)에 따라 처리하여 일반식(Id) 화합물을 얻는다.f 2 ) The general formula (XXIX) compound is treated according to step a 19 ) to obtain a general formula (Id) compound.

Figure kpo00032
Figure kpo00032

g) R1이 카복실산 에스테르 또는 CN인 일반식(Ia), (Ib), (Ic) 또는 (Id)의 화합물을 R1이 COOH인 상응하는 화합물로 전환시킨다.g) A compound of formula (la), (lb), (lc) or (Id) wherein R 1 is a carboxylic ester or CN is converted to the corresponding compound where R 1 is COOH.

적합한 방법은 수산화나트륨과 같은 염기로 가수분해하는 것이다.A suitable method is to hydrolyze with a base such as sodium hydroxide.

h) R1이 CH(OR9)2인 일반식(Ia), (Ib), (Ic) 또는 (Id)의 본발명 화합물을 R1이 CHO인 상응하는 화합물로 전환시킨다. 적합한 방법은 희무기산으로 가수분해하는 것이다.h) The invention compounds of formula (la), (lb), (lc) or (Id) wherein R 1 is CH (OR 9 ) 2 are converted to the corresponding compounds wherein R 1 is CHO. A suitable method is to hydrolyze with rare acid.

i) X, R2, R3및 R4가 저급알킬이 아니고 R1이 CH2OH인 일반식(Ia) 화합물 또는 R1이 CHO이고 공정 h)에 의해 제조된 일반식(Ia) 화합물을 R1이 COOH인 상응하는 화합물로 전환시킨다.i) a compound of formula (Ia) wherein X, R 2 , R 3 and R 4 are not lower alkyl and R 1 is CH 2 OH or a compound of formula (Ia) prepared by step h) wherein R 1 is CHO; Convert to the corresponding compound where R 1 is COOH.

적합한 방법은 과망간산칼륨으로 산화시키는 것이다.A suitable method is to oxidize with potassium permanganate.

j) R1이 COOH인 일반식(I) 화합물을 R1이 COZ인 화합물로 전환시킨다.j) A compound of formula (I) wherein R 1 is COOH is converted to a compound wherein R 1 is COZ.

Figure kpo00033
Figure kpo00033

적합한 방법은 SOZ2로 처리하는 것이다.A suitable method is to treat with SOZ 2 .

1) R1이 COZ인 일반식(I) 화합물은 산스캐빈저 존재 또는 부재하에

Figure kpo00034
, NH2OH 또는
Figure kpo00035
로 처리하여 R1
Figure kpo00036
, CONHOH 또는
Figure kpo00037
인 상응하는 화합물로 전환시킨다.1) Formula (I) compounds wherein R 1 is COZ, with or without acid scavenger
Figure kpo00034
, NH 2 OH or
Figure kpo00035
By treating R 1 as
Figure kpo00036
, CONHOH or
Figure kpo00037
Is converted to the corresponding compound.

Figure kpo00038
Figure kpo00038

m) R1이 CN인 일반식(I) 화합물을 R1

Figure kpo00039
인 상응하는 화합물로 전환시킨다. 적합한 방법은 디메틸포름아미드중의 NH3로 처리하는 것이다.a m) R 1 is CN in the general formula (I) compounds R 1 is
Figure kpo00039
Is converted to the corresponding compound. A suitable method is to treat with NH 3 in dimethylformamide.

Figure kpo00040
Figure kpo00040

n) R1이 COZ,

Figure kpo00041
, CONHOH,
Figure kpo00042
또는 가수분해 공정에 의해 COOH 그룹으로 전환될 수 있는 기타의 비특정 그룹인 일반식(I)화합물을 산 또는 염기 가수분해하여 R1이 COOH인 본 발명 화합물로 전환시킨다.n) R 1 is COZ,
Figure kpo00041
, CONHOH,
Figure kpo00042
Or other non-specific group (I) compounds, which may be converted to COOH groups by a hydrolysis process, by acid or base hydrolysis to convert to compounds of the invention wherein R 1 is COOH.

Figure kpo00043
Figure kpo00043

o) R1이 COOH인 일반식(I)화합물을 적합한 용매중에서 적합한 유기 또는 알카리/알카리토금속염기로 처리하여 염으로 전환시킨다.o) A compound of formula (I) wherein R 1 is COOH is converted to a salt by treatment with a suitable organic or alkali / alkaline metal base in a suitable solvent.

Figure kpo00044
Figure kpo00044

p) R이

Figure kpo00045
이고, R10이 저급알킬이며 X가 히드록시 또는 아미노가 아닌 일반식(XXXI) 화합물을 강염기로 처리한 후 적합한 친전자체로 처리하여 R2가 할로겐 또는 저급알킬인 일반식(XXXII)화합물을 얻는다.p) R is
Figure kpo00045
Where R 10 is lower alkyl and X is not hydroxy or amino, and is treated with a strong base followed by a suitable electrophile to obtain a compound of formula (XXXII) wherein R 2 is halogen or lower alkyl. .

Figure kpo00046
Figure kpo00046

바람직한 염기는 n-부틸리튬이고 바람직한 친전자체는 브롬, 요오드, 염소, N-할로석신이미드 및 알킬할라이드다.Preferred bases are n-butyllithium and preferred electrophiles are bromine, iodine, chlorine, N-halosuccinimide and alkyl halides.

q) 일반식(XXXIII) 화합물을 아세트산과 같은 용매중에서 할로겐원소로 처리하여 일반식(VII) 화합물을 얻는다.q) The compound of formula (XXXIII) is treated with a halogen element in a solvent such as acetic acid to give a compound of formula (VII).

Figure kpo00047
Figure kpo00047

상기식중 R2는 수소 또는 할로겐이고 R10은 수소 또는 저급알킬이며 R은

Figure kpo00048
이고 X는 할로겐이고 R3및 R4또는 이들 모두가 할로겐이 될 수 있다.Wherein R 2 is hydrogen or halogen and R 10 is hydrogen or lower alkyl and R is
Figure kpo00048
And X is halogen and R 3 and R 4 or both may be halogen.

r) 일반식(Ie) 화합물을 빙초산중의 질산으로 니트로화 하여 일반식(If)의 상응하는 화합물을 얻는다.r) The compound of formula (Ie) is nitrated with nitric acid in glacial acetic acid to give the corresponding compound of formula (If).

Figure kpo00049
Figure kpo00049

상기식에서 m은 1 또는 2이고 X는 NO2가 아니다.Wherein m is 1 or 2 and X is not NO 2 .

s) 일반식) Ig) 화합물을 탈알킬화하여 x가 히드록시인 상응하는 화합물을 얻는다.s) general formula) Ig) dealkylation of the compound to give the corresponding compound wherein x is hydroxy.

Figure kpo00050
Figure kpo00050

상기식에서 R은

Figure kpo00051
또는
Figure kpo00052
이고 x는 알콕시이다.Where R is
Figure kpo00051
or
Figure kpo00052
And x is alkoxy.

이 방법은 보론 트리브로마이드로 주의하여 처리한다.This method is carefully treated with boron tribromide.

t) x가 니트로인 것을 제외한 상기 공정 s)의 출발물질로서 기술된 화합물을 환원시키면 x가 아미노인 상응하는 화합물을 얻는다.t) Reduction of the compound described as starting material of step s) except that x is nitro gives the corresponding compound wherein x is amino.

이 방법에서는 에탄올성 염산수용액중의 철을 사용한다.In this method, iron in ethanol aqueous hydrochloric acid solution is used.

u) x가 아미노가 아닌 상기 공정 s)의 출발물질 화합물을 아실화하여 x가 아실아미노인 상응하는 본 발명화합물을 얻는다. 적합한 방법은 무수물로 아실화하는 것이다.u) Acylation of the starting compound of step s), wherein x is not amino, affords the corresponding compounds of the invention wherein x is acylamino. A suitable method is to acylate with anhydride.

v) R이 피리딜인 일반식(VII) 화합물을 산화제로 처리하여 R이

Figure kpo00053
인 상응하는 일반식(VII) 화합물을 얻는다.v) a compound of formula (VII) wherein R is pyridyl with an oxidant to
Figure kpo00053
To yield the corresponding compound of formula (VII).

적합한 산화제는 3-클로로-과벤조산이다.Suitable oxidizing agents are 3-chloro-perbenzoic acid.

상기 반응 단계의 반응시간과 정확한 반응의 조건은 사용된 특정의 반응물질과 용매에 따라 다르다.The reaction time of the reaction step and the conditions of the exact reaction depend on the specific reactants and solvent used.

모든 출발물질을 기지의 화합물이거나 또는 용이하게 구입할 수 있는 물질로부터 용이하게 제조될 수 있는 것이다.All starting materials are known compounds or can be readily prepared from readily available materials.

예를들면, 5-위치에 O-CH2-R1그룹이 존재하는 본 발명 화합물을 제조하는 a2), a4), a5), a12) 및 a13) 단계에서 사용될 수 있는 출발물질은 2-클로로-5-메톡시벤조산이다.For example, starting which can be used in steps a 2 ), a 4 ), a 5 ), a 12 ) and a 13 ) to prepare the compounds of the invention in which the O-CH 2 -R 1 group is present at the 5-position The substance is 2-chloro-5-methoxybenzoic acid.

이 물질은 공지의 방법에 의해 용이하게 구입할 수 있는 2-클로로-5-니트로아닐린으로부터 제조될수 있다. 예를 들면 디아조화 및 CuCN으로 처리하여 2-클로로-5-니트로 벤조니트릴을 수득한 후 에탄올성 염산 수용액중의 철분으로 환원시켜 5-아미노-2-클로로벤조니트릴을 얻고; 이어서 디아조화 반응으로 2-클로로-5-히드록시벤조니트릴을 얻고; 이어서 디메틸 설페이트로 메틸화하여 2-클로로-5-메톡시-벤조니트릴을 얻은 후 가수분해하여 2-클로로-5-메톡시-벤조산을 얻는다.This material can be prepared from 2-chloro-5-nitroaniline, which can be easily purchased by known methods. Treatment with diazotization and CuCN, for example, yields 2-chloro-5-nitro benzonitrile and then reduced with iron in an aqueous ethanol hydrochloric acid solution to give 5-amino-2-chlorobenzonitrile; Diazotization reaction then yields 2-chloro-5-hydroxybenzonitrile; It is then methylated with dimethyl sulfate to give 2-chloro-5-methoxy-benzonitrile and then hydrolyzed to give 2-chloro-5-methoxy-benzoic acid.

기타의 목적하는 치환 된 알콕시-오르토-할로벤조산, 알콕시 (히드록시)오르토-알콕시-(히드록시)벤조산, -알데히드 및 -니트릴 및 여러가지 할로-알콕시-(히드록시)-및 디알콕시(히드록시)-벤젠을 유사한 방법으로 또는 기타 통상의 방법으로 제조할 수 있다.Other desired substituted alkoxy-ortho-halobenzoic acids, alkoxy (hydroxy) ortho-alkoxy- (hydroxy) benzoic acids, -aldehydes and -nitriles and various halo-alkoxy- (hydroxy)-and dialkoxy (hydroxy ) -Benzene can be prepared in a similar manner or by other conventional methods.

본 발명화합물은 포유동물에서 이뇨작용을 일으키므로 이뇨제로서 유효하다. 이뇨작용은 다음 본문에 기술된 바와 유사한 방법으로 쥐에서 측정된다. [참조:C.M. Kagawa와 M.J. Kalm, Arch. Intern Pharmacodyn. 137,241(1962)].The compound of the present invention is effective as a diuretic because it causes diuretic action in mammals. Diuretic activity is measured in mice in a manner similar to that described in the following text. [See: C.M. Kagawa and M.J. Kalm, Arch. Intern Pharmacodyn. 137,241 (1962).

약물을 6마리 새앙쥐에게 경구투여하고 평균배설 뇨량을 기지의 이뇨제인 우레아 1000㎎/㎏을 경구투여한 새앙쥐 6마리의 대조그룹에서 배설된 평균 용적과 비교한다. 그 결과 약물/우레아의 비율이 1보다 크면 이뇨작용이 있다는 것을 나타내는 것이다. 본 발명 화합물과 표준 이뇨제인 티에닐산 및 에타크린산의 이뇨작용 시험 결과는 표 1과 같다.The drug is administered orally to six birds and the mean excretion urine volume is compared with the average volume excreted in the six control rats orally administered 1000 mg / kg of the known diuretic urea. As a result, a drug / urea ratio greater than 1 indicates that there is a diuretic effect. The diuretic test results of the compound of the present invention and the standard diuretics thienic acid and ethacrynic acid are shown in Table 1.

[표 1]TABLE 1

Figure kpo00054
Figure kpo00054

본 발명 화합물을 1일 0.1 내지 500㎎/㎏의 용량을 경구, 비경구 또는 정맥주사로 환자에게 투여했을 때 이뇨 작용을 나타낸다. 바람직한 용량 범위는 1.0 내지 200㎎/㎏이다.Diuretic effect is obtained when a compound of the present invention is administered to a patient by oral, parenteral or intravenous doses of 0.1 to 500 mg / kg per day. Preferred dosage ranges are 1.0 to 200 mg / kg.

본 발명 화합물은 또한 포유류에서 혈압 강하작용이 있기 때문에 항고혈압제로 유효하다. 항고혈압 작용은 간접적인 꼬리 때리기 방법으로 본태성 고혈압인 쥐에게 측정한다. [참조:A. Schwartz, Ed., Methods in Phamacology, voll, page 135, Appleton-Century-Crofts, New York, New York 1971]. 이방법에서는 5마리의 그룹에 3일간 약물을 경구투여하고 동일한 수의 대조그룹과 비교한다. 투여 후 3일째에 혈압 강하를 측정한다. 본 발명의 몇몇 화합물 시험에서의 항고혈압 작용(평균 동맥혈압의 ㎜ 감소로 표시)을 다음표 II에 나타낸다.The compound of the present invention is also effective as an antihypertensive agent because it has a blood pressure lowering effect in mammals. Antihypertensive action is measured in rats with essential hypertension by indirect tail hitting. [Reference: A. Schwartz, Ed., Methods in Phamacology, voll, page 135, Appleton-Century-Crofts, New York, New York 1971]. In this method, five groups were orally administered drug for 3 days and compared with the same number of control groups. Blood pressure drop is measured on day 3 after administration. The antihypertensive action (expressed in mm reduction in mean arterial blood pressure) in some compound tests of the present invention is shown in Table II.

[표 II]TABLE II

Figure kpo00055
Figure kpo00055

항고혈압 작용은 본 발명 화합물을 1일 0.1 내지 500㎎/㎏을 경구, 비경구 또는 정맥투여했을 때 유황하다. 바람직한 용량 범위는 1일 1.0 내지 200㎎/㎏ 이다.Antihypertensive action is sulfur when the compound of the present invention is administered orally, parenterally or intravenously at 0.1 to 500 mg / kg per day. Preferred dosage ranges are 1.0 to 200 mg / kg per day.

본발명 화합물은 포유동물에서 뇨산배설을 증진 시키기 때문에 뇨산뇨증 치료제로서 유효하다. 뇨산배설작용은 6마리의 위스타계 쥐의 그룹에 충분량의 증류수에 현탁 또는 용해한 시험 화합물을 25㎎/㎏ 용량 경구투여하여 측정한다. 상응하는 대조그룹에는 물만을 동일량 투여한다. 뇨를 5시간 동안 수집하고 뇨산의 양을 유리코스퀀트(UricosquantR)시약을 사용하여 애보트 바이오크로마틱 분석기(Abbott Biochromatic Analyzer)로 측정한다. 각 그룹에 대한 결과는 쥐의 ㎏당 배설된 뇨산의 평균 ㎎으로서 표시한다. 처리그룹은 대조그룹과 통계적인 유의성을 비교한다. 일반적으로, 2.5㎎ U.A/㎏ 이상이면 뇨산배설 작용이 있는 것으로 생각된다. 대표적 데이타는 표 III과 같다.The present invention is effective as a therapeutic agent for uric acid urination because it enhances uric acid excretion in mammals. Uric acid excretion is measured by oral administration of a test compound suspended or dissolved in a sufficient amount of distilled water in a group of six Wistar rats. Only the same amount of water is administered to the corresponding control group. Urine is collected for 5 hours and the amount of uric acid is measured with an Abbott Biochromatic Analyzer using a Uricosquant R reagent. Results for each group are expressed as mean mg of uric acid excreted per kg of rat. The treatment group compares statistical significance with the control group. Generally, it is considered that there is a uric acid excretion effect at 2.5 mg UA / kg or more. Representative data are shown in Table III.

[표 III]TABLE III

Figure kpo00056
Figure kpo00056

뇨산배설 작용은 본발명 화합물 1일 0.1 내지 500㎎/㎏ 용량을 경구, 비경구 또는 정맥으로 환자에게 투여했을때 유효하다. 바람직한 용량 범위는 1.0 내지 200㎎/㎏ 이다.Uric acid excretion is effective when a dose of 0.1 to 500 mg / kg of the compound of the present invention is administered orally, parenterally or intravenously. Preferred dosage ranges are 1.0 to 200 mg / kg.

본 발명은 화합물은 이뇨작용 및 뇨산배설 작용을 모두 지니는 특이한 잇점이 있다. 알려진 바와 같이, 많은 환자들은 통상의 이뇨제로 치료받는 동안 혈액중 뇨산농도의 증가를 경험한다. 상승된 뇨산의 농도는 통풍성 관절염 환자에게는 심각한 문제이다. 또한, 상승된 뇨산 농도는 심장혈 관계 질환이 있을 때 위험요소로 대두되고 있다. 따라서, 이뇨작용을 일으킴과 아울러 뇨산배설을 증가시키는 동시 작용은 여기에 기술된 화합물의 중요한 장점이다.The present invention has the unique advantage that the compound has both diuretic and uric acid excretion. As is known, many patients experience increased uric acid levels in the blood while being treated with conventional diuretics. Elevated uric acid levels are a serious problem for patients with gouty arthritis. In addition, elevated uric acid levels are emerging as a risk factor in cardiovascular disease. Therefore, the simultaneous action of causing diuretic action and increasing uric acid excretion is an important advantage of the compounds described herein.

본발명 화합물은 다음과 같다.The present compounds are as follows.

Figure kpo00057
Figure kpo00057

Figure kpo00058
Figure kpo00058

Figure kpo00059
Figure kpo00059

본 발명 화합물의 유효량을 여러 가지 방법으로 예를 들면 캅셀 또는 정제로서 경구로, 멸균용액 또는 현탁액으로 비경구로 어떤 경우에는 멸균용액으로 정맥투여할 수 있다. 유리산의 최종 생성물은 자체로도 유효하지만 안정성, 결정화가 편리함, 용해도 증가등의 면에서 약학적으로 무독한 염의 형태로 제형화하여 투여할 수 있다.An effective amount of a compound of the present invention may be administered orally in a variety of ways, eg as capsules or tablets, parenterally in sterile solutions or suspensions and, in some cases, sterile solutions. The final product of the free acid is effective on its own but can be administered in the form of a pharmaceutically toxic salt in terms of stability, ease of crystallization and increased solubility.

본 발명의 활성화합물은 불활성 희석제 또는 식용담체와 함께 경구투여하거나 또는 젤라틴 캅셀중에 충진시키거나 정제로 압착시킬 수 있다. 경구투여용으로는 본 발명의 활성화합물을 부형제와 혼합하여 정제, 트로치, 캅셀, 엘릭서, 현탁액, 시럽, 오블라아토(wafer), 츄잉검 등과 같은 제형으로 사용한다. 이와 같은 제제는 적어도 0.5%의 활성화합물을 함유하나 특정의 제형에 따라 다르고 단위중량이 4% 내지 70%인 것이 편리하다. 이와 같은 조성물중의 활성화합물의 량은 적합한 용량에 따른다.The active compounds of the present invention can be administered orally with an inert diluent or edible carrier, or packed into gelatin capsules or compressed into tablets. For oral administration, the active compounds of the present invention are mixed with excipients and used in the form of tablets, troches, capsules, elixirs, suspensions, syrups, oblato, chewing gum and the like. Such formulations contain at least 0.5% of active compound, but are dependent on the particular formulation and conveniently have a unit weight of 4% to 70%. The amount of active compound in such a composition depends on the suitable dose.

본 발명에 따르는 바람직한 조성물 및 제제는 경구용 단위용량 제형이 1.0 내지 300㎎의 활성화합물을 함유하도록 제조된 것이다.Preferred compositions and preparations according to the invention are prepared so that oral unit dosage forms contain 1.0 to 300 mg of active compound.

정제, 환제, 캅셀제, 트로치 등은 다음의 성분을 함유할 수 있다. 미세 결정 셀루로즈, 검 트라가칸트 또는 젤라틴과 같은 결합제; 전분 또는 유당과 같은 부형제; 알긴산, 프리모겔, 옥수수전분 등과 같은 붕해제; 마그네슘 스테아레이트 또는 스테로텍스와 같은 활탁제; 콜로이드성 실리콘 디옥사이드와 같은 윤활제; 서당 또는 사카린과 같은 감미제를 가하거나 페퍼민트, 메틸 살리실레이트 또는 오렌지방향제와 같은 방향제를 가할 수 있다.Tablets, pills, capsules, troches, and the like may contain the following components. Binders such as microcrystalline cellulose, gum tragacanth or gelatin; Excipients such as starch or lactose; Disintegrants such as alginic acid, primogel, corn starch and the like; Lubricants such as magnesium stearate or sterotex; Lubricants such as colloidal silicon dioxide; Sweeteners such as sucrose or saccharin can be added or fragrances such as peppermint, methyl salicylate or orange fragrance.

단위용량 제형이 캅셀일 때는 상기 물질뿐만 아니라 지방유 같은 액체 담체를 함유할 수 있다. 기타의 단위용량 제형은 제피물질과 같은 용량단위의 물리적 형태를 변화시키는 여러가지 물질을 함유할 수 있다.When the unit dosage form is a capsule, it may contain not only said substance but also a liquid carrier such as fatty oil. Other unit dosage forms may contain various materials that change the physical form of the dosage unit, such as a coating material.

따라서 정제 또는 환제는 당, 셀락 또는 기타 장용 피복제로 피복시킬 수 있다. 시럽은 활성화합물뿐만 아니라 감미제로서 서당 및 특정보존제, 염료 및 착색제 및 방향제를 함유할 수 있다. 이들의 여러가지 조성물을 제조하는데 사용되는 물질은 약학적으로 순수하고 상용량에서 무독하여야 한다.Thus tablets or pills can be coated with sugars, shellac or other enteric coatings. Syrups may contain sucrose and certain preservatives, dyes and colorants and fragrances as sweeteners as well as active compounds. The materials used to prepare these various compositions should be pharmaceutically pure and nontoxic at normal doses.

치료목적으로 비경구 투여할 경우에는 본 발명 활성화합물을 용액 또는 현탁액으로 제조한다.For parenteral administration for therapeutic purposes, the active compounds of the present invention are prepared as solutions or suspensions.

이들 제제는 적어도 0.1%의 활성 화합물을 함유하나 0.5 내지 30중량%로 변화시킬 수 있다. 이들 조성물중 활성화합물의 량은 적합한 용량에 따른다. 본 발명에 따르는 바람직한 조성물 및 제제는 비경구단위 용량에 활성화합물이 0.5 내지 100㎎ 함유된 것이다.These formulations contain at least 0.1% of active compound but can vary from 0.5 to 30% by weight. The amount of active compound in these compositions depends on the suitable dose. Preferred compositions and preparations according to the invention are those which contain from 0.5 to 100 mg of the active compound in a parenteral dosage.

용액 또는 현탁액 또한 다음 화합물을 함유할 수 있다; 주사용수, 식염수, 비휘발성오일, 폴리에틸렌글리콜, 글리세린, 프로필렌 글리콜 또는 기타의 합성용매와 같은 무균 희석제; 벤질알콜 또는 메틸 파라벤같은 항균제; 아스코르브산 또는 황산수소나트륨 같은 항산화제; 에틸렌디아민테트라 아세트산과 같은 킬레이트제; 아세테이트, 시트레이트 또는 포스페이트와 같은 완충제와 염화나트륨 또는 덱스트로즈와 같은 농도 조절용 시약. 비경구 제제는 유리 또는 플라스틱으로 제조된 앰플, 1회용 시린지 또는 수회용 바이알에 충진시킬 수 있다.Solutions or suspensions may also contain the following compounds; Sterile diluents such as water for injection, saline, nonvolatile oil, polyethylene glycol, glycerin, propylene glycol or other synthetic solvents; Antibacterial agents such as benzyl alcohol or methyl parabens; Antioxidants such as ascorbic acid or sodium hydrogen sulfate; Chelating agents such as ethylenediaminetetra acetic acid; Buffers such as acetate, citrate or phosphate and reagents for concentration adjustment such as sodium chloride or dextrose. Parenteral preparations may be filled in ampoules, disposable syringes or disposable vials made of glass or plastic.

대표적 화합물 및 방법을 이용한 다음 실시예에서 본 발명을 더욱 설명한다.The invention is further illustrated in the following examples using representative compounds and methods.

[실시예 1]Example 1

a. 100㎖의 디클로로 에탄중의 31.6g의 2-플루오로벤조일 클로라이드 용액에 26.5g의 염화알루미늄을 30분에 걸쳐 가한다. 완전히 가하면 혼합물이 황색으로 변하고 다시 검게 된다. 그 후에 암색의 혼합물에 50㎖의 1,2-디클로로에탄중 32g의 2,3-디클로로아니졸 용액을 적가한다. 완전히 가한후에 혼합물을 2시간동안 진탕하고 100의 농염산과 100㎖의 분쇄한 얼음에 붓는다.a. To 31.6 g of 2-fluorobenzoyl chloride solution in 100 ml of dichloro ethane is added 26.5 g of aluminum chloride over 30 minutes. Upon complete addition the mixture turns yellow and becomes black again. To the dark mixture is then added dropwise a solution of 32 g of 2,3-dichloroanisol in 50 ml of 1,2-dichloroethane. After complete addition the mixture is shaken for 2 hours and poured into 100 concentrated hydrochloric acid and 100 ml of crushed ice.

두 가지상의 혼합물중 유기상을 감압하에서 증발시키고 수용성 혼합물을 에테르로 추출한다. 함한 에테르 추출물을 10% 탄산칼륨용액 및 물로 세척하고 탈수하고 에테르를 증발 건고하여 회백색 고형물질이 잔류되면 이를 에테르-헥산 혼합물로 재결정하여 융점이 74° 내지 77℃인 2'-플루오로-4-메톡시-2,3-디클로로벤조페논을 얻는다.The organic phase in the mixture of two phases is evaporated under reduced pressure and the aqueous mixture is extracted with ether. The ether extract was washed with 10% potassium carbonate solution and water, dehydrated and the ether was evaporated to dryness. When an off-white solid remained, it was recrystallized from an ether-hexane mixture to give a 2'-fluoro-4- having a melting point of 74 ° to 77 ° C. Obtain methoxy-2,3-dichlorobenzophenone.

b. 38.5g의 2'-플루오로-4-메톡시-2,3-디클로로 벤조페논과 250㎖의 벤젠중의 34.7g의 염화알루미늄을 5시간동안 환류시키고 100㎖의 농염산과 100㎖의 얼음의 혼합물에 붓는다. 두 가지상의 혼합물을 에틸아세테이트로 추출하고 모은 추출물을 탈수하고 농축 건조시켜 고형잔류물을 얻는다. 잔류물을 헥산으로 처리하고 생성된 고형물질을 에테르-헥산 혼합물로부터 재결정하여 2,3-디클로로-4-히드록시-2'-플루오로-벤조페논을 얻는다. 융점 : 128° 내지 131℃.b. 38.5 g of 2'-fluoro-4-methoxy-2,3-dichloro benzophenone and 34.7 g of aluminum chloride in 250 ml of benzene were refluxed for 5 hours and a mixture of 100 ml of concentrated hydrochloric acid and 100 ml of ice was added. Pour into. The mixture of two phases is extracted with ethyl acetate and the combined extracts are dehydrated and concentrated to dryness to obtain a solid residue. The residue is treated with hexane and the resulting solid is recrystallized from an ether-hexane mixture to give 2,3-dichloro-4-hydroxy-2'-fluoro-benzophenone. Melting point: 128 ° to 131 ° C.

c. 31.8g의 2,3-디클로로-4-히드록시-2'-플루오로-벤조페논과 150㎖의 피리딘중의 15.3g의 히드록시아민 염산염을 64시간 동안 환류시킨다. 그 후에 피리딘을 감압하에서 증발시키고 5% 염산 수용액을 가한다. 산성화된 용액을 에틸 아세테이트로 추출하고 모은 추출물을 농축건조하기 전에 탈수시킨다. 생성된 고형물질을 에탄올 수용액으로 재결정하여 2,3-디클로로-4-히드록시-2'-플루오로벤조페논 욕심을 얻는다. 융점 : 168° 내지 175℃.c. 31.8 g of 2,3-dichloro-4-hydroxy-2'-fluoro-benzophenone and 15.3 g of hydroxyamine hydrochloride in 150 ml of pyridine are refluxed for 64 hours. The pyridine is then evaporated under reduced pressure and 5% hydrochloric acid aqueous solution is added. The acidified solution is extracted with ethyl acetate and the combined extracts are dehydrated before being concentrated to dryness. The resulting solid material is recrystallized from an aqueous ethanol solution to obtain 2,3-dichloro-4-hydroxy-2'-fluorobenzophenone greedy. Melting point: 168 ° to 175 ° C.

d. 120㎖의 디메틸포름아미드와 120㎖의 벤젠중의 18.4g의 2,3-디클로로-4-히드록시-2'-플루오로 벤조페논 옥심과 3.6g의 나트륨 하이드라이드를 80 내지 85℃에서 3시간 동안 유지시킨다. 그후에 혼합물을 주위온도로 만들고 30㎖의 디메틸포름아미드중의 11.0g의 에틸브로모 아세테이트를 적가한다.d. 18.4 g of 2,3-dichloro-4-hydroxy-2'-fluoro benzophenone oxime and 3.6 g of sodium hydride in 120 ml of dimethylformamide and 120 ml of benzene for 3 hours Keep it on. The mixture is then brought to ambient temperature and 11.0 g of ethylbromo acetate in 30 ml of dimethylformamide is added dropwise.

완전히 적가후에, 혼합물을 30분간 진탕하고 물을 가해 여분의 나트륨 하이드라이드를 분해시킨다. 혼합물을 에틸 아세테이트로 추출하고 모은 추출물을 탈수하고 증발 건조하여 고형의 잔류물을 얻는다. 잔류물을 95% 에틸 알콜로 재결정하여 융점이 102° 내지 104℃인 순수한 에틸{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.After complete dropping, the mixture is shaken for 30 minutes and water is added to decompose the extra sodium hydride. The mixture is extracted with ethyl acetate and the combined extracts are dehydrated and evaporated to dryness to give a solid residue. The residue was recrystallized from 95% ethyl alcohol to give pure ethyl {[7-chloro-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} with a melting point of 102 ° to 104 ° C. Acetate is obtained.

Figure kpo00060
Figure kpo00060

[실시예 2]Example 2

10.0g의 에틸{[7-클로로-3-(2-플루오로페닐-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트, 100㎖의 10% 수산화나트륨 및 350㎖의 에틸알콜의 혼합물을 3.5시간 동안 환류시킨다. 에틸알콜을 감압하에서 제거하고 잔류물을 염산으로 산성화하여 고형침전을 생성한다. 침전물을 여과하여 수집하고 탈수한다. 탈수된 생성물을 95% 에틸알콜로 재결정하여 융점이 190° 내지 191℃인 생성물 {[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.10.0 g of ethyl {[7-chloro-3- (2-fluorophenyl-1,2-benzisooxazol-6-yl] oxy} acetate, a mixture of 100 ml of 10% sodium hydroxide and 350 ml of ethyl alcohol The mixture is refluxed for 3.5 hours, the ethyl alcohol is removed under reduced pressure and the residue is acidified with hydrochloric acid to produce a solid precipitate The precipitate is collected by filtration and dehydrated The dehydrated product is recrystallized from 95% ethyl alcohol to give a melting point of 190 The product {[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetic acid is obtained at ° C to 191 ° C.

[실시예 3]Example 3

a. 3.8g의 (2,3-디클로로-4-히드록시페닐)-2'-티에닐메타논과 2.0g의 히드록실아민 염산염의 혼합물을 20㎖의 피리딘중에서 6시간 동안 환류시킨다. 그 후에, 피리딘을 감압하에서 증발시킨다. 잔류물에 5% 염산을 가하고 혼합물을 산성화하여 에틸 아세테이트로 추출한다. 추출물을 물로 세척하고 탈수하고 증발 건조시킨다. 잔류물을 물과 에탄올의 혼합물로 재결정하여 융점이 179 내지 183℃인 (2,3-디클로로-4-히드록시페닐)-2'-티에닐메타논 옥심을 얻는다.a. A mixture of 3.8 g of (2,3-dichloro-4-hydroxyphenyl) -2'-thienylmethanone and 2.0 g of hydroxylamine hydrochloride is refluxed in 20 ml of pyridine for 6 hours. Thereafter, pyridine is evaporated under reduced pressure. 5% hydrochloric acid is added to the residue and the mixture is acidified and extracted with ethyl acetate. The extract is washed with water, dehydrated and evaporated to dryness. The residue is recrystallized from a mixture of water and ethanol to give (2,3-dichloro-4-hydroxyphenyl) -2'-thienylmethanone oxime having a melting point of 179 to 183 ° C.

b. 30㎖의 디메틸포름아미드와 30㎖의 톨루엔중의 3.0g의 (2,3-디클로로-4-히드록시-페닐)-2'-티에닐메타논옥심의 혼합물에 0.62g의 나트륨 히드라이드를 가한다. 그 후에 반응 혼합물을 100℃에서 2시간동안 115℃에서 2.5시간 동안 유지시킨다. 혼합물을 냉각하고 여기에 10㎖의 디메틸포름아미드중의 1.9g의 에틸브로모아세테이트 용액을 적가한다. 완전히 가한 후에, 반응 혼합물을 2.25시간 동안 진탕하고 물을 가해 과잉의 나트륨 히드라이드를 분해시킨다. 반응 혼합물을 에틸 아세테이트로 추출하고 추출물을 물로 세척하고 탈수하고 증발시킨다. 잔류물을 에탄올로 재결정하여 융점이 142 내지 143℃인 에틸{[7-클로로-3-(2-티에닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.b. 0.62 g of sodium hydride was added to a mixture of 30 g of dimethylformamide and 3.0 g of (2,3-dichloro-4-hydroxy-phenyl) -2'-thienylmethanone oxime in 30 ml of toluene. do. The reaction mixture is then held at 100 ° C. for 2 hours at 115 ° C. for 2.5 hours. Cool the mixture and add dropwise 1.9 g of ethyl bromoacetate solution in 10 ml of dimethylformamide. After complete addition, the reaction mixture is shaken for 2.25 hours and water is added to decompose excess sodium hydride. The reaction mixture is extracted with ethyl acetate and the extract is washed with water, dehydrated and evaporated. The residue is recrystallized from ethanol to give ethyl {[7-chloro-3- (2-thienyl) -1,2-benzisoxazol-6-yl] oxy} acetate having a melting point of 142 to 143 ° C.

Figure kpo00061
Figure kpo00061

[실시예 4]Example 4

a. 100㎖의 피리딘중의 18.0g의 2,3-디클로로-4-히드록시-벤조페논과 9.3g의 히드록실아민 염산염의 용액을 2시간 동안 환류시킨다. 그 후에 피리딘을 감압하에서 증발시키고 잔류용액을 5% 염산과 에틸아세테이트 사이에서 분배시킨다. 에틸아세테이트 추출물을 물로 세척하고 탈수하고 증발하여 2,3-디클로로-4-히드록시 벤조페논옥심을 얻는다.a. A solution of 18.0 g 2,3-dichloro-4-hydroxy-benzophenone and 9.3 g hydroxylamine hydrochloride in 100 ml pyridine is refluxed for 2 hours. The pyridine is then evaporated under reduced pressure and the remaining solution is partitioned between 5% hydrochloric acid and ethyl acetate. The ethyl acetate extract is washed with water, dehydrated and evaporated to give 2,3-dichloro-4-hydroxy benzophenone oxime.

전술한 2,3-디클로로-4-히드록시벤조페논을 실시예 1(a)와 (b)에서 기술된 방법으로 2-플루오로 벤조일염산염 대신에 염화벤조일을 사용하여 제조한다.The above-mentioned 2,3-dichloro-4-hydroxybenzophenone is prepared using benzoyl chloride instead of 2-fluoro benzoyl hydrochloride by the method described in Examples 1 (a) and (b).

b. 50㎖의 디메틸포름아미드와 50㎖의 톨루엔중의 2,3-디클로로-4-히드록시벤조페논옥심과 2.6g의 나트륨 히드라이드의 용액을 118℃로 가열하고 50분간 유지시킨다. 그 후에, 반응물을 냉각하고 50㎖의 디메틸포름아미드중의 7.9g의 에틸 브로모 아세테이트를 적가한다. 완전히 적가한 후에 반응 혼합물을 주위온도에서 40분간 진탕한다. 진탕 혼합물에 물을 적가하여 과잉의 나트륨 히드라이드를 분해시킨다. 톨루엔은 감압하에서 증발하고 생성된 침전물을 여과하여 모으고 에테르로 세척하여 융점이 130° 내지 132℃인 에틸 [(7-클로로-3-페닐-1,2-벤즈이소옥사졸-6-일)옥시] 아세테이트를 얻는다.b. A solution of 2,3-dichloro-4-hydroxybenzophenone oxime and 2.6 g sodium hydride in 50 ml of dimethylformamide and 50 ml of toluene was heated to 118 ° C. and held for 50 minutes. Thereafter, the reaction is cooled and 7.9 g of ethyl bromo acetate in 50 ml of dimethylformamide is added dropwise. After complete dropping the reaction mixture is shaken for 40 minutes at ambient temperature. Water is added dropwise to the shake mixture to break up excess sodium hydride. Toluene was evaporated under reduced pressure and the resulting precipitate was collected by filtration and washed with ether to give ethyl [(7-chloro-3-phenyl-1,2-benzisoxazol-6-yl) oxy] having a melting point of 130 ° to 132 ° C. Acetate is obtained.

Figure kpo00062
Figure kpo00062

[실시예 5]Example 5

160㎖의 에틸 알콜중의 8.3g의 에틸[7-클로로-3-페닐-1,2-벤즈이소옥사졸-6-일)옥시]아세테이트의 용액에 6㎖의 7N 수산화나트륨을 가한다. 그후에, 반응 혼합물을 45분간 환류시킨다. 침전물을 여과시켜 모으고 에틸 알콜 및 물로 세척한다. 침전물을 200㎖의 온수에 현탁시키고 이 혼합물을 농염산으로 산성화한다. 산성화된 혼합물을 1시간 동안 진탕하고 회색 침전물을 여과하여 모은다. 침전물을 에틸 아세테이트로 재결정하여 융점이 219° 내지 221℃인 순수한 [(7-클로로-3-페닐-1,2-벤즈이소옥사졸-6-일)옥시] 아세트산을 얻는다.To a solution of 8.3 g ethyl [7-chloro-3-phenyl-1,2-benzisooxazol-6-yl) oxy] acetate in 160 ml ethyl alcohol is added 6 ml 7N sodium hydroxide. Thereafter, the reaction mixture is refluxed for 45 minutes. The precipitate is collected by filtration and washed with ethyl alcohol and water. The precipitate is suspended in 200 ml of warm water and the mixture is acidified with concentrated hydrochloric acid. The acidified mixture is shaken for 1 hour and the gray precipitate is collected by filtration. The precipitate is recrystallized from ethyl acetate to give pure [(7-chloro-3-phenyl-1,2-benzisoxazol-6-yl) oxy] acetic acid having a melting point of 219 ° to 221 ° C.

Figure kpo00063
Figure kpo00063

[실시예 6]Example 6

19.8g의 3,2-디클로로-4-히드록시페닐-2'-푸릴메타는 옥심을 200㎖의 디메틸포름아미드에 용해하고 4.8g의 나트륨 히드라이드를 가한다. 수소 가스발생이 끝난 후에 반응 혼합물을 130℃까지 가열한다.19.8 g of 3,2-dichloro-4-hydroxyphenyl-2'-furylmeth dissolve oxime in 200 ml of dimethylformamide and add 4.8 g of sodium hydride. After the hydrogen gas evolution is over, the reaction mixture is heated to 130 ° C.

혼합물을 5℃까지 냉각하고 냉각 혼합물을 20㎖의 디메틸포름아미드중의 16.7g 용액에 가한다. 45분간 진탕후에 반응 혼합물을 물에 부어 결정성 생성물을 얻는다.The mixture is cooled to 5 ° C. and the cooling mixture is added to a 16.7 g solution in 20 ml of dimethylformamide. After shaking for 45 minutes, the reaction mixture is poured into water to give the crystalline product.

생성물을 여과시켜 모아서 에틸 알콜 및 에테르로 세척하고 에틸 알콜-에틸 아세테이트 혼합물로 재결정하여 에틸 [(7-클로로-3-(2-푸릴)-1,2-벤즈이소옥사졸-6일)옥시] 아세테이트를 얻는다.The product was collected by filtration, washed with ethyl alcohol and ether, recrystallized from ethyl alcohol-ethyl acetate mixture to ethyl [(7-chloro-3- (2-furyl) -1,2-benzisoxazol-6yl) oxy] acetate Get

Figure kpo00064
Figure kpo00064

[실시예 7]Example 7

500㎖의 비등하는 95% 에틸 알콜중의 15.0g의 에틸 {[(7-클로로-3-(2-푸릴)-1,2-벤즈이소옥사졸-6-일)]옥시} 아세테이트의 비등현탁액에 10㎖의 50% 수산화나트륨을 가해서 나트륨염을 침전시킨다.To a boiling suspension of 15.0 g of ethyl {[(7-chloro-3- (2-furyl) -1,2-benzisoxazol-6-yl)] oxy} acetate in 500 ml of boiling 95% ethyl alcohol 10 ml of 50% sodium hydroxide is added to precipitate the sodium salt.

300㎖의 95% 에틸 알콜을 가하고 30분간 비등시킨다. 반응 혼합물을 서서히 냉각시키고 100㎖의 5% 염산 용액을 가한다. 생성물을 냉각시키면서 분리하고 250㎖의 물을 가하여 희석된 혼합물을 얼음으로 냉각시킨다. 침전물을 여과시켜 모으고 이소프로필 알콜로 재결정하여 융점이 230° 내지 233℃인 {[7-클로로-3-(2-푸릴)-1,2-벤즈이소옥사졸-6-일옥시} 아세테이트를 얻는다.300 ml of 95% ethyl alcohol is added and boiled for 30 minutes. The reaction mixture is cooled slowly and 100 ml of 5% hydrochloric acid solution is added. The product is separated with cooling and 250 ml of water is added to cool the diluted mixture with ice. The precipitate is collected by filtration and recrystallized with isopropyl alcohol to give {[7-chloro-3- (2-furyl) -1,2-benzisoxazol-6-yloxy} acetate having a melting point of 230 ° to 233 ° C.

Figure kpo00065
Figure kpo00065

[실시예 8]Example 8

a. 28.3g의 (2,3-디클로로-4-히드록시페닐-(5'-메틸-2'-티에닐)메타논과 14.0g의 히드록실아민 염산염을 300㎖의 피리딘중에서 16시간 동안 환류시킨다. 그 후에 용매를 감압하에서 제거하고 잔류물을 5% 염산으로 처리한다. 처리된 잔류물을 디클로로에탄과 에테르 혼합물로 추출하고 탈수하고 용매를 증발 제거시킨다. 생성물을 헥산으로 처리하면 목적하는 옥심, (2,3-디클로로-4-히드록시페닐)-(5'-메틸-2'-티에닐)메타논 옥심이 생성된다.a. 28.3 g of (2,3-dichloro-4-hydroxyphenyl- (5'-methyl-2'-thienyl) methanone and 14.0 g of hydroxylamine hydrochloride are refluxed in 300 ml of pyridine for 16 hours. The solvent is then removed under reduced pressure and the residue is treated with 5% hydrochloric acid The treated residue is extracted with dichloroethane and ether mixture and dehydrated and the solvent is evaporated off.The product is treated with hexane to give the desired oxime, (2 , 3-dichloro-4-hydroxyphenyl)-(5'-methyl-2'-thienyl) methanone oxime is produced.

b. 200㎖의 디메틸포름아미드중의 상기 옥심 혼합물에 5.3g의 나트륨 히드라이드를 가한다. 반응 혼합물을 120℃에서 1.5시간 동안 유지하고 130℃에서 1시간 동안 140℃에서 1시간 동안 유지한 후 35℃로 냉각한다. 냉각 혼합물에 20㎖의 디메틸포름아미드중의 13.3g의 에틸 브로모아세테이트를 가하고 혼합물을 20분간 진탕한다. 반응 혼합물을 염화나트륨 포화용액에 부어 결정성 생성물을 얻어 이것을 여과하여 모은다. 생성물을 메틸 알콜 및 에테르로 세척한 후 이소프로필 알콜로 재결정하여 융점이 149° 내지 150℃인 에틸 {[7-클로로-3-(5-메틸-2-티에닐)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.b. 5.3 g of sodium hydride is added to the oxime mixture in 200 ml of dimethylformamide. The reaction mixture is maintained at 120 ° C. for 1.5 hours and at 130 ° C. for 1 hour at 140 ° C. for 1 hour and then cooled to 35 ° C. To the cold mixture is added 13.3 g of ethyl bromoacetate in 20 ml of dimethylformamide and the mixture is shaken for 20 minutes. The reaction mixture is poured into saturated sodium chloride solution to obtain a crystalline product which is collected by filtration. The product was washed with methyl alcohol and ether and then recrystallized with isopropyl alcohol to yield ethyl {[7-chloro-3- (5-methyl-2-thienyl) -1,2-benzisoocta having a melting point of 149 ° to 150 ° C. Sazol-6-yl] oxy} acetate.

Figure kpo00066
Figure kpo00066

[실시예 9]Example 9

(2,3-디클로로-4-히드록시페닐)-(5'-메틸-3'-푸릴)메타논 대신 (2,3-디클로로-4-히드록시페닐)-(5'-메틸-2'-티에닐)메타논을 사용하고 실시예 8(a)에 기술된 방법을 시행한 후 실시예 8(b)에 기술된 방법에 의해 융점이 139° 내지 141℃인 에틸 {[7-클로로-3-(5-메틸-2-푸릴)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.(2,3-dichloro-4-hydroxyphenyl)-(5'-methyl-2 'instead of (2,3-dichloro-4-hydroxyphenyl)-(5'-methyl-3'-furyl) methanone -Thienyl) methanone and following the method described in Example 8 (a) followed by the method described in Example 8 (b) with ethyl {[7-chloro- with a melting point of 139 ° to 141 ° C. 3- (5-methyl-2-furyl) -1,2-benzisoxazol-6-yl] oxy} acetate is obtained.

Figure kpo00067
Figure kpo00067

[실시예 10]Example 10

100㎖의 에틸 알콜중의 15.0g의 에틸 {[7-클로로-3-(5-메틸-2-푸릴)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트 현탁액에 10㎖의 50% 수산화나트륨 용액을 가한다. 반응 혼합물을 1.5시간 동안 강하게 진탕하면서 환류시키고 100㎖의 5%염산을 가한다. 생성 용액을 냉각하고 물로서 희석하고 생성물을 침전시킨다. 생성물을 여과하여 모으고 메틸 알콜로 재결정하여 융점이 217°내지 219℃인 {[7-클로로-3-(5-메틸-2-푸릴)-1,2-벤즈 이소옥사졸-6-일]옥시} 아세트산을 얻는다.10 mL of 50 in 15.0 g of ethyl {[7-chloro-3- (5-methyl-2-furyl) -1,2-benzisoxazol-6-yl] oxy} acetate suspension in 100 mL of ethyl alcohol % Sodium hydroxide solution is added. The reaction mixture is refluxed with vigorous shaking for 1.5 hours and 100 ml of 5% hydrochloric acid is added. The resulting solution is cooled, diluted with water and the product precipitates out. The product was collected by filtration and recrystallized with methyl alcohol to obtain {[7-chloro-3- (5-methyl-2-furyl) -1,2-benzisoxazol-6-yl] oxy having a melting point of 217 ° to 219 ° C. } Get acetic acid.

Figure kpo00068
Figure kpo00068

[실시예 11]Example 11

a. 2,3-디클로로-4-히드록시-4-메틸-벤조 페논과 12.5g의 히드록실아민 염산염의 혼합물을 200㎖의 피리딘중에서 2시간 동안 환류시킨다. 그후에 피리딘을 감압하에서 증발시키고 잔류물을 에틸 아세테이트와 5%염산 사이에서 분배시킨다. 에틸 아세테이트 추출물을 물로 세척하고 탈수하고 농축 건조시켜 2,3-디클로로-4-히드록시-4'-메틸벤조 페논 옥심을 얻는다.a. A mixture of 2,3-dichloro-4-hydroxy-4-methyl-benzo phenone and 12.5 g of hydroxylamine hydrochloride is refluxed in 200 ml of pyridine for 2 hours. The pyridine is then evaporated under reduced pressure and the residue is partitioned between ethyl acetate and 5% hydrochloric acid. The ethyl acetate extract is washed with water, dehydrated and concentrated to dryness to afford 2,3-dichloro-4-hydroxy-4'-methylbenzo phenone oxime.

b. 상기 옥심과 5.2g의 나트륨 히드라이드의 혼합물을 300㎖의 디메틸포름 아미드중에서 87℃에서 3시간동안 유지시킨다. 혼합물을 주위온도까지 냉각하고 50㎖의 디메틸포름아미드중의 16.0g의 에틸 브로모 아세테이트를 적가한다. 완전히 적가한 후에 혼합물을 30분간 진탕하고 물에 부어 융점이 157내지 159℃인 에틸 {[7-클로로-3-(4-톨릴)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.b. The mixture of oxime and 5.2 g of sodium hydride is held in 300 ml of dimethylformamide at 87 ° C. for 3 hours. The mixture is cooled to ambient temperature and 16.0 g of ethyl bromo acetate in 50 ml of dimethylformamide is added dropwise. After complete dropping, the mixture was shaken for 30 minutes and poured into water to yield ethyl {[7-chloro-3- (4-tolyl) -1,2-benzisoxazol-6-yl] oxy} acetate with a melting point of 157 to 159 ° C. Get

[실시예 12]Example 12

20g의 에틸 {[7-클로로-3-(4-톨릴)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트와 15㎖의 50% 수산화나트륨의 혼합물을 600㎖의 에틸 알콜중에서 1시간 동안 환류시킨다. 그 후에 더운 혼합물을 500㎖의 물로 희석하고 농염산으로 산성화한다. 산성화된 현탁액을 30분간 진탕하고 여과하고 여과 케이크를 디메틸포름아미드로 재결정하여 융점이 257내지 260℃인 {[7-클로로-3-(4-톨릴)-1,2-1,2-벤즈 이소옥사졸-6-일]옥시} 아세트산을 얻는다.A mixture of 20 g ethyl {[7-chloro-3- (4-tolyl) -1,2-benzisooxazol-6-yl] oxy} acetate and 15 ml of 50% sodium hydroxide in 1 ml of 600 ml ethyl alcohol Reflux for time. The hot mixture is then diluted with 500 ml of water and acidified with concentrated hydrochloric acid. The acidified suspension was shaken for 30 minutes, filtered and the filter cake was recrystallized from dimethylformamide to obtain {[7-chloro-3- (4-tolyl) -1,2-1,2-benziso having a melting point of 257 to 260 ° C. Oxazol-6-yl] oxy} acetic acid.

Figure kpo00069
Figure kpo00069

[실시예 13]Example 13

a. 41g의(2,3-디클로로-4-히드록시페닐)-4'-클로로벤조페논과 18.9g의 히드록실아민 염산염의 혼합물을 300㎖의 피리딘중에서 2시간 동안 환류시킨다. 그 후에 피리딘을 감압하에서 제거하고 잔류물을 에틸아세테이트와 5%염산 사이에서 분배한다. 에틸 아세테이트를 물로 세척하고 탈수하고 농축 건조하여, 3,3-디클로로-4-히드록시-4'-클로로벤조페논 옥심을 얻는다.a. A mixture of 41 g of (2,3-dichloro-4-hydroxyphenyl) -4'-chlorobenzophenone and 18.9 g of hydroxylamine hydrochloride is refluxed in 300 ml of pyridine for 2 hours. The pyridine is then removed under reduced pressure and the residue is partitioned between ethyl acetate and 5% hydrochloric acid. Ethyl acetate is washed with water, dehydrated and concentrated to dryness to afford 3,3-dichloro-4-hydroxy-4'-chlorobenzophenone oxime.

b. 41.5g의 옥심과 7.9g의 나트륨 히드라이드의 혼합물을 300㎖의 디메틸포름아미드중 111℃에서 2시간동안 유지한다. 그후에 반응 혼합물을 주위온도까지 냉각하고 그후에 50㎖의 디메틸포름아미드중의 23g의 에틸 브로모아세테이트의 혼합물을 적가한다. 완전히 적가한 후 반응 혼합물을 30분간 진탕하고 16시간동안 방치한다. 혼합물을 물에 부어 침전을 얻고 여과하여 융점이 179℃인 에틸 {[7-클로로-3-(4-페닐-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.b. A mixture of 41.5 g of oxime and 7.9 g of sodium hydride is maintained at 111 ° C. in 300 ml of dimethylformamide for 2 hours. The reaction mixture is then cooled to ambient temperature and then a mixture of 23 g of ethyl bromoacetate in 50 ml of dimethylformamide is added dropwise. After complete dropwise addition, the reaction mixture was shaken for 30 minutes and left for 16 hours. The mixture is poured into water to give a precipitate which is filtered to give ethyl {[7-chloro-3- (4-phenyl-1,2-benzisoxazol-6-yl] oxy} acetate having a melting point of 179 ° C.

[실시예 14]Example 14

25g의 에틸 {7-클로로-3-(4-클로로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트 및 20㎖의 50% 수산화나트륨의 혼합물을 에틸 알콜중에서 1시간 동안 환류시킨다. 더운 혼합물을 300㎖의 물로 희석하고 농염산으로 산성화한다. 산성화된 혼합물을 30분간 진탕하고 여과하고 여과 케이크를 디메틸포름아미드-에틸 아세테이트 혼합물로 재결정하여 융점이 254℃내지 257℃인 {[7-클로로-3-(4-클로로페닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.A mixture of 25 g of ethyl {7-chloro-3- (4-chlorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetate and 20 ml of 50% sodium hydroxide at reflux in ethyl alcohol for 1 hour Let's do it. The hot mixture is diluted with 300 ml of water and acidified with concentrated hydrochloric acid. The acidified mixture was shaken for 30 minutes, filtered and the filter cake recrystallized from a dimethylformamide-ethyl acetate mixture to yield {[7-chloro-3- (4-chlorophenyl) -1,2- with a melting point of 254 ° C to 257 ° C. Benz isoxoxazol-6-yl] oxy} acetic acid.

Figure kpo00070
Figure kpo00070

상기 실시예에서, 특이적으로 표시되지는 않았지만, 옥심 전구체는 실시예 1과 유사한 방법으로 적합한 케톤으로부터 제조된다.In the above examples, although not specifically indicated, oxime precursors are prepared from suitable ketones in a similar manner as in Example 1.

[실시예 15]Example 15

40㎖의 에틸 알콜중의 0.72g의 에틸{[7-클로로-3-(2-티에닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세테이트와 10㎖의 농수산화나트륨 수용액의 현탁액을 1시간 동안 환류시킨다. 그 후에 에틸 알코올 진공중에서 증발 제거한다. 잔류 현탁액을 농염산으로 산성화하고 주위온도에서 30분간 진탕한다. 생성된 조생성물을 여과하여 모으고 에틸 알콜로 재결정하여 융점이 217°내지 220℃인 생성물{[7-클로로-3-(2-티에닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.0.72 g of ethyl {[7-chloro-3- (2-thienyl) -1,2-benzisoxazol-6-yl] oxy} acetate in 10 ml of 40 ml ethyl alcohol and 10 ml aqueous sodium hydroxide solution The suspension of was refluxed for 1 hour. Then evaporated off in ethyl alcohol vacuum. The remaining suspension is acidified with concentrated hydrochloric acid and shaken at ambient temperature for 30 minutes. The resulting crude product was collected by filtration and recrystallized with ethyl alcohol to give a product having a melting point of 217 ° to 220 ° C. [[7-Chloro-3- (2-thienyl) -1,2-benzisoxazol-6-yl] Oxy} acetic acid is obtained.

Figure kpo00071
Figure kpo00071

[실시예 16]Example 16

a. 32.8g의 3-메틸-2-티오펜카복실산 염화물과 35.4g의 2,3-디클로로아니졸과 26.7g의 염화 알루미늄의 반응 혼합물을 200㎖의 이유화탄소중에서 40시간동안 환류시키고 얼음-염산에 붓는다.a. A reaction mixture of 32.8 g of 3-methyl-2-thiophencarboxylic acid chloride, 35.4 g of 2,3-dichloroanizol and 26.7 g of aluminum chloride is refluxed in 200 ml of carbon wed for 40 hours and poured into ice-hydrochloric acid. .

결정성 생성물을 여과하여 모으고 헥산으로 세척하고 톨루엔-헥산 혼합물로 재결정하여 융점이 136내지 138℃인(2,3-디클로로-4-메톡시)(3-메틸-2-티에닐)메타논을 얻는다.The crystalline product was collected by filtration, washed with hexane and recrystallized with a toluene-hexane mixture to give (2,3-dichloro-4-methoxy) (3-methyl-2-thienyl) methanone with a melting point of 136 to 138 ° C. Get

Figure kpo00072
Figure kpo00072

b. 0.6g의(2,3-디클로로-4-메톡시)(3-메틸-2-티에닐)메타논과 피리딘중의 NH2OH HCl의 혼합물을 상응하는 옥심으로 전환시킨다. 그 후에 옥심(이성체의 혼합물)(37.8g)을 70㎖의 디메틸포름 아미드에 용해하고 용액을 100㎖의 디메틸포름아미드중의 3.3g의 나트륨 히드라이드의 현탁액에 가한다.b. A mixture of 0.6 g of (2,3-dichloro-4-methoxy) (3-methyl-2-thienyl) methanone and NH 2 OH HCl in pyridine is converted to the corresponding oxime. Oxime (mixture of isomers) (37.8 g) is then dissolved in 70 ml of dimethylformamide and the solution is added to a suspension of 3.3 g sodium hydride in 100 ml of dimethylformamide.

반응이 완결된 후 물에 붓는다. 수용성 혼합물의 pH를 희염산으로 6내지 7로 조절한다. 생성된 침전을 여과하여 모으고 에테르로 잘 세척하고 톨루엔-헥산 혼합물로 재결정하여 융점이 154내지 156℃인 7-클로로-3-(3-메틸-2-티에닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.After the reaction is complete, pour into water. The pH of the aqueous mixture is adjusted to 6-7 with dilute hydrochloric acid. The resulting precipitate was collected by filtration, washed well with ether and recrystallized with a toluene-hexane mixture to give 7-chloro-3- (3-methyl-2-thienyl) -6-methoxy-1, having a melting point of 154 to 156 占 폚. Obtain 2-benzisoxazole.

Figure kpo00073
Figure kpo00073

c. 13.3g의 7-클로로-3-(3-메틸-2-티에닐)-6-메톡시-1,2-벤즈이소옥사졸과 CH2Cl2중의 25g의B Br3의 혼합물을 18시간 동안 환류시키고 H2O에 부어 에테르로 추출한다. 에테르 추출물을 탈수하고 증발하고 헥산으로 처리하여 융점이 197내지 198℃인 7-클로로-6-히드록시-3-(3-메틸-2-티에닐-1,2-벤즈이소옥사졸을 얻는다.c. A mixture of 13.3 g of 7-chloro-3- (3-methyl-2-thienyl) -6-methoxy-1,2-benzisoxazole and 25 g of B Br 3 in CH 2 Cl 2 was refluxed for 18 hours. Pour into H 2 O and extract with ether. The ether extract is dehydrated, evaporated and treated with hexane to give 7-chloro-6-hydroxy-3- (3-methyl-2-thienyl-1,2-benzisoxazole having a melting point of 197 to 198 ° C.

Figure kpo00074
Figure kpo00074

d. 60㎖ DMF중의 10.3g의 7-클로로-6-히드록시-3-(3-메틸-2-티에닐)-1,2-벤즈 이소옥사졸을 40㎖의 DMF중의 NaH(1.1g)현탁액에 가한다. 에틸 브로모아세테이트(6.7g)를 가하고 반응 혼합물을 30분동안 50℃로 가열한다. 100㎖ H2O 및 25%수용성 NaOH를 가하고 반응 혼합물을 3시간 동안 90℃까지 가열한다. 반응 혼합물을 H2O에 부어 농염산으로 산성화한다. 산성화된 혼합물을 에테르, 물로 추출하고 세척 후 탈수한다. 증발시키고 에틸 아세테이트-헥산 혼합물로 재결정하여 {[7-클로로-3-(3-메틸-2-티에닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.d. 10.3 g of 7-chloro-6-hydroxy-3- (3-methyl-2-thienyl) -1,2-benzisoxazole in 60 mL DMF was added to a NaH (1.1 g) suspension in 40 mL DMF. Add. Ethyl bromoacetate (6.7 g) is added and the reaction mixture is heated to 50 ° C. for 30 minutes. 100 mL H 2 O and 25% water soluble NaOH are added and the reaction mixture is heated to 90 ° C. for 3 h. The reaction mixture is poured into H 2 O and acidified with concentrated hydrochloric acid. The acidified mixture is extracted with ether, water, washed and dehydrated. Evaporate and recrystallize with ethyl acetate-hexane mixture to give {[7-chloro-3- (3-methyl-2-thienyl) -1,2-benz isoxazol-6-yl] oxy} acetic acid.

Figure kpo00075
Figure kpo00075

[실시예 17]Example 17

실시예 8b의 15.0g의 에틸{[7-클로로-3-(5-메틸-2-티에닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트와 50% NaOH 10㎖의 혼합물을 800㎖의 에탄올중에서 30분간 환류시키고 100㎖의 5%염산을 가하고 용액을 균질화한다. 생성물이 결정화되면 용액을 냉각하고 다시 물을 가한다. 생성물을 여과하고 이소프로판올로 재결정하여 {[7-클로로-3-(5-메틸-2-티에닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.A mixture of 10 mL of 50% NaOH with 15.0 g of ethyl {[7-chloro-3- (5-methyl-2-thienyl) -1,2-benzisoxazol-6-yl] oxy} acetate in Example 8b Was refluxed in 800 ml of ethanol for 30 minutes, 100 ml of 5% hydrochloric acid was added and the solution was homogenized. Once the product crystallizes, cool the solution and add water again. The product is filtered and recrystallized with isopropanol to give {[7-chloro-3- (5-methyl-2-thienyl) -1,2-benz isoxoxazol-6-yl] oxy} acetic acid.

Figure kpo00076
Figure kpo00076

[실시예 18]Example 18

3-푸로일 클로라이드(18.0g)와 2,3-디클로로 아니졸(24.7g)을 125㎖의 CS2내에 용해하고 처음에5℃에서 다음의 실온에서 AlCl3(18.7g)로 처리한다. 5시간 후에 반응을 얼음/HCl로 완결시키고 CH2Cl2로 추출한다. 탈수 및 증발하여 결정생성물을 얻는데 이것을 헥산으로 처리하여 융점이 118내지 122℃인 4-(3-푸로일)-2,3-디클로로아니졸을 얻는다.3-furoyl chloride (18.0 g) and 2,3-dichloro anisol (24.7 g) are dissolved in 125 ml CS 2 and initially treated with AlCl 3 (18.7 g) at 5 ° C. and then at room temperature. After 5 hours the reaction is complete with ice / HCl and extracted with CH 2 Cl 2 . Dehydration and evaporation yields a crystal product which is treated with hexane to give 4- (3-furoyl) -2,3-dichloroanisol having a melting point of 118 to 122 ° C.

16㎖의 농염산(0.186몰)을 14.2g의 피리딘에 가해 피리딘 HCl의 용해조를 제조하고 질소기류하에서 혼합물을 210℃로 가열하고 H2O를 증류 제거시킨다. 아니졸(50g)을 부분적으로 가하고 1시간동안 계속 가열하여 용액을 얼음에 부어 에틸 아세테이트로 추출한다. 탈수 및 증발시켜 융점이 138내지 142℃인 4-(3-플루일)-2,3-디클로로페놀을 얻는다.16 ml of concentrated hydrochloric acid (0.186 mol) was added to 14.2 g of pyridine to prepare a dissolution tank of pyridine HCl, and the mixture was heated to 210 ° C. under nitrogen stream and H 2 O was distilled off. Anisol (50 g) was added in part and heating continued for 1 hour, then the solution was poured on ice and extracted with ethyl acetate. Dehydration and evaporation yields 4- (3-fluyl) -2,3-dichlorophenol having a melting point of 138-142 ° C.

페놀을 피리딘중의 히드록실아민 염산염과 혼합하여 3시간 동안 환류시킨다. 피리딘을 증발시키고 생성혼합물을 염산으로 산성화하고 에틸 아세테이트로 추출한다. 에틸 아세테이트 추출물을 물로 세척하고 탈수하고 증발 건조하여 옥심을 얻는데 이것을 100㎖와 DMF에 용해하고 100㎖의 DMF중의 NaH(70g)현탁액에 가한다. 2시간동안 120℃에서 가온시킨 후 반응물질을 45℃로 냉각하고 20㎖의 DMF중의 에틸브로모 아세테이트(24.0g)를 가한다. 함수로 반응/완결시키고 생성된 고형생성물을 여과하고 에탄올 및 에테르로 세척하고 조 페녹시 에스테르를 얻는다. 조에스테르를 45분간10㎖의 50%를 NaOH에 함유하는 에탄올(500㎖)중에서 환류하여 산성화하고 냉각시켜 결정성 산을 얻는다. 산을 비등 메탄올중에서 현탁시켜 재결정화되면 용해될때까지 DMF를 가한다. 물을 가하면 즉시 결정화되어 융점이 225내지 227℃인 {[7-클로로-3-(3-푸르벤)-1,2-즈이소옥사졸-6-일]옥시}아세트산이 수득된다.The phenol is mixed with hydroxylamine hydrochloride in pyridine and refluxed for 3 hours. Pyridine is evaporated and the resulting mixture is acidified with hydrochloric acid and extracted with ethyl acetate. The ethyl acetate extract was washed with water, dehydrated and evaporated to dryness to obtain an oxime, which was dissolved in 100 mL and DMF and added to a NaH (70 g) suspension in 100 mL DMF. After warming at 120 ° C. for 2 hours, the reaction mass was cooled to 45 ° C. and ethylbromo acetate (24.0 g) in 20 mL DMF was added. The reaction / completed with brine and the resulting solid product are filtered off and washed with ethanol and ether to give crude phenoxy ester. The crude ester is refluxed in ethanol (500 ml) containing 10 ml of 50% in NaOH for 45 minutes, acidified and cooled to give crystalline acid. The acid is suspended in boiling methanol and recrystallized and DMF is added until dissolved. The addition of water immediately crystallised to give {[7-chloro-3- (3-furben) -1,2-ziisoxazol-6-yl] oxy} acetic acid having a melting point of 225 to 227 ° C.

Figure kpo00077
Figure kpo00077

[실시예 19]Example 19

a. 100㎖의 1,2-디클로로 에탄중의 24.6g의 2,6-디플루오로 벤조일클로라이드 용액에 18.5g의 AlCl3를 30분간 가한다. 100㎖의 1,2-디클로로 에탄중의 22.5g의 2,3-디클로로아니졸 용액을 가한다.a. 18.5 g of AlCl 3 is added to a solution of 24.6 g of 2,6-difluoro benzoyl chloride in 100 ml of 1,2-dichloro ethane for 30 minutes. 22.5 g 2,3-dichloroanisol solution in 100 mL 1,2-dichloro ethane are added.

혼합물을 1시간 동안 진탕하고 100㎖의 염산과 얼음에 부어 넣는다. 유기층을 분리하고 수용액층을CHCl3로 추출한다. 유기 추출물을 물로 세척하고, 탈수(Na2SO4)하고 증발하여 오일을 얻는데 이것을 헥산으로 결정화하여 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논을 얻는데 이것을 에테르로 재결정 한다.The mixture is shaken for 1 hour and poured into 100 ml of hydrochloric acid and ice. The organic layer is separated and the aqueous layer is extracted with CHCl 3 . The organic extract was washed with water, dehydrated (Na 2 SO 4 ) and evaporated to give an oil which was crystallized from hexane to give 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone. Recrystallize with ether.

Figure kpo00078
Figure kpo00078

b. 50.5g의 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논, 44.27g의 히드록실아민 HCl의 혼합물을 200㎖피리딘 중에서 48시간 동안 환류시킨다. 피리딘을 감압하에서 증발시키고 잔류물을 5%HCl과 에틸 아세테이트 사이에서 분배시킨다. 추출물을 물로 세척하고 Na2SO4상에서 탈수시키고, 증발하여 이성체의 혼합물을 얻는다. 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논 옥심의 분석시료를 95에탄올로부터 재결정한다.b. A mixture of 50.5 g of 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone, 44.27 g of hydroxylamine HCl is refluxed for 48 h in 200 ml pyridine. Pyridine is evaporated under reduced pressure and the residue is partitioned between 5% HC1 and ethyl acetate. The extract is washed with water, dehydrated over Na 2 SO 4 and evaporated to give a mixture of isomers. Analytical samples of 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone oxime are recrystallized from 95ethanol.

Figure kpo00079
Figure kpo00079

c. 200㎖의 DMF중의 5g의 NaH의 혼합물에 250㎖의 DMF중의 48g의 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논 옥심을 질소기류하 약 40℃의 온도에서 적가한다. 가한 후에, 혼합물을 30분간 진탕하고 빙수에 붓는다. 이성체의 혼합물인 조생성물을 여과하고 실리카겔상에서 추출액으로 CHCl3를 사용하여 크로마토그라피하면 융점이 175내지179℃인 7-클로로-3-(2,6-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸이 톨루엔으로부터 재결정된다.c. To a mixture of 5 g NaH in 200 ml DMF, 48 g 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone oxime in 250 ml DMF was subjected to a temperature of about 40 ° C. under a nitrogen stream. Drop by After addition, the mixture is shaken for 30 minutes and poured into ice water. The crude product, a mixture of isomers, was filtered and chromatographed with CHCl 3 as the extract on silica gel to give 7-chloro-3- (2,6-difluorophenyl) -6-methoxy- with a melting point of 175 to 179 ° C. 1,2-benzisoxazole is recrystallized from toluene.

Figure kpo00080
Figure kpo00080

d. 10.8g의 7-클로로-3-(2,6-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 및 40.3g의 피리딘 HCl의 혼합물을200℃에서 1시간 동안 가열하고 진탕시킨 빙수에 붓는다. 7-클로로-3-(2,6-디플루오로페닐)-6-히드록시-1,2-벤즈이소옥사졸 생성물이 침전되면 여과하고 탈수한다.d. A mixture of 10.8 g of 7-chloro-3- (2,6-difluorophenyl) -6-methoxy-1,2-benzisoxazole and 40.3 g of pyridine HCl was heated at 200 ° C. for 1 hour and shaken Pour into iced water. If 7-chloro-3- (2,6-difluorophenyl) -6-hydroxy-1,2-benzisoxazole product precipitates, it is filtered and dehydrated.

분석시료를 톨루엔으로 재결정한다.Reanalyze the sample with toluene.

Figure kpo00081
Figure kpo00081

e. 1.18g의 NaH와 9.2g의 7-클로로-3-(2,6-디플루오로페닐)-6-히드록시-1,2-벤즈이소옥사졸의 혼합물을 15㎖의 DMF중에서 1시간 동안 진탕한다. 40㎖의DMF중의 6.06g의 에틸브로모아세테이트 용액을 적가하고 30분동안 진탕한다. 10㎖의 50% NaOH를 가하고 반응 혼합물을 80℃에서 1시간동안 가온한다. 농염산을 산성이 될때까지 가온시킨 용액에 가한다.e. A mixture of 1.18 g NaH and 9.2 g 7-chloro-3- (2,6-difluorophenyl) -6-hydroxy-1,2-benzisoxazole is shaken in 15 ml of DMF for 1 hour. . 6.06 g of ethylbromoacetate solution in 40 ml of DMF is added dropwise and shaken for 30 minutes. 10 mL of 50% NaOH is added and the reaction mixture is warmed at 80 ° C. for 1 h. Concentrated hydrochloric acid is added to the warmed solution until it is acidic.

물을 가하여 {[7-클로로-3-(2,6-디플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시 아세트산을 침전시키고 이것을 여과하고 탈수하고 톨루엔-아세토니트릴로 재결정하여 융점이 170내지 172℃인 생성물을 얻는다.Water was added to precipitate {[7-chloro-3- (2,6-difluorophenyl) -1,2-benzisooxazol-6-yl] oxy acetic acid, which was filtered and dehydrated and recrystallized from toluene-acetonitrile. To obtain a product having a melting point of 170 to 172 캜.

Figure kpo00082
Figure kpo00082

[실시예 20]Example 20

a. 1,2-디클로로에탄 100㎖중의 20.36g의 플루오로신나모일 클로라이드와 14.4g의 알루미늄 클로라이드의 혼합물을 1,2-디클로로 에탄중의 17.7g의 2,3-디클로로 아니졸을 적가하면서 1시간 동안 교반한다. 반응물을 한 시간 동안 약 80℃까지 가온시키고 농염산 및 얼음100㎖에 붓는다. 수용액층을 클로로포름으로 추출하고 합한 유기층은 물로 세척하고 황산나트륨으로 탈수하고 증발시켜 고체 잔류물을 얻는다. 잔류물을 헥산으로 처리하여 융점 137내지 138℃인4-(트란스-α-플루오로신나모일)-2,3-디클로로아니졸을 얻는다. 시료를 톨루엔으로 재결정한다.a. A mixture of 20.36 g of fluorocinnamoyl chloride and 14.4 g of aluminum chloride in 100 ml of 1,2-dichloroethane was added dropwise to 17.7 g of 2,3-dichloro anisol in 1,2-dichloro ethane for 1 hour. Stir. The reaction is warmed to about 80 ° C. for one hour and poured into 100 ml of concentrated hydrochloric acid and ice. The aqueous layer is extracted with chloroform and the combined organic layers are washed with water, dehydrated with sodium sulfate and evaporated to give a solid residue. The residue is treated with hexane to give 4- (trans-α-fluorocinnamoyl) -2,3-dichloroanisol having a melting point of 137 to 138 ° C. Recrystallize the sample from toluene.

Figure kpo00083
Figure kpo00083

b. 4-(트란스-α-플루오로신나모일)-2,3-디클로로아니졸 26.6g과 하이드록실아민 하이드로클로 라이드 22.7g의 혼합물을 18시간 동안 환류한다.b. A mixture of 26.6 g of 4- (trans-α-fluorocinnamoyl) -2,3-dichloroanizol and 22.7 g of hydroxylamine hydrochloride is refluxed for 18 hours.

피리딘을 진공에서 증류하고 잔류물을 5%염산으로 처리한다. 생성물을 여과, 건조하고 에테르-헥산으로 세척하여 이성체의 혼합물을 얻는다. 융점 222내지 238℃인 4-(트란스-플루오로신나모일)-2,3-디클로로아니졸옥심의 시료를 에탄올로 재결정하여 얻는다.Pyridine is distilled in vacuo and the residue is treated with 5% hydrochloric acid. The product is filtered, dried and washed with ether-hexane to give a mixture of isomers. A sample of 4- (trans-fluorocinnamoyl) -2,3-dichloroanizol oxime having a melting point of 222 to 238 ° C is obtained by recrystallization with ethanol.

Figure kpo00084
Figure kpo00084

c. DMF 60㎖중의 나트륨하이드록사이드 0.43g과 4-α-트란스플루오로신나모일)-2,3-디클로로 아니졸옥심 4g의 혼합물을 한 시간 반동안 교반하고 빙수에 붓는다. 생성된 침전물을 여과하고 건조하여 7-클로로-3-(트란스-베타-플루오로스티릴)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다. 톨루엔으로 재결정하여 순수 생성물을 얻는다.c. A mixture of 0.43 g sodium hydroxide and 60 g of 4-α-transfluorocinnamoyl) -2,3-dichloro anisoleoxime in 60 mL DMF is stirred for an hour and a half and poured into ice water. The resulting precipitate is filtered and dried to afford 7-chloro-3- (trans-beta-fluorostyryl) -6-methoxy-1,2-benzisoxazole. Recrystallization from toluene gives pure product.

Figure kpo00085
Figure kpo00085

d. 7-클로로-3-(트란스-β-플루오로스티릴)-6-메톡시-1,2-벤즈이소옥사졸 1.4g과피리딘하이드로 클로라이드 5.6g의 혼합물을 200℃에서 1시간 동안 가열하고 얼음물에 강하게 교반하면서 붓는다.d. A mixture of 1.4 g of 7-chloro-3- (trans-β-fluorostyryl) -6-methoxy-1,2-benzisooxazole and 5.6 g of pyridinehydrochloride was heated at 200 ° C. for 1 hour and poured into ice water. Pour with vigorous stirring.

융점 226내지 229℃인 7-클로로-3-(트란스-β-플루오로스티릴)-6-하이드록시-1,2-벤즈이소옥사졸의 생성물이 침전되면 여과하고 건조한다.The product of 7-chloro-3- (trans-β-fluorostyryl) -6-hydroxy-1,2-benzisoxazole having a melting point of 226 to 229 ° C. is filtered and dried.

Figure kpo00086
Figure kpo00086

e. DMF100㎖중의 NaH0.84g에 50㎖ DMF중의 7-클로로-3-(트란스-β-플루오로스티릴)-6-하이드록시-1,2-벤즈이소옥사졸 6.77g을 질소기압하에 적가한다. 혼합물을 1시간 동안 교반하고 이때 에틸 브로모아세테이트 4.2g을 여기에 적가한다.e. To 0.84 g of NaH in 100 ml of DMF, 6.77 g of 7-chloro-3- (trans-β-fluorostyryl) -6-hydroxy-1,2-benzisoxazole in 50 ml DMF was added dropwise under nitrogen atmosphere. The mixture is stirred for 1 hour, at which time 4.2 g of ethyl bromoacetate is added dropwise.

반응물을 30분동안 교반하고 50%수산화나트륨 15㎖를 가하고 반응물을 1시간 동안 80℃로 가열한다. 반응 혼합물을 농황산으로 산성으로 하고 물을 가하여 생성물을 침전시킨다. 조 생성물은 여과하고, 건조하여 95%에탄올로 재결정하여 융점 200내지 203℃인 7-클로로-3-(트란스-β-플루오로-스티릴)-1,2-벤즈이소옥사졸-6-일)옥시 아세트산을 얻는다.The reaction is stirred for 30 minutes, 15 ml of 50% sodium hydroxide is added and the reaction is heated to 80 ° C. for 1 hour. The reaction mixture is acidified with concentrated sulfuric acid and water is added to precipitate the product. The crude product was filtered, dried and recrystallized from 95% ethanol to 7-chloro-3- (trans-β-fluoro-styryl) -1,2-benzisoxazol-6-yl with a melting point of 200 to 203 ° C. Obtain oxy acetic acid.

Figure kpo00087
Figure kpo00087

[실시예 21]Example 21

a. 1,2-디클로로에탄 200㎖중의 2,4-디플루오로 벤조일클로라이드 52.23g 용매에 AlCl 40g을 30분에 걸쳐 가한다. 1,2-디클로로에탄 100㎖중의 2,3-디클로로아니졸 48.3g용액을 적가한다. 가스가 천천히 기화하며 온도는 약 섭씨 30도까지 상승된다. 혼합물을 농염산 및 얼음에 붓는다. 유기층은 분리하고 수용액층은 클로로포름으로 2회 추출한다. 합한 유기층을 물로 세척, 황산나트륨으로 건조 증발시켜 오일을 얻는다. 헥산으로 처리하여 2,3-디클로로-4-메톡시-2',4'-디플루오로벤조페논이 수득되면 에테르로 재결정한다.a. 40 g of AlCl was added over 30 minutes to a 52.23 g solvent of 2,4-difluoro benzoyl chloride in 200 ml of 1,2-dichloroethane. A solution of 48.3 g of 2,3-dichloroanizol in 100 ml of 1,2-dichloroethane is added dropwise. The gas slowly evaporates and the temperature rises to about 30 degrees Celsius. Pour the mixture into concentrated hydrochloric acid and ice. The organic layer was separated and the aqueous layer was extracted twice with chloroform. The combined organic layers are washed with water and dried by evaporation with sodium sulfate to give an oil. Treatment with hexane yields 2,3-dichloro-4-methoxy-2 ', 4'-difluorobenzophenone, which is recrystallized from ether.

Figure kpo00088
Figure kpo00088

b. 피리딘 300㎖중의 2,3-디클로로-4-메톡시-2',4'-디플루오로벤조페논 67g에 하이드록실아민 하이드로클로라이드 58g을 가하고 생성된 혼합물을 18시간 동안 환류시킨다. 피리딘은 진공에서 증류하고 잔류물을 5%염산과 에틸아세테이트에 분배한다. 에틸아세테이트 추출물을 물로 세척하고 황산나트륨상에서 건조후 증발시키면 이성체의 혼합물로서 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논 옥실이 얻어진다. 시료를 95%에탄올로 재결정한다.b. To 67 g of 2,3-dichloro-4-methoxy-2 ', 4'-difluorobenzophenone in 300 ml of pyridine is added 58 g of hydroxylamine hydrochloride and the resulting mixture is refluxed for 18 hours. Pyridine is distilled under vacuum and the residue is partitioned between 5% hydrochloric acid and ethyl acetate. Ethyl acetate extracts were washed with water, dried over sodium sulfate and evaporated to afford 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone oxyl as a mixture of isomers. Recrystallize the sample from 95% ethanol.

Figure kpo00089
Figure kpo00089

c. DMF 100㎖중의 NaH 5.7g혼합물에 DMF 250㎖에 녹인 2,3-디클로로-4-메톡시-2',6'-디플루오로벤조페논옥심 53g을 약 30℃로 유지하면서 적가한다. 혼합물을 한 시간 반동안 교반한 후 생성물에 물을 가하면 생성물이 침전된다. 이성체의 혼합물인 조생성물을 용출제로서 톨루엔-헥산을 사용하여 실리카겔상에서 크로마토 그라피하여 7-클로로-3-(2,4-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸의 순수물질을 얻어 톨루엔으로 재결정한다.c. To a mixture of 5.7 g of NaH in 100 ml of DMF was added dropwise while maintaining 53 g of 2,3-dichloro-4-methoxy-2 ', 6'-difluorobenzophenone oxime dissolved in 250 ml of DMF. After stirring the mixture for an hour and a half, water is added to the product to precipitate the product. The crude product, a mixture of isomers, was chromatographed on silica gel using toluene-hexane as eluent to give 7-chloro-3- (2,4-difluorophenyl) -6-methoxy-1,2-benzisoxazole. Obtain a pure substance and recrystallize with toluene.

Figure kpo00090
Figure kpo00090

d. 7-클로로-3-(2,4-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 7.1g과 피리딘하이드로클로라이드 27.8g의 고체 혼합물을 한 시간 동안 200℃에서 가열하고 혼합물을 강하게 교반하면서 얼음물에 부어 생성물을 침전시킨다. 생성물을 여과하고 건조하여 7-클로로-3-(2,4-디플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸을 얻어 톨루엔으로 재결정한다. 융점 186내지 190℃.d. A solid mixture of 7.1 g of 7-chloro-3- (2,4-difluorophenyl) -6-methoxy-1,2-benzisooxazole and 27.8 g of pyridinehydrochloride was heated at 200 ° C. for an hour and the mixture Is poured into ice water with vigorous stirring to precipitate the product. The product is filtered and dried to afford 7-chloro-3- (2,4-difluorophenyl) -6-hydroxy-1,2-benzisoxazole, which is recrystallized from toluene. Melting point 186-190 캜.

Figure kpo00091
Figure kpo00091

e. DMF100㎖중의 NaH 0.86g의 혼합물에 질소가스 존재하에 DMF 50㎖중의 7-클로로-3-(2,4-디플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸 6.9g의 용액을 적가하고 DMF 25㎖중의 에틸브로모아세테이트 4.41g을 가한다. 혼합물을 30분동안 교반하고 50%수산화나트륨을 가하고 섭씨 80내지 85℃에서 1시간 동안 가열한다.e. A solution of 6.9 g of 7-chloro-3- (2,4-difluorophenyl) -6-hydroxy-1,2-benzisoxazole in 50 ml of DMF in a mixture of 0.86 g of NaH in 100 ml of DMF in the presence of nitrogen gas. Was added dropwise and 4.41 g of ethylbromoacetate in 25 ml of DMF was added. The mixture is stirred for 30 minutes, 50% sodium hydroxide is added and heated at 80 to 85 ° C. for 1 hour.

이때 농염산은 혼합물이 산성이 될때까지 가한다. 물을 가하여 {[7-클로로-3-(2,4-디플루오로페닐)-1,2-젠즈이소옥사졸-6-일]옥시}아세트산을 침전시키고 그 톨루엔-아세토니트릴로 재결정한다.Concentrated hydrochloric acid is added until the mixture becomes acidic. Water is added to precipitate {[7-chloro-3- (2,4-difluorophenyl) -1,2-zenzioxoxazol-6-yl] oxy} acetic acid and recrystallize from the toluene-acetonitrile.

Figure kpo00092
Figure kpo00092

[실시예 22]Example 22

a. 디메틸설페이드(94.64g)를 물(300㎖)에 녹인 2,5-디클로로페놀(122.25g)과 수산화나트륨(31.5g)의 냉각 교반용액에 40분에 걸쳐 적가한다.a. Dimethyl sulfide (94.64 g) was added dropwise over 40 minutes to a cooling stirred solution of 2,5-dichlorophenol (122.25 g) and sodium hydroxide (31.5 g) dissolved in water (300 mL).

이 혼합을 1시간 동안 실온에서 교반하고 다시 2시간 동안 환류한 후 다시 실온으로 냉각한다. 유기층을 분리하고 잔류의 수용층의 에테르 추출물과 합한다. 에테르 용액을 탈수(포화 염화나트륨, 황산나트륨, 탄산칼슘)시키고 에테르를 제거하여 2,5-디클로로아니졸을 얻는다. 증류시키면 무색 액체(진공흡인기로 섭씨 115℃)를 얻는다.The mixture is stirred for 1 hour at room temperature, refluxed for another 2 hours and then cooled back to room temperature. The organic layer is separated and combined with the ether extract of the residual aqueous layer. The ether solution is dehydrated (saturated sodium chloride, sodium sulfate, calcium carbonate) and ether is removed to give 2,5-dichloroanisol. Distillation gives a colorless liquid (115 ° C. with vacuum aspirator).

이유화탄소(25㎖)중의 O-플루오로벤조일클로라이드 용액을 실온에서 이유화탄소(450㎖)중의(58.67g) 현탁액에 가하고 실온에서 이유화탄소(25㎖)중의 2,5-디클로로아니졸 70.8g을 가한다. 혼합물을 실온에서 4시간 동안 교반하면 이동안 침전물이 형성된다.A solution of O-fluorobenzoylchloride in carbon wetting (25 ml) was added to a suspension in carbon wetting (450 ml) (58.67 g) at room temperature and 70.8 g of 2,5-dichloroanizol in carbon wetting (25 ml) at room temperature. Add. The mixture is stirred at room temperature for 4 hours during which time a precipitate forms.

혼합물을 한시간 동안 환류한 후 냉각하고 AlCl358g을 가한다. 생성된 혼합물을 2시간 동안 환류하고 시간동안 실온에서 교반한다. 혼합물을 얼음/염산에 붓고 메틸렌 디클로라이드로 추출하여 오일을 얻는다. 헥산-에테르로 처리하여 고체를 얻는다. 디이소프로필에테르로 재결정하면 약 94℃에서 일부 용해된후 약 120℃에서 용해되는 고체가 얻어진다. 여액으로부터 용매를 제거한후 남은 고체를 석유에테르-에테르로 처리하여 2,5-디클로로-4-(2-플루오로벤조일)아니졸을 얻어 메탄올로 재결정한다.The mixture is refluxed for one hour, then cooled and 58 g AlCl 3 is added. The resulting mixture is refluxed for 2 hours and stirred at room temperature for hours. The mixture is poured into ice / hydrochloric acid and extracted with methylene dichloride to give an oil. Treatment with hexane-ether gives a solid. Recrystallization with diisopropyl ether gives a solid which is partially dissolved at about 94 ° C. and then dissolved at about 120 ° C. After the solvent was removed from the filtrate, the remaining solid was treated with petroleum ether-ether to obtain 2,5-dichloro-4- (2-fluorobenzoyl) anizol and recrystallized from methanol.

Figure kpo00093
Figure kpo00093

b. 피리딘(25㎖)중의 2,5-디클로로-4-(2-플루오로벤조일)아니졸(3g)과 하이드록실아민 하이드로클로라이드(1.4g)의 혼합물을 케톤체가 없어질때까지 수시간 동안 환류한다. 피리딘을 고 진공하에서 제거하고 잔류물을 물로 희석한 후 클로로포름으로 추출한다.b. A mixture of 2,5-dichloro-4- (2-fluorobenzoyl) anizol (3 g) and hydroxylamine hydrochloride (1.4 g) in pyridine (25 mL) was refluxed for several hours until the ketone body disappeared. Pyridine is removed under high vacuum and the residue is diluted with water and extracted with chloroform.

클로로포름 용액을 건조하고 클로로포름을 제거하여 고체를 얻고 이것을 에테르로 재결정하면 융점 188℃인(Z)-2'-플루오로-2,5-디클로로-4-메톡시벤조페논 옥심을 얻는다.The chloroform solution is dried and the chloroform is removed to give a solid which is recrystallized with ether to give (Z) -2′-fluoro-2,5-dichloro-4-methoxybenzophenone oxime having a melting point of 188 ° C.

Figure kpo00094
Figure kpo00094

c. DMF(20㎖)중의 (Z)-2'-플루오로-2,5-디클로로-4-메톡시벤조페논옥심(3.14g)용액을 (20㎖)중의 DMF(0.6g) 교반현탁액에 적가한다. 혼합물을 실온에서 18시간 동안 교반하고, 얼음/물에 붓고 클로로포름으로 추출한다. 클로로포름 용액을 불포화염화나트륨용액으로 세척하고 황산나트륨-황산마그네슘상에서 건조시킨다. 클로로포름을 제거하여 잔류물을 얻고 석유에테르-에테르로 처리하면 융점 165내지 166℃인 고형물을 얻는다. 여액으로부터 용매를 제거하여 고형물을 얻고 석유에테르-에테르로 처리하여 융점 165내지 166℃인 5-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.c. (Z) -2'-fluoro-2,5-dichloro-4-methoxybenzophenone oxime (3.14 g) solution in DMF (20 mL) was added dropwise to DMF (0.6 g) stirred suspension in (20 mL). . The mixture is stirred at rt for 18 h, poured into ice / water and extracted with chloroform. The chloroform solution is washed with unsaturated sodium chloride solution and dried over sodium sulfate-magnesium sulfate. Removal of chloroform gives a residue, which is treated with petroleum ether-ether to give a solid having a melting point of 165 to 166 ° C. The solvent is removed from the filtrate to give a solid which is treated with petroleum ether-ether to give 5-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 165 to 166 ° C. .

Figure kpo00095
Figure kpo00095

α. 디클로로에탄(30㎖)중의 5-클로로-3-(2-플루오로페닐-6-메톤시-1,2-벤즈이소옥사졸(1g)과 보론 트리브로마이드(1.3㎖) 용액을 약 24시간 동안 환류한다. 반응혼합물을 얼음-물에 붓고 디클로로메탄으로 추출하여 융점 180내지 182℃인 고형의 5-클로로-3-(2-플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸을 얻는다.α. A solution of 5-chloro-3- (2-fluorophenyl-6-methonesi-1,2-benzisoxazole (1 g) and boron tribromide (1.3 ml) in dichloroethane (30 ml) was refluxed for about 24 hours. The reaction mixture is poured into ice-water and extracted with dichloromethane to give solid 5-chloro-3- (2-fluorophenyl) -6-hydroxy-1,2-benzisoxazole having a melting point of 180 to 182 ° C. Get

Figure kpo00096
Figure kpo00096

e. DMF(40㎖)중의 5-클로로-3-(2-플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸(14.8g)을 DMF(40㎖)중의 나트륨 하이드리드(3.0g)의(현탁액에 실온에서 적가하고 혼합물을 30분동안 실온에서 교반한다.e. 5-chloro-3- (2-fluorophenyl) -6-hydroxy-1,2-benzisoxazole (14.8 g) in DMF (40 mL) was dissolved in sodium hydride (3.0 g) in DMF (40 mL). To the suspension is added dropwise at room temperature and the mixture is stirred for 30 minutes at room temperature.

DMF(40㎖)중의 에틸브로모아세테이트(10.31g) 용액을 적가하고 혼합물을 실온에서 18시간 동안 교반한다. DMF중에 현탁시킨 NaH 0.3g을 가한 후 1g의 에틸브로모아세테이트를 가한다. 혼합물을 50℃에서 1시간반 동안 가열한다. 에테르 추출물을 물 및 포화 염화나트륨으로 세척하여 황산나트륨으로 건조하고 용매를 제거하여 고형물을 얻는다. 석유에테르-에테르(1'1)로 처리하여 융점 114내지 115℃인 에틸 {[5-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.A solution of ethylbromoacetate (10.31 g) in DMF (40 mL) is added dropwise and the mixture is stirred at room temperature for 18 hours. 0.3 g of NaH suspended in DMF is added followed by 1 g of ethyl bromoacetate. The mixture is heated at 50 ° C. for 1 and a half hours. The ether extract is washed with water and saturated sodium chloride, dried over sodium sulfate and the solvent is removed to give a solid. Ethyl {[5-chloro-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetate having a melting point of 114 to 115 ° C by treatment with petroleum ether-ether (1'1) Get

Figure kpo00097
Figure kpo00097

f. 에틸 {[5-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트(14g), 수산화나트륨(8g), 에탄올(500㎖)과 물(300㎖)의 혼합물을 5시간 동안 환류하고 빙욕중에서 냉각하고 농염산으로 산성화한다. 현탁액을 클로로포름으로 추출하고 추출물을 포화 염화나트륨으로 건조시켜 클로로포름을 제거하면 융점 214내지 215℃인 고형물을 얻는다. 아세토니트릴-톨루엔의 3:2혼합물로 재결정하여 {[5-클로로-3-(2-플루오로페닐) 1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.f. Ethyl {[5-chloro-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetate (14 g), sodium hydroxide (8 g), ethanol (500 mL) and water ( 300 ml) of the mixture is refluxed for 5 hours, cooled in an ice bath and acidified with concentrated hydrochloric acid. The suspension is extracted with chloroform and the extract is dried with saturated sodium chloride to remove chloroform to give a solid having a melting point of 214 to 215 ° C. Recrystallization with a 3: 2 mixture of acetonitrile-toluene yields {[5-chloro-3- (2-fluorophenyl) 1,2-benzisoxazol-6-yl] oxy} acetic acid.

Figure kpo00098
Figure kpo00098

[실시예 23]Example 23

a. 1,2-디클로로에탄(150㎖)중의 3,4-디클로로 벤조일클로 라이드 57.6g 용액에 30분에 걸쳐 AlCl336.7g을 가한다. 생성된 혼합물에 2,3-디클로로아니졸 44.26g을 적가한다. 가스가 증발되면 반응혼합물은 한시간동안 60℃까지 가열한다. 이 후 혼합물을 농염산 150㎖ 및 얼음 150㎖에 붓고 클로로포름과 에탄올로 추출한다. 얻은 유기층을 10% 탄산칼륨 수용액 및 물로 세척하고 황산나트륨상에서 건조한후 증발시켜 융점 113내지 140℃인 2-디클로로-4-메톡시-3',4'-디클로로벤조페논을 얻는다.a. To a solution of 57.6 g of 3,4-dichloro benzoyl chloride in 1,2-dichloroethane (150 mL) is added 36.7 g of AlCl 3 over 30 minutes. To the resulting mixture is added dropwise 44.26 g of 2,3-dichloroanizol. Once the gas has evaporated the reaction mixture is heated to 60 ° C. for one hour. The mixture is then poured into 150 ml of concentrated hydrochloric acid and 150 ml of ice and extracted with chloroform and ethanol. The obtained organic layer was washed with 10% aqueous potassium carbonate solution and water, dried over sodium sulfate and evaporated to give 2-dichloro-4-methoxy-3 ', 4'-dichlorobenzophenone having a melting point of 113 to 140 ° C.

b. 벤젠 400㎖중의 2,3-디클로로-4-메톡시-3',4'-디클로로벤조페논 59g과 AlCl 40g의 혼합물을 5시간 동안 환류시킨 후 실온까지 냉각하여 18시간 동안 그대로 유지한다. 혼합물을 농염산 200㎖ 및 얼음 200㎖에 붓고 30분동안 실온에서 교반한다. 에틸아세테이트를 혼합물에 가하고 에틸아세테이트/벤젠 층은 물로 세척하고 황산나트륨으로 건조하고 증발시켜 융점 179°내지 180℃인 2,3-디클로로-4-하이드록시-3',4'-디클로로벤조페논을 얻는다.b. A mixture of 59 g of 2,3-dichloro-4-methoxy-3 ', 4'-dichlorobenzophenone and 40 g of AlCl in 400 ml of benzene was refluxed for 5 hours, then cooled to room temperature and maintained for 18 hours. The mixture is poured into 200 ml of concentrated hydrochloric acid and 200 ml of ice and stirred for 30 minutes at room temperature. Ethyl acetate is added to the mixture and the ethyl acetate / benzene layer is washed with water, dried over sodium sulfate and evaporated to give 2,3-dichloro-4-hydroxy-3 ', 4'-dichlorobenzophenone having a melting point of 179 ° to 180 ° C. .

c. 피리딘 300㎖중의 2,3-디클로로-4-하이드록시-3',4'-디클로로벤조페논 35.43g과 하이드록실아민 15.29g을 2시간 동안 환류한다. 피리딘을 진공중에서 증발시킨다. 잔류물을 에틸아세테이트와 5% 염산에 분배한다. 추출물을 물로 세척하고 황산나트륨으로 건조후 증발시켜 상응하는 옥실을 얻는다.c. 35.43 g of 2,3-dichloro-4-hydroxy-3 ', 4'-dichlorobenzophenone and 15.29 g of hydroxylamine in 300 ml of pyridine are refluxed for 2 hours. Pyridine is evaporated in vacuo. The residue is partitioned between ethyl acetate and 5% hydrochloric acid. The extract is washed with water, dried over sodium sulfate and evaporated to afford the corresponding oxyl.

DMF 300㎖중의 옥심 35g 용액에 NaH 6.0g을 가하고 혼합물을 1시간 45분동안 103℃의 내부온도까지 가열한후 3/4시간동안 내부온도 100℃까지 가열한다. 반응혼합물을 실온까지 냉각하고 DMF 50㎖중의 에틸브로모아세테이트 18.37g 용액을 적가한다. 혼합물을 약 64시간동안 교반하고 물에 붓고 생성된 침전물을 여과하고 헥산으로 세척한다. 조생성물을 에탄올로 재결정하여 융점 123내지 125℃인 에틸 {[7-클로로-3-(3,4-디클로로페닐)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.6.0 g of NaH was added to a 35 g solution of oxime 35 mL in DMF and the mixture was heated to an internal temperature of 103 ° C. for 1 hour 45 minutes and then to an internal temperature of 100 ° C. for 3/4 hours. The reaction mixture is cooled to room temperature and a solution of 18.37 g of ethyl bromoacetate in 50 ml of DMF is added dropwise. The mixture is stirred for about 64 hours, poured into water and the resulting precipitate is filtered and washed with hexane. The crude product is recrystallized from ethanol to give ethyl {[7-chloro-3- (3,4-dichlorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetate having a melting point of 123 to 125 ° C.

에탄올 400㎖중의 에스테르 19g의 현탁액에 50% 수산화나트륨 20㎖을 가한다. 침전물이 생성되면 이종혼합물을 1시간 동안 환류한다. 가온된 혼합물에 400㎖의 물을 가하고 농염산을 가하여 혼합물을 산성으로 한다.20 ml of 50% sodium hydroxide is added to a suspension of 19 g of ester in 400 ml of ethanol. When a precipitate is formed, the heterogeneous mixture is refluxed for 1 hour. 400 ml of water is added to the warmed mixture and concentrated hydrochloric acid is added to make the mixture acidic.

현탁액을 30분동안 교반하고 DMF-에틸아세테이트로 재결정하여 융점 222내지 224℃인 {[7-클로로-3-(3,4-디클로로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.The suspension was stirred for 30 minutes and recrystallized from DMF-ethylacetate to produce {[7-chloro-3- (3,4-dichlorophenyl) -1,2-benzisoxazol-6-yl] oxy having a melting point of 222 to 224 ° C. } Acetic acid is obtained.

Figure kpo00099
Figure kpo00099

[실시예 24]Example 24

a. 실시예 23a의 프리덴-크레프트 반응을 AlCl336.7g 및 2,3-디클로로아니졸 44.26g과 O-클로로벤조일 클로라이드 48.13g에 대해 시행하면 융점 117내지 120℃인 2,3-디클로로-4-메톡시-2'-클로로벤조페논의 백색 결정성 물질이 얻어진다.a. The Frieden-Craft reaction of Example 23a was carried out on 36.7 g of AlCl 3 and 44.26 g of 2,3-dichloroanizol and 48.13 g of O-chlorobenzoyl chloride with a melting point of 117 to 120 ° C. for 2,3-dichloro-4-meth A white crystalline material of oxy-2'-chlorobenzophenone is obtained.

b. 2,3-디클로로-4-메톡시-2'-클로로벤조페논 68g과 벤젠 500㎖중의 AlCl358.6g를 사용하는 것을 제외하고는 실시예 23b의 공정을 반복한다. 얻은 생성물을 톨루엔으로 재결정하여 융점 74내지 77℃인 2,3-디클로로-4-하이드록시-2'-클로로벤조페논을 얻는다.b. The process of Example 23b is repeated except that 68 g of 2,3-dichloro-4-methoxy-2'-chlorobenzophenone and 58.6 g of AlCl 3 in 500 ml of benzene are used. The obtained product is recrystallized from toluene to give 2,3-dichloro-4-hydroxy-2'-chlorobenzophenone having a melting point of 74 to 77 캜.

c. 피리딘 350㎖중의 2,3-디클로로-4-하이드록시-2'-클로로벤조페논 용액에 하이드록실아민 하이드로클로라이드 25.02g을 가한다. 혼합물을 2시간 동안 환류한다. 피리딘을 진공중에서 증발시키고 잔류물을 에틸 아세테이트와 5%염산에 분배시킨다. 에틸아세테이트 추출물을 물로 세척하고 황산나트륨으로 건조하고 증발시켜 상응하는 옥심을 얻는다. DMF 300㎖중의 옥심 49g 용액에 NaH 9.12g을 가하고 혼합물을 1시간 동안 내부온도 80내지 84℃가 될때까지 가열한다. 반응 혼합물을 실온까지 냉각하고 DMF50㎖중을 에틸브로모 아세테이트 27.5g용액을 가한다. 혼합물을 30분동안 교반하고 물을 가하여 과잉의 NaH를 분해한다. 생성물을 에틸아세테이트로 추출한다. 에틸아세테이트 추출물을 10% 수산화나트륨 및 물로 세척하고 황산나트륨상에서 탈수하고 증발시켜 혼합물을 얻는다. 혼합물을 용출제로서 클로로포름을 사용하여 실리카겔상에서 크로마토그라피하여 에틸 {[7-클로로-3-(2-클로로페닐)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.c. 25.02 g of hydroxylamine hydrochloride is added to a 2,3-dichloro-4-hydroxy-2'-chlorobenzophenone solution in 350 ml of pyridine. The mixture is refluxed for 2 hours. Pyridine is evaporated in vacuo and the residue is partitioned between ethyl acetate and 5% hydrochloric acid. The ethyl acetate extract is washed with water, dried over sodium sulfate and evaporated to give the corresponding oxime. 9.12 g of NaH is added to a 49 g solution of oxime in 300 ml DMF and the mixture is heated to an internal temperature of 80 to 84 ° C. for 1 hour. The reaction mixture was cooled to room temperature and 27.5 g of ethylbromo acetate was added to 50 ml of DMF. The mixture is stirred for 30 minutes and water is added to decompose excess NaH. The product is extracted with ethyl acetate. The ethyl acetate extract is washed with 10% sodium hydroxide and water, dehydrated over sodium sulfate and evaporated to give a mixture. The mixture is chromatographed on silica gel using chloroform as eluent to afford ethyl {[7-chloro-3- (2-chlorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetate.

뜨거운 에탄올 200㎖중 에스테르 5.86g 용액에 50% 수산화나트륨 6㎖을 가한다. 침전물을 형성하면 현탁액을 1시간동안 환류한다. 물 200㎖을 혼합물에 가하고 농염산물을 충분히 가하여 혼합물을 산성으로 한다. 혼합물을 실온에서 18시간 교반한다. 고형 생성물이 침전되면 이를 여과하고 톨루엔으로 재결정하여 융점 165내지 168℃인 {[7-클로로-3-(2-클로로페닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.To a solution of 5.86 g of ester in 200 ml of hot ethanol, 6 ml of 50% sodium hydroxide is added. When the precipitate forms, the suspension is refluxed for 1 hour. 200 ml of water is added to the mixture and concentrated hydrochloric acid is added to make the mixture acidic. The mixture is stirred at rt for 18 h. When the solid product precipitates, it is filtered and recrystallized with toluene to obtain {[7-chloro-3- (2-chlorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid having a melting point of 165 to 168 캜. Get

Figure kpo00100
Figure kpo00100

[실시예 25]Example 25

a. 실시예 23a의 프리델-크레프트 반응을 1,2-디클로로에탄 125㎖중의 2,3-디클로로아니졸 35.4g, 0-톨루오일 클로라이드 32.4g 및 AlCl328g으로 반복하여 2,3-디클로로-4-메톡시-2'-메틸벤조페논을 얻는다.a. The Friedel-Crafts reaction of Example 23a was repeated with 35.4 g of 2,3-dichloroanizol, 32.4 g of 0-toluoyl chloride and 28 g of AlCl 3 in 125 ml of 1,2-dichloroethane and then 2,3-dichloro-4- Obtain methoxy-2'-methylbenzophenone.

b. 실시예 23b의 방법을 2,3-디클로로-4-메톡시-2'-메틸벤조페논, 벤젠 300㎖중의 AlCl334.6g을 사용하는 것을 제외하고 반복한다. 얻은 생성물을 톨루엔으로 재결정하여 2,3-디클로로-4-하이드록시-2'-메틸벤조페논을 얻는다. 피리딘을 진공에서 증발시키고 잔류물을 에틸아세테이트 및 5% 염산에 분배한다. 에틸아세테이트 추출물을 물로 세척, 황산나트륨으로 탈수 증발시켜 상응하는 옥심을 얻는다. DMF 50㎖ 및 톨루엔 50㎖중의 옥심 12g용액에 NaH 2.43g을 가한다.b. The method of Example 23b was repeated except using 34.6 g of 2,3-dichloro-4-methoxy-2'-methylbenzophenone, AlCl 3 in 300 ml of benzene. The obtained product is recrystallized from toluene to give 2,3-dichloro-4-hydroxy-2'-methylbenzophenone. Pyridine is evaporated in vacuo and the residue is partitioned between ethyl acetate and 5% hydrochloric acid. The ethyl acetate extract is washed with water and dehydrated with sodium sulfate to give the corresponding oxime. 2.43 g of NaH is added to a 12 g solution of oxime in 50 ml of DMF and 50 ml of toluene.

혼합물을 질소기류하에서 51/4시간 동안 내부온도 95내지 98℃까지 가열한다. 다시 DMF 50㎖을 가하고 계속 2시간 동안 내부온도를 95℃로 유지한다. 반응 혼합물을 30℃까지 냉각하고 에틸브로모아세테이트 7.5g을 적가한다. 적가가 끝난 후 1시간 동안 혼합물을 교반한다. 물을 가하고 생성물을 에틸아세테이트로 추출하고 황산나트륨 상에서 건조하고 증발시켜 에틸 {[7-클로로-3-(2-톨일)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.The mixture is heated to an internal temperature of 95-98 ° C. for 51/4 hours under a stream of nitrogen. Add 50 ml of DMF again and keep the internal temperature at 95 ℃ for 2 hours. The reaction mixture is cooled to 30 ° C. and 7.5 g ethylbromoacetate is added dropwise. The mixture is stirred for 1 hour after the addition is completed. Water is added and the product is extracted with ethyl acetate, dried over sodium sulfate and evaporated to afford ethyl {[7-chloro-3- (2-tolyl) -1,2-benzisoxazol-6-yl] oxy} acetate.

뜨거운 에탄올 500㎖중의 에스테르 13.95g 용액에 50% 수산화나트륨 13㎖을 가한다. 침전물이 생성되면 현탁액을 1시간 반동안 환류하고 물 500㎖을 가하고 농황산을 가하여 혼합물을 산성화시킨다. 냉각시켜 고체생성물이 침전되면 이것을 여과하고 톨루엔으로 재결정하여 융점 179내지 181℃인 {[7-클로로-3-(2-톨일)-1,2-벤즈이소옥사졸-6-일]옥시} 아세트산을 얻는다.To a solution of 13.95 g of ester in 500 ml of hot ethanol is added 13 ml of 50% sodium hydroxide. Once a precipitate is formed, the suspension is refluxed for one and a half hours, 500 ml of water is added and concentrated sulfuric acid is added to acidify the mixture. After cooling, the solid product precipitated and was filtered and recrystallized with toluene to remove {[7-chloro-3- (2-tolyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid having a melting point of 179 to 181 ° C. Get

Figure kpo00101
Figure kpo00101

[실시예 26]Example 26

a. 실시예 23a의 프리델-크레프트 반응을 2,3-디메틸 벤조일클로라이드 33.7g, 2,3-디클로로아니졸 54g 및 AlCl326.7g으로 반복하여 2,3-디클로로-4-메톡시-2',3'-디메틸벤조페논을 제조한다.a. The Friedel-Craft reaction of Example 23a was repeated with 33.7 g of 2,3-dimethyl benzoyl chloride, 54 g of 2,3-dichloroanizol and 26.7 g of AlCl 3 to repeat 2,3-dichloro-4-methoxy-2 ', 3 Prepare '-dimethylbenzophenone.

b. 실시예 23b 반응을 벤젠 300㎖중의 2,3-디클로로-4-메톡시-2',3'-디메틸벤조페논을 사용하여 반복한다. 얻어진 생성물을 톨루엔으로 재결정하여 2,3-디클로로-4-하이드록시-2',3'-디메틸벤조페논을 얻는다.b. Example 23b The reaction is repeated using 2,3-dichloro-4-methoxy-2 ', 3'-dimethylbenzophenone in 300 ml of benzene. The obtained product is recrystallized with toluene to give 2,3-dichloro-4-hydroxy-2 ', 3'-dimethylbenzophenone.

c. 피리딘 250㎖중의 2,3-디클로로-4-하이드록시-2',3'-디메틸벤조페논 31g과 하이드록실아민 하이드로클로라이드 30.5g의 혼합물을 약 1주일 동안 환류한다. 피리딘을 진공하에서 증발시키고 잔류물을 에틸아세테이트 및 5% 염산에 분배한다. 에틸아세테이트 추출물을 세척하고 황산나트륨상에서 건조하고 증발시킨다. 헥산으로 처리하여 2,3-디클로로-4-하이드록시-2',3'-디메틸벤조페논옥심을 얻는다.c. A mixture of 31 g of 2,3-dichloro-4-hydroxy-2 ', 3'-dimethylbenzophenone and 30.5 g of hydroxylamine hydrochloride in 250 ml of pyridine is refluxed for about one week. Pyridine is evaporated in vacuo and the residue is partitioned between ethyl acetate and 5% hydrochloric acid. The ethyl acetate extracts are washed, dried over sodium sulphate and evaporated. Treatment with hexanes affords 2,3-dichloro-4-hydroxy-2 ', 3'-dimethylbenzophenone oxime.

d. DMF 70㎖중의 2,3-디클로로-4-하이드록시-2',3'-디메틸벤조페논옥심 5g 용액에 NaH 0.96g을 가한다. 내부온도를 7시간 동안 95내지 120℃로 유지시킨 후 혼합물을 1.5시간 동안 130℃로 가열한다. 반응 혼합물은 냉각하고 에틸브로모아세테이트 2.94g을 적가한다. 혼합물을 1시간 동안 교반하고 물을 적가한다. 생성물을 여과하고 95% 에탄올로 재결정하여 융점 89내지 91℃인 에틸{[7-클로로-3-(2,3-디메틸페닐)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트를 얻는다.d. To a 5 g solution of 2,3-dichloro-4-hydroxy-2 ', 3'-dimethylbenzophenone oxime in 70 ml of DMF was added 0.96 g of NaH. The internal temperature is maintained at 95-120 ° C. for 7 hours and then the mixture is heated to 130 ° C. for 1.5 hours. The reaction mixture is cooled and 2.94 g of ethylbromoacetate is added dropwise. The mixture is stirred for 1 hour and water is added dropwise. The product was filtered and recrystallized with 95% ethanol to give ethyl {[7-chloro-3- (2,3-dimethylphenyl) -1,2-benzisoxazol-6-yl] oxy} acetate having a melting point of 89 to 91 ° C. Get

Figure kpo00102
Figure kpo00102

e. 에틸{[7-클로로-3-(2,3-디메틸페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트 2g, 에탄올 50㎖ 및 50% 수산화나트륨 5㎖의 현탁액을 1시간 동안 환류한다. 뜨거운 물 50㎖ 혼합물에 농염산을 충분히 가하여 반응 혼합물이 산성화되도록 한다. 냉각하고 물을 가하면 융점 170내지 172℃인 {[7-클로로-3-(2,3-디메틸페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산이 침전한다.e. A suspension of 2 g of ethyl {[7-chloro-3- (2,3-dimethylphenyl) -1,2-benzisooxazol-6-yl] oxy} acetate, 50 ml of ethanol and 5 ml of 50% sodium hydroxide was added for 1 hour. Reflux for a while. Sufficient hydrochloric acid is added to a 50 ml mixture of hot water to allow the reaction mixture to acidify. Cooling and adding water precipitates {[7-chloro-3- (2,3-dimethylphenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid with a melting point of 170 to 172 ° C.

Figure kpo00103
Figure kpo00103

[실시예 27]Example 27

a. 무수 THF 150㎖중의 2-브로모피리딘 29.3g을-65℃까지 냉각시킨 2.6M의 n-부틸리튬 75㎖에 가한다. 2,3-디클로로-4-메톡시벤즈알데히드(38.0g)를 THF 300㎖에 가하고 반응 혼합물을 실온이 되도록 한다. 이것을 물에 붓고 결정성 생성물을 여과하고 에테르로 세척, 탈수시켜 융점 174내지 176℃인 α-(2,3-디클로로-4-메톡시페닐)-2-피리딘메탄올을 얻는다.a. 29.3 g of 2-bromopyridine in 150 mL of dry THF is added to 75 mL of 2.6 M n-butyllithium cooled to -65 占 폚. 2,3-Dichloro-4-methoxybenzaldehyde (38.0 g) is added to 300 mL of THF and the reaction mixture is allowed to come to room temperature. It is poured into water and the crystalline product is filtered off, washed with ether and dehydrated to give α- (2,3-dichloro-4-methoxyphenyl) -2-pyridinmethanol having a melting point of 174 to 176 ° C.

b. α-(2,3-디클로로-4-메톡시페닐)-2-피리핀 메탄올(31.86g)을 초산 600㎖ 및 물 100㎖에 녹인다. 무수크롬(11.0g)을 5분동안 가한다. 3시간 후 반응 혼합물을 물에 붓고 에테르로 추출한다. 합한 유기층은 10% 탄산수소나트륨 및 함수로 잘 세척하여 건조한다. 감압하에서 용매를 제거하여 융점 104내지 107℃인(2,3-디클로로-4-메톡시페닐)(2-피리딜)메탄올의 결정성 생성물을 얻는다.b. α- (2,3-dichloro-4-methoxyphenyl) -2-pyripine methanol (31.86 g) is dissolved in 600 ml of acetic acid and 100 ml of water. Anhydrous chromium (11.0 g) is added for 5 minutes. After 3 hours the reaction mixture is poured into water and extracted with ether. The combined organic layers are washed well with 10% sodium hydrogen carbonate and brine and dried. The solvent is removed under reduced pressure to obtain a crystalline product of (2,3-dichloro-4-methoxyphenyl) (2-pyridyl) methanol having a melting point of 104 to 107 캜.

Figure kpo00104
Figure kpo00104

c. (2,3-디클로로-4-메톡시페닐)(20피리딜) 메탄올(32.0g)을 하이드록실아민 30g을 함유하는 에탄올 300㎖중에서 4시간 동안 환류한다. 반응 생성물을 물에 붓고 NH4OH로 알카리성으로 한 다음 에틸아세테이트로 추출한다. 탈수하고 증발시켜 E-(2-피리딜)(2,3-디클로로-4-메톡시-페닐)메탄온옥심과 Z-(2-피리딜)(2,3-디클로로-4-메톡시-페닐)메탄온옥심의 조혼합물을 얻는다.c. (2,3-dichloro-4-methoxyphenyl) (20pyridyl) methanol (32.0 g) is refluxed in 300 ml of ethanol containing 30 g of hydroxylamine for 4 hours. The reaction product is poured into water, made alkaline with NH 4 OH and extracted with ethyl acetate. Dehydration and evaporation resulted in E- (2-pyridyl) (2,3-dichloro-4-methoxy-phenyl) methanone oxime and Z- (2-pyridyl) (2,3-dichloro-4-methoxy- A crude mixture of phenyl) methanone oxime is obtained.

옥심 혼합물을 DMF 200㎖에 녹이고 150㎖ DMF내의 NaH 3.1g 현탁액에 가한다. 15분후 반응 혼합물을 물에 붓고 생성물을 여과한다. 이소프로판올로 재결정하여 미반응의 E-옥심을 제거시키고 융점 164 내지 166℃인 7-클로로-6-메톡시-3-(2-피리딜)-1,2-벤즈이소옥사졸을 얻는다.The oxime mixture is taken up in 200 ml of DMF and added to a 3.1 g suspension of NaH in 150 ml DMF. After 15 minutes the reaction mixture is poured into water and the product is filtered off. Recrystallization with isopropanol removes unreacted E-oxime and affords 7-chloro-6-methoxy-3- (2-pyridyl) -1,2-benzisoxazole having a melting point of 164 to 166 ° C.

Figure kpo00105
Figure kpo00105

d. 7-클로로-6-메톡시-3-(2-피리딜)-1,2-벤즈 이소옥사졸(24.4g)을 48% 하이드로브로마이드 450㎖중에서 환류시킨다. 침전된 하이드로브로마이드 염을 여과시키고 에테르로 세척 10% 탄산수소나트륨 용액으로 중화시킨다. 유리염기를 여과하고 건조하여 융점 209내지 211℃ 인 7-클로로-6-하이드록시-3-(2-피리딜)-1,2-벤즈이소옥사졸을 얻는다.d. 7-Chloro-6-methoxy-3- (2-pyridyl) -1,2-benz isoxoxazole (24.4 g) is refluxed in 450 ml of 48% hydrobromide. Precipitated hydrobromide salt is filtered and neutralized with 10% sodium bicarbonate solution washed with ether. The free base is filtered and dried to give 7-chloro-6-hydroxy-3- (2-pyridyl) -1,2-benzisoxazole having a melting point of 209 to 211 ° C.

Figure kpo00106
Figure kpo00106

e. 7-클로로-6-하이드록시-3-(2-피리딜)-1,2-벤즈이소옥사졸(10.0g)을 DMF 80㎖에 녹이고 DMF 50㎖중의 NaH(1.1g)의 빙냉현탁액에 가한다. 수소의 기화가 끝났을때, DMF 20㎖중의 에틸 브로모 아세테이트(7.5g)를 가한다. 다시 90분후 물 200㎖와 50% 수산화나트륨 10㎖을 가하고 반응물을 45분동안 65℃로 가열한다. 혼합물을 물에 붓고 pH 1내지 2까지 산성화하고 고형생성물을 여과 건조하여 융점 255내지 256℃인 {[7-클로로-3-(2-피리딜)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.e. 7-Chloro-6-hydroxy-3- (2-pyridyl) -1,2-benzisooxazole (10.0 g) is dissolved in 80 ml of DMF and added to an ice-cold suspension of NaH (1.1 g) in 50 ml of DMF. . When the evaporation of hydrogen is complete, ethyl bromo acetate (7.5 g) in 20 ml of DMF is added. After 90 minutes, 200 ml of water and 10 ml of 50% sodium hydroxide are added and the reaction is heated to 65 ° C. for 45 minutes. The mixture was poured into water, acidified to pH 1-2, and the solid product was filtered and dried to produce {[7-chloro-3- (2-pyridyl) -1,2-benzisoxazol-6-yl having a melting point of 255 to 256 ° C. ] Oxy} acetic acid.

Figure kpo00107
Figure kpo00107

[실시예 28]Example 28

a. 7-클로로-6-하이드록시-3-(2-피리딜)-1,2-벤즈이소옥사졸(9.9g)을 60ㅅ에서 빙초산 600㎖에 녹인다. 이때 m-클로로-과벤조산(85%의 8.3g)을 가한다. 14시간 동안 60℃에서 가열한후 반응물을 물 2ℓ에 붓고 생성물을 여과하고 메탄올 및 에테르로 세척한다. 얻은 생성물을 DMF/물로부터 재결정하여 헤미하이드레이트 형태의 융점 214℃인 7-클로로-6-하이드록시-3-(2-피리딜)-1,2-벤즈이소옥사졸 1'-옥사이드를 얻는다.a. Dissolve 7-chloro-6-hydroxy-3- (2-pyridyl) -1,2-benzisoxazole (9.9 g) in 600 ml of glacial acetic acid at 60 ° C. At this time, m-chloro-perbenzoic acid (85% of 8.3 g) is added. After heating at 60 ° C. for 14 h the reaction is poured into 2 L of water and the product is filtered off and washed with methanol and ether. The obtained product is recrystallized from DMF / water to give 7-chloro-6-hydroxy-3- (2-pyridyl) -1,2-benzisoxazole 1'-oxide having a melting point of 214 ° C in the form of hemihydrate.

Figure kpo00108
Figure kpo00108

b. 7-클로로-6-하이드록시 3-(2-피리딜)-1,2-벤즈이소옥사졸 1'-옥사이드(7.30g)을 DMF 20㎖에 녹이고 DMF 50㎖중의 NaH(1.33g)현탁액에 가한다. 15분후 DMF 20㎖중의 에틸브로모 아세테이트(5.0g)를 가하고 반응물을 10시간 동안 50℃에서 가열한다. 반응물을 물로 식히고 산성화하여 침전물을 여과시키고 잘 건조한다. 침전물을 다시 NaH 1.33g 및 DMF중의 에틸브로모아세테이트 5.0g으로 처리한다. 30분후 물 200㎖와 50% 수산화나트륨 10㎖을 가하고 반응 혼합물을 30분동안 50℃에서 가열한다. 이후 이것을 산성화시키고 융점 214℃(d)인 {[7-클로로-3-(2-피리딜)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산 1'-옥사이드를 얻는다.b. Dissolve 7-chloro-6-hydroxy 3- (2-pyridyl) -1,2-benzisoxazole 1'-oxide (7.30 g) in 20 ml of DMF and add to NaH (1.33 g) suspension in 50 ml of DMF. do. After 15 minutes ethylbromo acetate (5.0 g) in 20 mL DMF is added and the reaction is heated at 50 ° C. for 10 hours. The reaction is cooled with water and acidified to filter the precipitate and dry well. The precipitate is again treated with 1.33 g of NaH and 5.0 g of ethyl bromoacetate in DMF. After 30 minutes, 200 ml of water and 10 ml of 50% sodium hydroxide are added and the reaction mixture is heated at 50 ° C. for 30 minutes. This is then acidified and a {[7-chloro-3- (2-pyridyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid 1'-oxide having a melting point of 214 ° C (d).

Figure kpo00109
Figure kpo00109

[실시예 29]Example 29

a. m-디메톡시벤젠(27.6g) 및 0-플루오로벤조일클로라이드(31.7g)를 디클로로에탄 200㎖에 녹이고 AlCl3(28.0g)를 가한다. 두시간 후 다시 AlCl356g을 가하고 반응물을 1.5시간 동안 60℃에서 가열한다. 이후 이것을 물에 붓고 에틸아세테이트로 추출한다. 건조하고 증발시켜 결정성 화합물을 얻는다. 톨루엔으로 처리하여 융점 109내지 111℃인 2,4-디하이드록시-2'-플루오로벤조페논을 얻는다.a. m-dimethoxybenzene (27.6 g) and 0-fluorobenzoylchloride (31.7 g) are dissolved in 200 mL of dichloroethane and AlCl 3 (28.0 g) is added. After two hours, 56 g of AlCl 3 was added again and the reaction was heated at 60 ° C. for 1.5 h. It is then poured into water and extracted with ethyl acetate. Dry and evaporate to give crystalline compound. Treatment with toluene yields 2,4-dihydroxy-2'-fluorobenzophenone having a melting point of 109-111 占 폚.

Figure kpo00110
Figure kpo00110

b. 2,4-디하이드록시-2'-플루오로벤조페논 (25.0g)을 하이드록실아민 하이드로클로라이드 17.1g을 함유하는 피리딘 250㎖중에서 18시간동안 환류한다. 반응 혼합물을 에테르 및 5%염산에 분배하고 유기층을 분리한다. 건조하고 증발시키고, 톨루엔으로 재결정하여 융점 170내지 172℃인 2,4-디하이드록시-2'-플루오로벤조페논 [E-옥심]의 순수한 이성체를 얻는다.b. 2,4-dihydroxy-2'-fluorobenzophenone (25.0 g) is refluxed for 18 hours in 250 ml of pyridine containing 17.1 g of hydroxylamine hydrochloride. The reaction mixture is partitioned between ether and 5% hydrochloric acid and the organic layer is separated. Dry, evaporate and recrystallize with toluene to obtain pure isomers of 2,4-dihydroxy-2'-fluorobenzophenone [E-oxime] having a melting point of 170 to 172 ° C.

Figure kpo00111
Figure kpo00111

c. E-옥심 2,4-디하이드로-2'-플루오로벤조페논 옥심(18.6g)을 5시간 동안 무수아세트산 18.0㎖중에서 50℃로 가열하고 6시간 동안 60℃로 가온시킨다. 추가의 무수초산 3.0㎖을 가하고 반응물을 73시간동안 실온에서 동요시키지 않고 방치한다. 반응 혼합물로부터 분리된 결정성 생성물을 냉에테르로 세척하여 융점 132내지 134℃인 E-4-아세톡시-2-하이드록시-2'-플루오로벤조페논 0-아세틸옥심을 얻는다.c. E-oxime 2,4-dihydro-2'-fluorobenzophenone oxime (18.6 g) is heated to 50 ° C. in 18.0 ml of acetic anhydride for 5 hours and warmed to 60 ° C. for 6 hours. An additional 3.0 ml of acetic anhydride is added and the reaction is left without shaking at room temperature for 73 hours. The crystalline product isolated from the reaction mixture is washed with cold ether to give E-4-acetoxy-2-hydroxy-2'-fluorobenzophenone 0-acetyloxime having a melting point of 132 to 134 ° C.

Figure kpo00112
Figure kpo00112

d. E-4-아세톡시-2-하이드록시-2'-플루오로벤조페논 0-아세틸옥심(18.4g)을 DMF 80㎖에 녹이고 DMF 100㎖중의 NaH(3.3g)냉각 현탁액에 가한다. 90분후 반응 혼합물을 물에 붓고 소량의 불용성침전물을 여과한다. 수용성 여액을 산성화하고 에테르로 추출하여 건조 및 증발 후 융점 206내지 210℃인 3-(2-플루오로페닐)-6-하이드록시-1,2-벤조이소옥사졸을 얻는다.d. E-4-acetoxy-2-hydroxy-2'-fluorobenzophenone 0-acetyloxime (18.4 g) is taken up in 80 ml of DMF and added to NaH (3.3 g) cooling suspension in 100 ml of DMF. After 90 minutes the reaction mixture is poured into water and a small amount of insoluble precipitate is filtered off. The aqueous filtrate is acidified and extracted with ether to give 3- (2-fluorophenyl) -6-hydroxy-1,2-benzoisoxazole having a melting point of 206 to 210 ° C. after drying and evaporation.

Figure kpo00113
Figure kpo00113

e. 3-(2-플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸(9.7g)을 DMF 80㎖에 녹이고 DMF 50㎖중의 나트륨 하이드라이드(1.4g)냉각 현탁액에 가한다. 수소발생이 끝났을 때 DMF20㎖중의 에틸브로모아세테이트(7.5g)을 가하고 반응 혼합물을 실온이 되도록 한다. 2시간 후 DMF20㎖와 50% NaOH 10㎖을 가하고 반응물을 50℃에서 가열한다. 다시 30분후 생성물을 산성화시키고 여과하여 얻는다. 톨루엔/CH3CN으로 재결정하여 융점 182°내지 180℃인 {[3(2-플루오르페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.e. 3- (2-fluorophenyl) -6-hydroxy-1,2-benzisoxazole (9.7 g) is dissolved in 80 ml of DMF and added to sodium hydride (1.4 g) cooling suspension in 50 ml of DMF. At the end of hydrogen evolution, ethyl bromoacetate (7.5 g) in 20 mL of DMF is added and the reaction mixture is brought to room temperature. After 2 hours, 20 ml of DMF and 10 ml of 50% NaOH are added and the reaction is heated at 50 ° C. After another 30 minutes the product is acidified and filtered. Recrystallization with toluene / CH 3 CN gives {[3 (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid having a melting point of 182 ° to 180 ° C.

Figure kpo00114
Figure kpo00114

[실시예 30]Example 30

a. 실시예 23a p의 프리델-크레프트반응을 P-플루오로벤조일 클로라이드 31.55g, 디클로로아니졸 32g과 1,2-디클로로에탄중의 AlCl335.22g으로 반복한다. 얻은 조생성물은 따뜻한 헥산으로 처리하고 냉각하고 여과하여 2,3-디클로로-4-메톡시-4'-플루오로 벤조페논을 얻는다.a. The Friedel-Craft reaction of Example 23a p is repeated with 31.55 g P-fluorobenzoyl chloride, 32 g dichloroanizol and 35.22 g AlCl 3 in 1,2-dichloroethane. The crude product obtained is treated with warm hexane, cooled and filtered to give 2,3-dichloro-4-methoxy-4'-fluoro benzophenone.

b. 2,3-디클로로-4-메톡시-4'-플루오로벤조페논 39.5g과 피리딘 하이드로클로라이드 160g의 혼합물을 1시간동안 200℃에서 가열한다. 반응 혼합물을 교반하면서 얼음물에 붓고 침전을 형성시킨다. 침전물을 여과하고 약 18시간동안 건조하여 2,3-디클로로-4-하이드록시-4'-플루오로벤조페논을 얻는다.b. A mixture of 39.5 g of 2,3-dichloro-4-methoxy-4'-fluorobenzophenone and 160 g of pyridine hydrochloride is heated at 200 ° C. for 1 hour. The reaction mixture is poured into iced water with stirring to form a precipitate. The precipitate is filtered and dried for about 18 hours to give 2,3-dichloro-4-hydroxy-4'-fluorobenzophenone.

c. 피리딘 250㎖중의 2,3-디클로로-4-하이드록시-4'-플루오로벤조페논 용액에 하이드록실아민 HCl 34.6g을 가한다. 혼합물을 4시간 동안 환류한다. 피리딘을 진공중에서 증발시킨다. 잔류물을 5% HCl과 에틸아세테이트에 분배한다. 에틸아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 융점 150내지 150℃인 2,3-디클로로-4-하이드록시-4'-플루오로벤조페논 옥심을 이성체의 혼합물로서 얻는다.c. 34.6 g of hydroxylamine HCl is added to a 2,3-dichloro-4-hydroxy-4'-fluorobenzophenone solution in 250 ml of pyridine. The mixture is refluxed for 4 hours. Pyridine is evaporated in vacuo. The residue is partitioned between 5% HCl and ethyl acetate. The ethyl acetate extract is washed with water, dried over Na 2 SO 4 and evaporated to give 2,3-dichloro-4-hydroxy-4'-fluorobenzophenone oxime having a melting point of 150 to 150 ° C. as a mixture of isomers.

Figure kpo00115
Figure kpo00115

d. DMF50㎖중의 NaH 4.0g의 혼합물에 DMF 100㎖중의 2,3-디클로로-4-하이드록시-4'-플루오로벤조페논 옥심 20g의 용액 N2을기압하에 적가한다. 반응 혼합물을 2시간 동안 내부온도 96℃가 될때까지 가열한다. 반응 혼합물을 40℃까지 냉각하고 에틸브로모아세테이트 12.3g을 적가하고 혼합물을 1시간 동안 교반한다. 50 NaOH 20㎖와 물 100㎖을 가하고 반응물을 1시간 동안 80내지 90℃에서 가열한다. 반응 혼합물이 산성이 될때까지 농 HCl을 가하고 혼합물을 30분동안 교반하고 물을 가한다. 고형생성물을 여과하여 모으고 재결정시켜 융점 233내지 237℃인 {[7-클로로-3-(4-플루오로페닐)-1,2-벤즈이소옥사졸-6-일] 옥시} 아세트산의 순수물을 얻는다.d. To a mixture of 4.0 g of NaH in 50 ml of DMF is added dropwise a solution N 2 of 20 g of 2,3-dichloro-4-hydroxy-4'-fluorobenzophenone oxime in 100 ml of DMF under pressure. The reaction mixture is heated to an internal temperature of 96 ° C. for 2 hours. The reaction mixture is cooled to 40 ° C., 12.3 g ethylbromoacetate is added dropwise and the mixture is stirred for 1 hour. 20 mL of 50 NaOH and 100 mL of water are added and the reaction is heated at 80-90 ° C. for 1 hour. Concentrated HCl is added until the reaction mixture is acidic, the mixture is stirred for 30 minutes and water is added. The solid product is collected by filtration and recrystallized to obtain a pure product of {[7-chloro-3- (4-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetic acid having a melting point of 233 to 237 ° C. .

Figure kpo00116
Figure kpo00116

[실시예 31]Example 31

a. 2,6-디메톡시톨루엔(20.0g)과 0-플루오로벤조일 클로라이드(19.8g)을 디클로로에탄 250㎖에 녹이고 5℃까지 냉각시킨다. AlCl3를 부분적으로 가하고 완전히 끝났을 때 반응 혼합물을 30분이상 실온까지 가열한다. 이후 30분동안 환류한다. 이 후 이것을 5% HCl에 붓고 18시간동안 흔들지 않고 그대로 방치한다. 에테르로 추출하고, 건조하고, 농축하고 헥산으로 세척하여 융점 118내지 120℃인 2'플루오로-2-하이드록시-4-메톡시-3-메틸벤조페논의 결정성 물질을 얻는다.a. 2,6-dimethoxytoluene (20.0 g) and 0-fluorobenzoyl chloride (19.8 g) are dissolved in 250 ml of dichloroethane and cooled to 5 ° C. AlCl 3 is added in part and when complete the reaction mixture is heated to room temperature for at least 30 minutes. Then reflux for 30 minutes. This is then poured into 5% HCl and left unchanged for 18 hours. Extract with ether, dry, concentrate and wash with hexane to obtain crystalline material of 2'fluoro-2-hydroxy-4-methoxy-3-methylbenzophenone having a melting point of 118 to 120 ° C.

Figure kpo00117
Figure kpo00117

b. 2'플루오로-2-하이드록시-4-메톡시-3-메틸벤조페논(30.0g)을 하이드록실아민 하이드로클로라이드 32.0g을 함유한 피리딘 350㎖중에서 환류한다. 용매는 진공에서 제거하고 잔류물을 에테르 및 5% HCl에 분배한다. 에테르를 건조 농축시키고 조생성물을 수득하여 질소 기압하에서 30분동안 200℃에서의 용융 가열한다. 용융물을 냉각하고 고형물을 헥산으로 잘 처리하여 융점 167내지 169℃인 E-2'-플루오로-2-하이드록시-4-메톡시-3-메틸벤조페논옥심을 얻는다.b. 2'fluoro-2-hydroxy-4-methoxy-3-methylbenzophenone (30.0 g) is refluxed in 350 ml of pyridine containing 32.0 g of hydroxylamine hydrochloride. The solvent is removed in vacuo and the residue is partitioned between ether and 5% HCl. The ether is concentrated to dryness and the crude product is obtained and melt heated at 200 ° C. for 30 minutes under nitrogen atmosphere. The melt is cooled and the solid is well treated with hexane to give E-2'-fluoro-2-hydroxy-4-methoxy-3-methylbenzophenone oxime having a melting point of 167-169 ° C.

Figure kpo00118
Figure kpo00118

c. E-2'-플루오로-2-하이드록시-4-메톡시-3-메틸벤조페논 옥심(20.0g)을 무수아세트산 12㎖과 함께 1시간 동안 증기욕상에서 가열한다. 무수아세트산을 진공중에서 증발시키고 생성물을 에테르와 H2O 사이에서 분배하고, 이 후 에테르를 10 %NaHCO3로 세척한다. 증발시킨후 헥산으로 결정성물질을 처리하여 융점 83내지 86℃인 E-2'-플루오로-2-하이드록시-4-메톡시-3-메틸벤조는 0-아세틸옥심을 얻는다.c. E-2'-fluoro-2-hydroxy-4-methoxy-3-methylbenzophenone oxime (20.0 g) is heated in a steam bath with 12 ml of acetic anhydride for 1 hour. Acetic anhydride is evaporated in vacuo and the product is partitioned between ether and H 2 O, after which the ether is washed with 10% NaHCO 3 . After evaporation, the crystalline material was treated with hexane to give 0-acetyl oxime for E-2'-fluoro-2-hydroxy-4-methoxy-3-methylbenzo having a melting point of 83 to 86 占 폚.

Figure kpo00119
Figure kpo00119

d. E-2'-플루오로-2-하이드록시-3-메틸벤조페논 0-아세틸옥심(22.0g)을 DMF 100㎖에 녹이고 DMF 100㎖중의 NaH 2.5g 현탁액에 가한다. 빙욕으로 30℃이하의 온도를 유지한다. 40분 후 반응물을 H2O에 붓고 에테르로 추출한다. H2O로 잘 세척한 후 에테르를 건조시키고 증발시켜 결정성 생성물을 수득하여 냉헥산으로 세척하면 융점 105내지 108℃의 3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.d. E-2'-fluoro-2-hydroxy-3-methylbenzophenone 0-acetyloxime (22.0 g) was dissolved in 100 mL of DMF and added to a 2.5 g suspension of NaH in 100 mL of DMF. The temperature is kept below 30 ℃ in an ice bath. After 40 minutes the reaction is poured into H 2 O and extracted with ether. After washing well with H 2 O, the ether was dried and evaporated to give crystalline product, which was then washed with cold hexane to give 3- (2-fluorophenyl) -6-methoxy-1,2- with a melting point of 105 to 108 ° C. Obtain benzisoxazoles.

Figure kpo00120
Figure kpo00120

e. 3-(2-플루오로페닐)-6-메톡시-7-메틸-1,2-벤즈이소옥사졸(16.1g)을 피리딘 하이드로클로라이드 64g과 함께 2시간 동안 200℃에서 가열한다. 용융물을 H2O에 붓고 에틸아세테이트로 추출한다. 5% HCl로 세척후 에틸아세테이트를 건조하고 증발시켜 융점 216내지 219℃인 3-(2-플루오로페닐)-6-하이드록시-7-메틸-1,2-벤즈이소옥사졸을 얻는다.e. 3- (2-fluorophenyl) -6-methoxy-7-methyl-1,2-benzisooxazole (16.1 g) is heated with 64 g of pyridine hydrochloride at 200 ° C. for 2 hours. The melt is poured into H 2 O and extracted with ethyl acetate. After washing with 5% HCl, ethyl acetate was dried and evaporated to obtain 3- (2-fluorophenyl) -6-hydroxy-7-methyl-1,2-benzisoxazole having a melting point of 216 to 219 ° C.

Figure kpo00121
Figure kpo00121

f. 3-(2-플루오로페닐)-6-하이드록시-7-메틸-1,2-벤즈이소옥사졸(10.6g)을 DMF 90㎖에 녹이고 에틸브로모아세테이트 8.0g과 K2CO36.7g으로 처리한다. 반응물을 2시간 동안 60℃에서 가열하고 주위온도로 되게한다. 주위온도에서 18시간 후 물 200와 50% NaOH (15㎖)를 가하고 용액을 90분동안 90℃에서 가열한다. 건조하고 증발시켜 융점 158내지 160℃인 {[3-(2-플루오로페닐)-7-메틸-1,2-벤즈이소옥사졸-6-일]옥시}아세트산의 결정성 물질을 얻는다.f. Dissolve 3- (2-fluorophenyl) -6-hydroxy-7-methyl-1,2-benzisoxazole (10.6 g) in 90 mL of DMF, and use 8.0 g of ethyl bromoacetate and 6.7 g of K 2 CO 3 . Process. The reaction is heated at 60 ° C. for 2 hours and brought to ambient temperature. After 18 hours at ambient temperature water 200 and 50% NaOH (15 mL) are added and the solution is heated at 90 ° C. for 90 minutes. Drying and evaporation yields a crystalline material of {[3- (2-fluorophenyl) -7-methyl-1,2-benzisooxazol-6-yl] oxy} acetic acid having a melting point of 158 to 160 ° C.

Figure kpo00122
Figure kpo00122

[실시예 32]Example 32

a. m-클로로아니졸(28.5g)과 0-플루오로 벤조일 클로라이드(31.7g)을 디클로로에탄 200㎖에 녹이고 AlCl326.7g으로 10℃에서 처리한다. 건조하고 증발시키고 헥산으로 처리하여 2-클로로-2'-플루오로-4-메톡시벤조페논을 함유하는 물질을 얻는다. Et2O/헥산으로 재결정하여 융점 77내지 79℃인 2-클로로-2'-플루오로-4-메톡시벤제페논을 얻는다.a. m-chloroanizol (28.5 g) and 0-fluoro benzoyl chloride (31.7 g) are dissolved in 200 mL of dichloroethane and treated with 26.7 g of AlCl 3 at 10 ° C. Dry, evaporate and treat with hexane to give a material containing 2-chloro-2'-fluoro-4-methoxybenzophenone. Recrystallization with Et 2 O / hexane affords 2 -chloro-2'-fluoro-4-methoxybenzefenone having a melting point of 77 to 79 ° C.

Figure kpo00123
Figure kpo00123

b. 2-클로로-2'-플루오로-4-메톡시벤조페논 (15.5g)을 하이드록실아민 하이드로클로라이드 10.0g을 함유하는 피리딘 150㎖중에서 3시간 동안 환류한다. 피리딘을 진공중에서 제거하고 잔류물을 에테르와 5%HCl 사이에서 분배한다. 유기층을 건조하고 증발시켜 옥심의 이성체 혼합물을 얻는다. 혼합물을 DMF 50㎖에 녹이고 DMF 30㎖중의 NaH 1.5g현탁액에 가한다. 30분동안 60℃에서 가열한 후 반응 혼합물을 H2O에 붓고 에테르로 추출한다. 감압하에 농축하여 고체를 얻는다. 에테르로 재결정하여 융점 101내지 103℃인 3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.b. 2-Chloro-2'-fluoro-4-methoxybenzophenone (15.5 g) is refluxed for 3 h in 150 ml of pyridine containing 10.0 g of hydroxylamine hydrochloride. Pyridine is removed in vacuo and the residue is partitioned between ether and 5% HC1. The organic layer is dried and evaporated to yield an isomeric mixture of oximes. The mixture is taken up in 50 ml of DMF and added to a 1.5 g suspension of NaH in 30 ml of DMF. After heating at 60 ° C. for 30 minutes, the reaction mixture is poured into H 2 O and extracted with ether. Concentration under reduced pressure gives a solid. Recrystallization with ether gives 3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 101 to 103 캜.

Figure kpo00124
Figure kpo00124

c. 3-(2-플루오로페닐(-6-메톡시-1,2-벤즈이소옥사졸을 무수 THF 400㎖에 -40℃에서 녹이고 2.2M n-부틸리튬 21㎖로 처리한다. 1시간 동안 교반 후 에테르 90㎖중의 I2(11.7g)를 가한다. 반응 혼합물을 Na2S2O3에 부은 다음 H2O에 붓는다. 건조하고 농축하여 융점 135내지 138℃인 3-(2-플루오로페닐)-7-요도-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.c. 3- (2-fluorophenyl (-6-methoxy-1,2-benzisoxazole is dissolved in 400 ml of dry THF at -40 ° C and treated with 21 ml of 2.2 M n-butyllithium. After stirring for 1 hour I 2 (11.7 g) in 90 mL of ether is added The reaction mixture is poured into Na 2 S 2 O 3 and poured into H 2 O. Dried and concentrated to 3- (2-fluorophenyl with a melting point of 135 to 138 ° C. ) -7-urido-6-methoxy-1,2-benzisoxazole is obtained.

Figure kpo00125
Figure kpo00125

d. 3-(2-플루오로페닐)-7-요도-6-메톡시-1,1-벤즈이소옥사졸(8.2g)을 BBr36.6㎖을 함유하는 CH2Cl2130㎖중에서 18시간 동안 환류한다. 반응 혼합물을 H2O에 붓고 에테르로 추출한다. 건조하고 증발시켜 헥산으로 잘 처리한 후 융점 212내지 214℃인 3-(2-플루오로페닐)-6-하이드록시-7-요도-1,2-벤즈이소옥사졸의 결정성 생성물을 얻는다.d. 3- (2-fluorophenyl) -7-urido-6-methoxy-1,1-benzisoxazole (8.2 g) is refluxed for 18 h in 130 ml of CH 2 Cl 2 containing 6.6 ml of BBr 3 . . The reaction mixture is poured into H 2 O and extracted with ether. After drying and evaporation to good treatment with hexane, a crystalline product of 3- (2-fluorophenyl) -6-hydroxy-7-uredo-1,2-benzisoxazole having a melting point of 212 to 214 ° C is obtained.

Figure kpo00126
Figure kpo00126

e. DMF 80㎖중의 3-(2-플루오로페닐)-6-하이드록시-7-요도-1,2-벤즈이소옥사졸(7.80g)을 60℃에서 K2CO36.6g 및 에틸브로모아세테이트 7.1g으로 처리한다. 한 시간 후 온도를 90℃까지 상승시키고 H2O 80㎖와 50% NaOH8㎖를 가한다. 계속하여 30분 후 혼합물을 H2O에 붓고 산성화시킨 후 에테르로 추출, 건조, 증발시켜 융점 178내지 180℃인 {[3-(2-플루오로페닐)-7-요도-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.e. 6.6 g of K 2 CO 3 and ethyl bromoacetate 7.1 at 60 ° C. were treated with 3- (2-fluorophenyl) -6-hydroxy-7-urido-1,2-benzisooxazole (7.80 g) in 80 mL of DMF. Treat with g. After one hour the temperature was raised to 90 ° C. and 80 ml of H 2 O and 8 ml of 50% NaOH were added. After 30 minutes, the mixture was poured into H 2 O, acidified, extracted with ether, dried, and evaporated to produce {[3- (2-fluorophenyl) -7-uredo-1,2-benzi having a melting point of 178 to 180 ° C. Oxazol-6-yl] oxy} acetic acid is obtained.

Figure kpo00127
Figure kpo00127

[실시예 33]Example 33

a. 실시예 32b의 3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 10g을 무수 THF 400㎖에 녹이고 -40℃에서 2.2M n-부틸리듐 21㎖로 처리한다. 한 시간 동안 교반하고 브롬(2.5㎖)을 적가한다. 반응혼합물을 H2O에 붓고 에테르로 추출하고 용액으로 세척한다. 건조하고 증발시켜 원하는 브롬화생성물을 함유하는 물질인 융점 150내지 153℃의 7-브로모-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.a. 10 g of 3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole of Example 32b is dissolved in 400 mL of anhydrous THF and treated with 21 mL of 2.2 M n-butyliridium at -40 ° C. Stir for 1 hour and add dropwise bromine (2.5 mL). The reaction mixture is poured into H 2 O, extracted with ether and washed with solution. Drying and evaporation yields 7-bromo-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 150 to 153 ° C. which is a material containing the desired bromination product.

Figure kpo00128
Figure kpo00128

b. 7-브로모-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸(7.20g)을 BBr36.6㎖을 함유하는 CH2Cl2130㎖ 중에서 18시간 동안 환류한다. 반응 혼합물을 H2O에 붓고 에틸아세테이트로 추출한다. 증발하고 헥산으로 처리하여 융점 231내지 234℃인 상응하는 페놀을 얻는다. DMF 80㎖중의 페놀(6.30g)을 60℃에서 K2CO36.6g과 에틸브로모아세테이트 7.9g으로 처리한다. 한시간 후 DMF 80㎖와 50% NaOH8㎖을 가하고 온도를 90℃까지 올린다. 다시 45분 후 반응물을 산성화하고 에틸아세테이트로 추출한다. 증발하로 톨루엔/CH2CN으로 재결정하여 융점 180내지 182℃인 {[7-브로모-3-(2-플루오로 페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.b. 7-Bromo-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole (7.20 g) was refluxed in 130 ml of CH 2 Cl 2 containing 6.6 ml of BBr 3 for 18 hours. do. The reaction mixture is poured into H 2 O and extracted with ethyl acetate. Evaporation and treatment with hexanes yields the corresponding phenols having a melting point of 231 to 234 ° C. Phenol (6.30 g) in 80 ml of DMF was treated with 6.6 g of K 2 CO 3 and 7.9 g of ethyl bromoacetate at 60 ° C. After an hour, 80 ml of DMF and 8 ml of 50% NaOH are added and the temperature is raised to 90 ° C. After 45 minutes the reaction is acidified and extracted with ethyl acetate. Recrystallization with toluene / CH 2 CN under evaporation yields {[7-bromo-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid with a melting point of 180 to 182 ° C. .

Figure kpo00129
Figure kpo00129

[실시예 34]Example 34

a. 5℃에서 1,2-디클로로에탄 60㎖중의 2-클로로 레졸시놀 디메틸 에테르 4g과 2,3-디플루오로벤조일클로라이드 3.7g의 혼합물에 AlCl33.06g을 일부씩 가한다. 혼합물을 실온으로 가온시키고 30분동안 환류한다. 반응 혼합물을 농 HCl-얼음에 붓고 약 72시간 동안 방치한다. 수용액층을 추가의 유기용매로 추출하고 Na2SO4상에서 건조하고, 증발시켜 융점 161내지 132°인 3-클로로-2-하이드록시-4-메톡시-2',3'-디플루오로벤조페놀을 얻는다.a. 3.06 g of AlCl 3 is added in portions to a mixture of 4 g of 2-chloro resorcinol dimethyl ether and 3.7 g of 2,3-difluorobenzoyl chloride in 60 ml of 1,2-dichloroethane at 5 ° C. The mixture is allowed to warm to room temperature and refluxed for 30 minutes. The reaction mixture is poured into concentrated HCl-ice and left for about 72 hours. The aqueous layer was extracted with additional organic solvent, dried over Na 2 SO 4 and evaporated to 3-chloro-2-hydroxy-4-methoxy-2 ', 3'-difluorobenzo having a melting point of 161 to 132 °. Get phenol

Figure kpo00130
Figure kpo00130

b. 160㎖피리딘중의 3-클로로-2-하이드록시-4-메톡시-2',3'-디플루오로벤조페논 24g의 용액에 하이드록실 아민 22g을 가한다. 혼합물을 2시간 동안 환류하고 진공하에 피리딘을 증발시킨다. 잔류물을 에틸아세테이트를 HCl에 분배시킨다. 에틸 아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 두 개의 이성체로 구성된 미황색 고체를 얻는다. 이 고체를 약 13분동안 205℃에서 용융한다.b. To a solution of 24 g of 3-chloro-2-hydroxy-4-methoxy-2 ', 3'-difluorobenzophenone in 160 ml pyridine is added 22 g of hydroxyl amine. The mixture is refluxed for 2 hours and the pyridine is evaporated under vacuum. The residue is partitioned between ethyl acetate and HCl. The ethyl acetate extract is washed with water, dried over Na 2 SO 4 and evaporated to give a pale yellow solid consisting of two isomers. This solid is melted at 205 ° C. for about 13 minutes.

잔류물을 뜨거운 에틸아세테이트에 녹이고 증발시켜 건조하여 융점 198내지 199℃인 E-3-클로로-2',3'-디플루오로-2-하이드록시-4-메톡시 벤조페논 옥심을 얻는다.The residue is taken up in hot ethyl acetate and evaporated to dryness to afford E-3-chloro-2 ', 3'-difluoro-2-hydroxy-4-methoxy benzophenone oxime having a melting point of 198 to 199 ° C.

Figure kpo00131
Figure kpo00131

c. E-3-클로로-2',3'-디플루오로-2-하이드록시-4-메톡시 벤조페논 옥심 1.5g과 무수아세트산 0.67g을 30분동안 60℃에서 가온시킨다. 혼합물을 녹이고 고체화시킨다. 잔류물을 에틸 아세테이트와 10% NaHCO3에 분배한다. 에틸 아세테이트추출물을 세척하고 Na2SO4상에서 건조하여 증발시켜 융점 136내지 139℃인 E-3-클로로-2',3'-디플루오로-2-하이드록시-4-메톡시벤조페논 0-아세틸옥심을 얻는다.c. 1.5 g of E-3-chloro-2 ', 3'-difluoro-2-hydroxy-4-methoxy benzophenone oxime and 0.67 g of acetic anhydride are warmed at 60 ° C. for 30 minutes. The mixture is dissolved and solidified. The residue is partitioned between ethyl acetate and 10% NaHCO 3 . Ethyl acetate extracts were washed, dried over Na 2 SO 4 and evaporated to E-3-chloro-2 ', 3'-difluoro-2-hydroxy-4-methoxybenzophenone with a melting point of 136 to 139 ° C. Acetyl oxime is obtained.

Figure kpo00132
Figure kpo00132

d. DMF 200㎖중의 NaH 1.4g 혼합물에 DMF 200㎖중의 E-3-클로로-2',3'-디플루오로-2-하이드록시-4-메톡시 벤조페닐 0-아세틸옥심 19g의 용액을 질소기압하에 적가한다. 혼합물을 30분동안 교반하고 30분동안 45℃로 가온시킨다. 물을 가하여 생성물을 침전시키고 여과하고 건조하여 융점 184내지 189℃인 7-클로로-3-(2,3-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.d. To a 1.4 g NaH mixture in 200 mL of DMF, a solution of 19 g of E-3-chloro-2 ', 3'-difluoro-2-hydroxy-4-methoxy benzophenyl 0-acetyloxime in 200 mL of DMF was added to a nitrogen atmosphere. Drop by The mixture is stirred for 30 minutes and warmed to 45 ° C. for 30 minutes. Water is added to precipitate the product, filtered and dried to give 7-chloro-3- (2,3-difluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 184 to 189 ° C.

Figure kpo00133
Figure kpo00133

e. 7-클로로-3-(2,3-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 12g과 피리딘 HCl 50g의 고체 혼합물을 45분동안 200℃까지 가열한다. 혼합물을 강하게 교반시킨 얼음물에 넣고 융점 250내지 254℃인 7-클로로-6-하이드록시-3-(2,3-디플루오로페닐)-1,2-벤즈이소옥사졸을 침전시킨다.e. The solid mixture of 12 g of 7-chloro-3- (2,3-difluorophenyl) -6-methoxy-1,2-benzisooxazole and 50 g of pyridine HCl is heated to 200 ° C. for 45 minutes. The mixture is placed in strongly stirred ice water to precipitate 7-chloro-6-hydroxy-3- (2,3-difluorophenyl) -1,2-benzisoxazole having a melting point of 250 to 254 ° C.

Figure kpo00134
Figure kpo00134

f. DMF 120㎖중의 7-클로로-6-하이드록시-3-(2,3-디플루오로페닐) 1,2-벤즈이소옥사졸 12g용액에 K2CO36.36g을 가하고 뒤이어 Br CH2CO2C2H57.83g을 가한다. 반응물을 2시간 동안 60℃에서 가온시키고 18시간 동안 방치한다. 혼합물에 물 200㎖. 50% NaOH 15㎖을 가한다.f. 6.36 g of K 2 CO 3 was added to a 12 g solution of 7-chloro-6-hydroxy-3- (2,3-difluorophenyl) 1,2-benzisoxazole in 120 ml of DMF, followed by Br CH 2 CO 2 C Add 7.83 g of 2 H 5 . The reaction is warmed at 60 ° C. for 2 hours and left for 18 hours. 200 ml of water in the mixture. 15 ml of 50% NaOH is added.

혼합물을 90분동안 90℃로 가온시키고 물에 붓고 산성화시킨다.The mixture is warmed to 90 ° C. for 90 minutes, poured into water and acidified.

생성물을 에틸아세테이트로 추출하고 Na2SO4상에서 건조하고 증발시켜 1융점 183내지 187℃인 {[7-클로로-3-(2,3-디플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.The product was extracted with ethyl acetate, dried over Na 2 SO 4 and evaporated to produce {[7-chloro-3- (2,3-difluorophenyl) -1,2-benzisoxazole- having a melting point of 183 to 187 ° C. 6-yl] oxy} acetic acid.

Figure kpo00135
Figure kpo00135

[실시예 35]Example 35

피리딘 100㎖ 중의 실시예 1a의 2'-플루오로-4-메톡시-2,3-디클로로벤조페논 10g (0.033몰)용액에 하이드록실아민 HCl 3.17g을 가한다. 혼합물을 64시간 동안 환류한다. 피리딘을 증발하고 잔류물을 5% HCl과 에틸 아세테이트에 분배한다. 에틸 아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 융점 195내지 197℃인 2,3-디클로로-4-메톡시 2'-플루오로벤조페논을 얻는다.3.17 g of hydroxylamine HCl is added to a 10 g (0.033 mol) solution of 2'-fluoro-4-methoxy-2,3-dichlorobenzophenone of Example 1a in 100 ml of pyridine. The mixture is refluxed for 64 hours. Pyridine is evaporated and the residue is partitioned between 5% HCl and ethyl acetate. The ethyl acetate extract is washed with water, dried over Na 2 SO 4 and evaporated to give 2,3-dichloro-4-methoxy 2'-fluorobenzophenone having a melting point of 195-197 ° C.

Figure kpo00136
Figure kpo00136

b. DMF 50㎖중의 2,3-디클로로-4-메톡시-2'-플루오로벤조페논옥심 8g용액에 NaH 0.67g을 질소 기압하에 가한다. 혼합물을 1시간 동안 교반하고 물을 가하여 융점 155내지 158℃인 7-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻어 여과하고 건조한다.b. To a solution of 8 g of 2,3-dichloro-4-methoxy-2'-fluorobenzophenone oxime in 50 ml of DMF was added 0.67 g of NaH under nitrogen atmosphere. The mixture was stirred for 1 hour and water was added to give 7-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 155 to 158 ° C, filtered and dried.

Figure kpo00137
Figure kpo00137

c. 7-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 2g과 피리딘 하이드로클로라이드 20g의 고체혼합물을 1시간 동안 190내지 210℃에서 가열한다. 뜨거운 반응 혼합물을 강하게 교반시킨 얼음물에 붓는다. 혼합물을 약산성으로 한다. 여과 및 건조시켜 7-클로로-6-하이드록시-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 얻는다. 융점 140내지 141℃c. A solid mixture of 2 g of 7-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisooxazole and 20 g of pyridine hydrochloride is heated at 190 to 210 ° C. for 1 hour. The hot reaction mixture is poured into strongly stirred ice water. The mixture is made slightly acidic. Filtration and drying affords 7-chloro-6-hydroxy-3- (2-fluorophenyl) -1,2-benzisoxazole. Melting Point 140 ~ 141 ℃

Figure kpo00138
Figure kpo00138

d. 실시예 34f의 공정을 7-클로로-6-하이드록시-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 사용하여 시행하면 에틸{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.d. The process of Example 34f was carried out using 7-chloro-6-hydroxy-3- (2-fluorophenyl) -1,2-benzisoxazole, and ethyl {[7-chloro-3- (2-fluoro Lophenyl) -1,2-benzisooxazol-6-yl] oxy} acetate.

[실시예 36]Example 36

a. DMF 30㎖중의 실시예 35C의 7-클로로-6-하이드록시-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 DMF 30㎖중의 NaH 1.1g에 교반하면서 적가한다. 1시간 후 에틸-2-브로모프로피오네이트를 2.6㎖ 가하고 용액을 1.5시간 동안 교반한다. 용액을 얼음에 부은 후 융점 79℃인 에틸-2-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-9-일]옥시}프로피오네이트가 침전되면 여과하고 건조한다.a. 7-Chloro-6-hydroxy-3- (2-fluorophenyl) -1, 2-benzisoxazole of Example 35C in 30 ml of DMF was added dropwise with stirring to 1.1 g of NaH in 30 ml of DMF. After 1 hour, 2.6 ml of ethyl-2-bromopropionate is added and the solution is stirred for 1.5 hours. After pouring the solution on ice, ethyl-2-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisoxazol-9-yl] oxy} propionate having a melting point of 79 ° C. precipitates. Filtered and dried.

Figure kpo00139
Figure kpo00139

b. 에틸-2-{[7-클로로-3-(2-플루오로페닐)-1, 2-벤즈이소옥사졸-6-일]옥시}프로피오네이트 6.8g을 메탄올 35㎖에 녹이고 15% NaOH 25㎖를 가한다. 현탁액을 2시간 동안 가열한다. 반응 혼합물을 얼음에 붓고 HCl로 산성화시키고 고체가 침전되면 여과 후 진공중에서 건조하여 융점 159내지 161℃인 2-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-3-일]옥시}프로피온산을 얻는다.b. 6.8 g of ethyl-2-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} propionate was dissolved in 35 ml of methanol and 25 ml of 15% NaOH. Add. The suspension is heated for 2 hours. The reaction mixture was poured into ice, acidified with HCl, precipitated with solid, filtered and dried in vacuo to yield 2-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisoocta having a melting point of 159 to 161 ° C. Sazol-3-yl] oxy} propionic acid is obtained.

Figure kpo00140
Figure kpo00140

[실시예 37]Example 37

a. 1,2-디클로로에탄 250㎖중의 2,5-디플루오로벤조일클로라이드 21g과 2-클로로레졸시놀디메틸에테르 20.4g의 혼합물에 5내지 10℃에서 AlCl315.7g을 일부씩 가한다. 혼합물을 실온으로 가온시키고 30분동안 환류한다. 혼합물을 농 HCl 및 얼음에 붓고 약 1시간동안 교반한다. 생성물을 에틸아세테이트로 추출하고 Na2SO4상에서 건조하고 증발시켜 융점 178내지 180℃인 3-클로로-2',5'-디플루오로-2-하이드록시-4-메톡시벤조페논을 얻는다.a. To a mixture of 21 g of 2,5-difluorobenzoyl chloride and 20.4 g of 2-chlororesorcinoldimethyl ether in 250 ml of 1,2-dichloroethane was added 15.7 g of AlCl 3 at 5-10 ° C. in portions. The mixture is allowed to warm to room temperature and refluxed for 30 minutes. The mixture is poured into concentrated HCl and ice and stirred for about 1 hour. The product is extracted with ethyl acetate, dried over Na 2 SO 4 and evaporated to afford 3-chloro-2 ', 5'-difluoro-2-hydroxy-4-methoxybenzophenone having a melting point of 178 to 180 ° C.

Figure kpo00141
Figure kpo00141

b. 250㎖ 피리딘중의 3-클로로-2'-5'-디플루오로-2-하이드록시-4-메톡시벤조페논 28g과 하이드록실아민 HCl 26g의 혼합물을 3시간 동안 환류한다. 피리딘을 증발시키고 잔류물을 에틸아세테이트와 5% HCl에 분배한다. 에틸아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 이성체의 혼합물인 고체생성물을 얻는다. 고체를 약 30내지 45분동안200내지 21℃에서 가열하고 톨루엔으로 재결정하여 융점 209내지 210℃인 E-3-클로로-2',5'-디플루오로-2-하이드록시-4-메톡시벤조페놀옥심을 얻는다.b. A mixture of 28 g of 3-chloro-2'-5'-difluoro-2-hydroxy-4-methoxybenzophenone and 26 g of hydroxylamine HCl in 250 ml pyridine is refluxed for 3 hours. Pyridine is evaporated and the residue is partitioned between ethyl acetate and 5% HCl. The ethyl acetate extract is washed with water, dried over Na 2 SO 4 and evaporated to give a solid product that is a mixture of isomers. The solid is heated at 200 to 21 ° C. for about 30 to 45 minutes and recrystallized from toluene to give E-3-chloro-2 ′, 5′-difluoro-2-hydroxy-4-methoxy having a melting point of 209 to 210 ° C. Obtain benzophenol oxime.

Figure kpo00142
Figure kpo00142

c. 19g의 E-3-클로로-2',5'-디플루오로-2-하이드록시-4-메톡시벤조페논 옥심을 60℃에서 30분간 가온시킨다. 냉각하면 혼합물은 고체화한다. 잔류물을 에틸아세테이트와 10% NaHCO3에 분배한다. 에틸아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 융점 130내지 131℃인 E-3-클로로-2',5'-디플루오로-2-하이드록시-4-메톡시벤조페논 0-아세틸옥심을 얻는다.c. 19 g of E-3-chloro-2 ', 5'-difluoro-2-hydroxy-4-methoxybenzophenone oxime is warmed at 60 ° C for 30 minutes. Upon cooling the mixture solidifies. The residue is partitioned between ethyl acetate and 10% NaHCO 3 . Ethyl acetate extract was washed with water, dried over Na 2 SO 4 and evaporated to a melting point of 130 to 131 ° C. E-3-chloro-2 ', 5'-difluoro-2-hydroxy-4-methoxybenzophenone 0 Get acetyl oxime

Figure kpo00143
Figure kpo00143

d. N2기압하에서 NaH/DMF 200㎖ 현탁액에 50㎖중의 E-3-클로로-2',5'-디플루오로-2-하이드록시-4-메톡시벤조페논 0-아세틸옥심을 적가한다. 혼합물을 30분동안 교반하고 물을 가하여 융점 198 내지 199℃인 7-클로로-3-(2,5-디플루오로페닐)-6-메톡시-1,2-벤조이소옥사졸을 얻는다.d. To a 200 ml suspension of NaH / DMF under N 2 atm is added dropwise E-3-chloro-2 ', 5'-difluoro-2-hydroxy-4-methoxybenzophenone 0-acetyloxime in 50 ml. The mixture is stirred for 30 minutes and water is added to give 7-chloro-3- (2,5-difluorophenyl) -6-methoxy-1,2-benzoisoxazole having a melting point of 198 to 199 ° C.

Figure kpo00144
Figure kpo00144

e. 7-클로로-3-(2,5-디플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 10g과 피리딘 HCl 40g의 혼합물을 45분동안 200℃에서 가열한다. 고열혼합물을 강하게 교반시킨 얼음물에 부어 생성물을 침전시킨다. 생성물을 여과하고 건조하여 융점 256내지 257℃인 7-클로로-3-(2,5-디플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸을 얻는다.e. A mixture of 10 g of 7-chloro-3- (2,5-difluorophenyl) -6-methoxy-1,2-benzisooxazole and 40 g of pyridine HCl is heated at 200 ° C. for 45 minutes. The high thermal mixture is poured into strongly stirred ice water to precipitate the product. The product is filtered and dried to give 7-chloro-3- (2,5-difluorophenyl) -6-hydroxy-1,2-benzisoxazole having a melting point of 256 to 257 ° C.

Figure kpo00145
Figure kpo00145

f. DMF 100㎖중의 7-클로로-3-(2,5-디플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸 9.3g 용액에 DMF 4.97g과 에틸브로모아세테이트 200㎖을 적가한다. 이 혼합물의 물 50% NaOH 15㎖을 가한다. 혼합물을 90℃에서 90분동안 교반하고 물에 부은 후 산성화시킨다. 생성물을 에틸아세테이트로 추출하고 상에서 건조하고 증발시켜 {[7-클로로-3-(2,5-디플루오로페닐)-1,2-벤즈이소옥사졸-6-일)옥시]}아세트산을 얻는다.f. 4.97 g of DMF and 200 ml of ethyl bromoacetate are added dropwise to a solution of 9.3 g of 7-chloro-3- (2,5-difluorophenyl) -6-hydroxy-1,2-benzisoxazole in 100 ml of DMF. . 15 ml of water 50% NaOH of this mixture is added. The mixture is stirred at 90 ° C. for 90 minutes, poured into water and acidified. The product is extracted with ethyl acetate, dried over and evaporated to afford {[7-chloro-3- (2,5-difluorophenyl) -1,2-benzisoxazol-6-yl) oxy]} acetic acid.

Figure kpo00146
Figure kpo00146

[실시예 38]Example 38

a. 2-클로로레졸시놀디메틸에테르(3.4g)을 20㎖에 녹이고 TiCl4(4.3㎖)을 가한다. 이 용액에 디클로로메틸에테르(2.3g)을 가한다. 30분 후 반응 혼합물을 H2O에 붓고 에테르로 추출한다. 건조하고 증발시켜 융점 107내지 108℃인 3-클로로-2,4-디메톡시벤즈알데히드를 얻는다.a. Dissolve 2-chlororesorcinoldimethyl ether (3.4 g) in 20 ml and add TiCl 4 (4.3 ml). Dichloromethyl ether (2.3 g) is added to this solution. After 30 minutes the reaction mixture is poured into H 2 O and extracted with ether. Dry and evaporate to afford 3-chloro-2,4-dimethoxybenzaldehyde having a melting point of 10 < 7 >

Figure kpo00147
Figure kpo00147

b. 3-클로로-2,4-디메톡시벤즈알데히드(2.75g)을 AlCl31.8g을 함유한 디클로로에탄 20㎖중에서 30분동안 환류한다. 반응 혼합물을 H2O에 붓고 CH2Cl2로 추출한다. 증발하고 이소프로판올로 재결정하여 융점 125℃인 3-클로로-2-하이드록시-4-메톡시벤즈알데히드를 얻는다.b. 3-Chloro-2,4-dimethoxybenzaldehyde (2.75 g) was refluxed in 20 ml of dichloroethane containing 1.8 g of AlCl 3 for 30 minutes. The reaction mixture is poured into H 2 O and extracted with CH 2 Cl 2 . Evaporate and recrystallize with isopropanol to give 3-chloro-2-hydroxy-4-methoxybenzaldehyde having a melting point of 125 ° C.

Figure kpo00148
Figure kpo00148

c. 3-클로로-2-하이드록시-4-메톡시벤즈알데히드(1.48g)를 H2O 15㎖에 현탁시키고 하이드록실아민 0-설포닐산(1.08g)을 가하고 Na2SO40.1g을 가한다. 3시간 후 추가의 H2O 15㎖를 가한다. 총 4시간후 반응 혼합물을 8% NaHCO3로 처리하고 에테르로 추출한다. 증발하고 헥산으로 처리하여 고체생성물을 얻는다. 톨루엔/헥산으로 재결정하여 융점 115내지 11℃인 7-클로로-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.c. 3-Chloro-2-hydroxy-4-methoxybenzaldehyde (1.48 g) is suspended in 15 mL of H 2 O, hydroxylamine 0-sulfonyl acid (1.08 g) is added and 0.1 g Na 2 SO 4 is added. After 3 h additional 15 ml of H 2 O are added. After a total of 4 hours the reaction mixture is treated with 8% NaHCO 3 and extracted with ether. Evaporate and treat with hexane to give a solid product. Recrystallization from toluene / hexane yields 7-chloro-6-methoxy-1,2-benzisoxazole having a melting point of 115 to 11 ° C.

Figure kpo00149
Figure kpo00149

d. 실시예 34e와 f의 방법을 7-클로로-6-메톡시-1,2-벤즈이소옥사졸로 실시하여 {[7-클로로-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.d. The method of Examples 34e and f was carried out with 7-chloro-6-methoxy-1,2-benzisoxazole to obtain {[7-chloro-1,2-benzisoxazol-6-yl] oxy} acetic acid. .

[실시예 39]Example 39

a. 5내지 7℃에서 1,2-디클로로에탄 50㎖중의 2-클로로레졸시놀 디메틸에테르 1.7g와 0-트리플루오로메틸벤조일 클로라이드 2.08g의 용액에 염화 제2철 1.6g을 서서히 가한다. 혼합물을 실온까지 올리고 18시간 동안 방치한다. 반응 혼합물을 30분 동안 환류하고 5% HCl과 얼음에 붓는다. 수용액층을 추가의 유기용매로 추출한다. 합한 유기 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 융점 101내지 102℃인 3-클로로-2-하이드록시-4-메톡시-2'-트리플루오로메틸 벤조페논을 얻는다.a. 1.6 g of ferric chloride is slowly added to a solution of 1.7 g of 2-chlororesorcinol dimethyl ether and 2.08 g of 0-trifluoromethylbenzoyl chloride in 50 ml of 1,2-dichloroethane at 5 to 7 ° C. The mixture is raised to room temperature and left for 18 hours. The reaction mixture is refluxed for 30 minutes and poured into ice with 5% HCl. The aqueous layer is extracted with additional organic solvent. The combined organic extracts are washed with water, dried over Na 2 SO 4 and evaporated to afford 3-chloro-2-hydroxy-4-methoxy-2'-trifluoromethyl benzophenone having a melting point of 101 to 102 ° C.

Figure kpo00150
Figure kpo00150

b. 전항의 실시예(실시예 34와 같은)에 기술된 방법을 3-클로로-2-하이드록시-4-메톡시-2'-트리플루오로 메틸렌조페논으로 실시하여 상응하는 옥심을 얻고 옥심을 환화하고 산으로 하여 {[7-클로로-3-(2-트리플루오로메틸페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.b. The method described in the previous example (such as example 34) was carried out with 3-chloro-2-hydroxy-4-methoxy-2'-trifluoro methylenezophenone to give the corresponding oxime and cyclized oxime And {[7-chloro-3- (2-trifluoromethylphenyl) -1,2-benzisooxazol-6-yl] oxy} acetic acid is obtained as an acid.

[실시예 40]Example 40

a. 실시예 35b의 7-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 10g을 교반하면서 빙초산(800㎖)에 녹이고 염소가스를 30분동안 서서히 주입시켜 소량의 현탁된 출발물질을 함유하는 용액을 얻는다. 반응 혼합물을 18시간 동안 실온에서 교반한 후 반응 혼합물을 교반하면서 얼음물에 부으면 융점 121℃인 5,7-디클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸이 침전된다.a. 10 g of 7-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole of Example 35b was dissolved in glacial acetic acid (800 ml) with stirring, and chlorine gas was slowly injected for 30 minutes. A solution containing a small amount of suspended starting material is obtained. The reaction mixture was stirred at room temperature for 18 hours, and then the reaction mixture was poured into ice water with stirring to give 5,7-dichloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoocta having a melting point of 121 ° C. Soazole is precipitated.

Figure kpo00151
Figure kpo00151

b. 5,7-디클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 10g을 100g피리딘 하이드로클로라이드와 혼합하여 200℃에서 0.5시간 동안 가열한다. 고온의 용융물을 교반하면서 얼음물에 신속히 붓고 얻은 침전물을 여과하고 진공(64℃)중에서 48시간동안 건조한다. 고체를 톨루엔으로 재결정하여 융점 194내지 196℃인 5,7-디클로로-3-(2-플루오로-페닐-6-하이드록시-1,2-벤즈이소옥사졸을 얻는다.b. 10 g of 5,7-dichloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole are mixed with 100 g pyridine hydrochloride and heated at 200 ° C. for 0.5 h. The hot melt is quickly poured into iced water with stirring and the resulting precipitate is filtered and dried in vacuo (64 ° C.) for 48 hours. The solid is recrystallized from toluene to give 5,7-dichloro-3- (2-fluoro-phenyl-6-hydroxy-1,2-benzisoxazole having a melting point of 194 to 196 ° C.

Figure kpo00152
Figure kpo00152

c. NaH 1.4g을 교반하면서 DMF 50㎖에 현탁시킨다. DMF 50㎖중의 5,7-디클로로-3-(2-플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸 7.2g 용액을 적가한다. 용액을 1시간 동안 45℃까지 가열한다. DMF 20㎖중의 에틸브로모아세테이트(4.0g)를 적가하고 반응물을 2시간동안 40℃에서 교반한다.c. 1.4 g of NaH is suspended in 50 ml of DMF with stirring. A solution of 7.2 g of 5,7-dichloro-3- (2-fluorophenyl) -6-hydroxy-1,2-benzisoxazole in 50 ml of DMF was added dropwise. The solution is heated to 45 ° C. for 1 hour. Ethylbromoacetate (4.0 g) in 20 mL DMF was added dropwise and the reaction stirred at 40 ° C. for 2 hours.

용액을 물1ℓ에 붓고 교반하고 에틸아세테이트로 추출한다. 유기추출물을 포화NaCl용액으로 세척하고 용매를 진공중에서 제거하여 융점 105내지 106℃인 에틸{[5,7-디클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 얻는다.The solution is poured into 1 l of water, stirred and extracted with ethyl acetate. The organic extract was washed with saturated NaCl solution and the solvent was removed in vacuo to yield ethyl {[5,7-dichloro-3- (2-fluorophenyl) -1,2-benzisoxazole-6- having a melting point of 105 to 106 캜. General] oxy} acetate is obtained.

Figure kpo00153
Figure kpo00153

d. 에틸 {[5,7-디클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트를 용액이 될때까지 교반하면서 75% 에탄올/물(700㎖)중에서 가열한다.d. 75% ethanol / water (700 mL) with ethyl {[5,7-dichloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetate stirring until solution Heat in.

50%용액 20㎖를 가하면 침전이 형성된다.20 ml of 50% solution is added to form a precipitate.

계속하여 가열하고 교반하면 침전물이 용액이 되고 이를 2.5시간 교반한다. 에탄올을 진공중에서 증발시키고 잔류물을 10%HCl로 산성화한다. 침전된 고체를 여과하고 진공중에서 건조하여 융점 160내지 170℃인 {[5,7-디클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.Continue heating and stirring to precipitate the solution which is stirred for 2.5 hours. Ethanol is evaporated in vacuo and the residue is acidified with 10% HCl. The precipitated solid was filtered and dried in vacuo to afford {[5,7-dichloro-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid with a melting point of 160 to 170 ° C. Get

Figure kpo00154
Figure kpo00154

[실시예 41]Example 41

a. 50㎖ DMF중에 50%분산시킨 NaH(1.0g)현탁액에 50㎖ DMF중의 실시예 35℃의 7-클로로-3-(2-플루오로페닐)-6-하이드록시-1,2-벤즈이소옥사졸 5.0g을 가한다. 용액을 실온에서 1시간 동안 교반하고 5℃까지 냉각하고 즉시 N,N-디메틸티오 카바모일 클로라이드 3.5g을 전부 가한다.a. To a 50% DMF-dispersed NaH (1.0 g) suspension in 50 ml DMF, Example 35 ° C. 7-chloro-3- (2-fluorophenyl) -6-hydroxy-1,2-benzisoxazole in 50 ml DMF Add 5.0 g. The solution is stirred at room temperature for 1 hour, cooled to 5 ° C. and immediately 3.5 g of N, N-dimethylthio carbamoyl chloride are added all.

반응물을 60℃까지 서서히 가온시키고 2.5시간 동안 교반한다. 용액을 물에 붓고 추출물이 무색이 될때까지 메틸렌클로라이드로 추출한다. 합한 유기 추출물을 10% K2CO3로 세척하고 포화 NaCl로 세척한다. 용매를 진공중에서 제거하여 융점 153내지 154℃인 7-클로로-6-(0-N,N-디메틸티와카바밀)-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 얻는다.The reaction is slowly warmed up to 60 ° C. and stirred for 2.5 hours. The solution is poured into water and extracted with methylene chloride until the extract is colorless. The combined organic extracts are washed with 10% K 2 CO 3 and saturated NaCl. The solvent is removed in vacuo to give 7-chloro-6- (0-N, N-dimethylthiwacarbamyl) -3- (2-fluorophenyl) -1,2-benzisoxazole having a melting point of 153 to 154 ° C. .

Figure kpo00155
Figure kpo00155

b. 7-클로로-6-(0-N,N-디메틸카바모일)-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 45분동안 205℃에서 질소하에 가열한다. 얻은 냉각된 고체를 에틸 아세테이트로 재결정하여 프리즘상 무색이고 융점 140내지 142℃인 7-클로로-6-(S,N,N-디메틸카바밀)-3-(2-플로페닐)-1,2-벤즈이소옥사졸을 얻는다.b. 7-Chloro-6- (0-N, N-dimethylcarbamoyl) -3- (2-fluorophenyl) -1,2-benzisoxazole is heated under nitrogen at 205 ° C. for 45 minutes. The resulting cooled solid was recrystallized from ethyl acetate to give a prism colorless, 7-chloro-6- (S, N, N-dimethylcarbamyl) -3- (2-flophenyl) -1,2 with a melting point of 140 to 142 ° C. -Get benzisoxazole.

Figure kpo00156
Figure kpo00156

c. 7-클로로-6-(S-N,N-디메틸티오카바밀)-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-2.0g을 메탄올에 용해시키고 15%수용성 NaOH 25㎖를 가한다. 용액을 3시간 동안 환류한다. 반응 혼합물을 다량의 물에 붓고 HCl로 산성화시켜 융점 125내지 129℃인 7-클로로-3-(2-플루오로페닐)-6-멀캅토-1,2-벤즈이소옥사졸을 얻는다.c. 2.0 g of 7-chloro-6- (SN, N-dimethylthiocarbamyl) -3- (2-fluorophenyl) -1,2-benzisoxazole- was dissolved in methanol and 25 ml of 15% water-soluble NaOH was added. do. The solution is refluxed for 3 hours. The reaction mixture is poured into a large amount of water and acidified with HCl to give 7-chloro-3- (2-fluorophenyl) -6-mercapto-1,2-benzisoxazole having a melting point of 125 to 129 ° C.

Figure kpo00157
Figure kpo00157

d. 7-클로로-3-(2-플루오로페닐)-6-멀캅토-1,2-벤즈이소옥사졸 3.2g, K2CO33.1g 및 에틸브로모 아세테이트 3.67g을 DMF 60㎖에 가하고 교반하면서 50℃에서 2시간 동안 가온시킨다. 용액을 700㎖ H2O에 붓고 에틸 아세테이트로 추출한다.d. 3.2 g of 7-chloro-3- (2-fluorophenyl) -6-mercapto-1,2-benzisooxazole, 3.1 g K 2 CO 3 and 3.67 g ethylbromo acetate were added to 60 ml of DMF and stirred Warm at 50 ° C. for 2 hours. The solution is poured into 700 mL H 2 O and extracted with ethyl acetate.

합한 유기 추출물을 K2CO3상에서 건조하고 용매를 진공중에서 제거하여 에틸{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]티오}아세테이트를 얻는다.The combined organic extracts were dried over K 2 CO 3 and the solvent was removed in vacuo to afford ethyl {[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] thio} acetate. Get

Figure kpo00158
Figure kpo00158

e. 에틸{[7-클로로-3-(2-플루오로페닐-1,2-벤즈이소옥사졸-6-일]티오}아세테이트를 교반 및 가온시키면서 에탄올 50㎖에 녹인다. NaOH 50% 용액 3㎖를 25㎖의 물에 가하고 고체 침전물을 얻는다. 1시간후 에탄올을 제거하고 잔류물을 HCl로 산성화한다. 침전물을 여과하고 건조하여 융점 165℃인 {[5,7-디클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]-티오}아세트산을 얻는다.e. Dissolve ethyl {[7-chloro-3- (2-fluorophenyl-1,2-benzisoxazol-6-yl] thio} acetate in 50 ml of ethanol while stirring and warming. Add 1 mL of water to give a solid precipitate, after 1 h ethanol is removed and the residue is acidified with HCl The precipitate is filtered and dried to produce {[5,7-dichloro-3- (2-fluoro) with a melting point of 165 ° C. Phenyl) -1,2-benzisooxazol-6-yl] -thio} acetic acid.

Figure kpo00159
Figure kpo00159

[실시예 42]Example 42

a. 100㎖디클로로메탄중의 0-플루오로벤조일 클로라이드용액(47.6g)에 약30분에 걸쳐 AlCl3(40.0g)을 일부씩 가한다. 생성된 암색 용액에 120㎖디클로로 메탄중의 1-클로로-3,5-디메톡시벤젠(52.0g)용액을 15분에 걸쳐 적가한다. 4시간 동안 실온에서 교반 후 혼합물을 얼음회 HCl용액 1ℓ에 붓고 30분동안 교반한다. 유기층을 모으고, 오일을 증발시키고, 에테르에 녹여 물로 세척하고 NaOH용액 및 물로 희석하고 포화 NaCl 또는 무수 MgSO4로 건조한다. 여과후, 용매를 증발시켜 고체를 얻고 실리카겔로 정제하고 디클로로 메탄으로 용출시켜 융점 88내지 92℃인 2-클로로-4,6-디메톡시-2'-플루오로벤조페논을 얻는다.a. To a solution of 0-fluorobenzoyl chloride (47.6 g) in 100 mL dichloromethane is partially added AlCl 3 (40.0 g) over about 30 minutes. To the resulting dark solution was added dropwise a solution of 1-chloro-3,5-dimethoxybenzene (52.0 g) in 120 ml dichloromethane over 15 minutes. After stirring for 4 hours at room temperature, the mixture is poured into 1 L of ice-lime HCl solution and stirred for 30 minutes. The organic layers are combined, the oil is evaporated, dissolved in ether, washed with water, diluted with NaOH solution and water and dried over saturated NaCl or anhydrous MgSO 4 . After filtration, the solvent is evaporated to give a solid which is purified by silica gel and eluted with dichloromethane to give 2-chloro-4,6-dimethoxy-2'-fluorobenzophenone having a melting point of 88 to 92 캜.

Figure kpo00160
Figure kpo00160

b. 150㎖디클로로에탄 150㎖중의 2-클로로-4,6-디메톡시-2'-플루오로벤조페논(33g)용액에 15분에 걸쳐 AlCl3(15g)를 일부씩 가한다. 3시간 동안 90℃에서 환류교반 후 혼합물을 냉각하고, 얼음-회염산 용액 1ℓ에 붓고, 30분동안 교반하고 에테르로 추출한다. 에테르/디클로로에탄 용액은 물로 세척하고 건조한 후(포화 NaCl, 무수 HgSO4), 여과한다.b. To a solution of 2-chloro-4,6-dimethoxy-2'-fluorobenzophenone (33 g) in 150 mL of 150 mL dichloroethane was partially added AlCl 3 (15 g) over 15 minutes. After stirring under reflux at 90 ° C. for 3 hours, the mixture is cooled, poured into 1 L of ice-dichloric acid solution, stirred for 30 minutes and extracted with ether. The ether / dichloroethane solution is washed with water, dried (saturated NaCl, anhydrous HgSO 4 ) and filtered.

여과후 용매를 증발시켜 융점 85내지 90℃인 2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논을 얻는다.After filtration the solvent is evaporated to afford 2-chloro-2'-fluoro-6-hydroxy-4-methoxybenzophenone having a melting point of 85 to 90 ° C.

Figure kpo00161
Figure kpo00161

c. 피리딘 125㎖에 2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논(28.5g)과 하이드록실아민 하이드로클로라이드(14g)를 가한다. 3시간 동안 120℃에서 환류 교반 후, 혼합물을 냉각하고 피리딘을 증발시켜 황색의 반고체를 얻는다. 고체를 에테르에 녹이고 물로 세척하고 건조한다(포화 NaCl, 무수 MgSO4).c. To 125 ml of pyridine is added 2-chloro-2'-fluoro-6-hydroxy-4-methoxybenzophenone (28.5 g) and hydroxylamine hydrochloride (14 g). After reflux stirring at 120 ° C. for 3 hours, the mixture is cooled and pyridine is evaporated to yield a yellow semisolid. The solid is dissolved in ether, washed with water and dried (saturated NaCl, anhydrous MgSO 4 ).

여과후 용매를 증발시키고 석유 에테르로 처리하면 고체화된 융점 130내지 140℃인 Z-2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논 옥심을 얻는다.After filtration the solvent is evaporated and treated with petroleum ether to give Z-2-chloro-2'-fluoro-6-hydroxy-4-methoxybenzophenone oxime having a solidified melting point of 130 to 140 ° C.

Figure kpo00162
Figure kpo00162

d. Z-2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논옥심을 실시예 29℃에 기술된 것과 같이 무수초산과 반응시키면 E-2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논 0-아세틸옥심을 얻는다.d. When Z-2-chloro-2'-fluoro-6-hydroxy-4-methoxybenzophenone oxime is reacted with acetic anhydride as described in Example 29 ° C, E-2-chloro-2'-fluoro -6-hydroxy-4-methoxybenzophenone 0-acetyloxime is obtained.

e. 20㎖ DMF중의 NaH현탁액에 ㎖중의 E-2-클로로-2'-플루오로-6-하이드록시-4-메톡시벤조페논-0-아세틸옥심을 가한다. 2시간 동안 실온에서 교반 후, 혼합물을 얼음물 1ℓ에 붓고 30분동안 교반하고 침전물을 모은다. 침전물을 물로 세척하고 건조하여 융점 113내지 115℃인-4-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.e. To the NaH suspension in 20 mL DMF is added E-2-chloro-2'-fluoro-6-hydroxy-4-methoxybenzophenone-0-acetyloxime in mL. After stirring for 2 hours at room temperature, the mixture is poured into 1 l of ice water, stirred for 30 minutes and the precipitate collected. The precipitate is washed with water and dried to give 4-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 113 to 115 ° C.

Figure kpo00163
Figure kpo00163

f. 실시예 19d 및 e와 같은 전술된 실시예의 기술된 방법으로 4-클로로-3-(2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 사용하여 융점 172내지 174℃인 {[4-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.f. Melting point 172 to 174 ° C. using 4-chloro-3- (2-fluorophenyl) -6-methoxy-1,2-benzisoxazole in the process described in the foregoing examples such as Examples 19d and e. {[4-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetic acid is obtained.

[실시예 43]Example 43

a. 150㎖이유화탄소중의 펜아세틸 클로라이듸 교반 용액에 30분에 걸쳐 AlCl3(22g)을 일부씩 가한 후 50㎖이유화탄소중의 2,3-디클로로아니졸 용액을 가한다. 3시간 동안 환류(50℃)교반한후, 혼합물을 냉각시키고 AlCl3(22g)를 가하고 혼합물을 2시간 동안 환류하면서 교반한다. 혼합물을 냉각하고 냉 15%HCl용액에 붓고 30분동안 교반하고 에틸아세테이트/에틸 에테르로 추출한다. 유기추출물을 물로 세척하고 건조한다(포화 NaCl, 무수 MgSO4). 여과후, 용매를 증발시켜 융점 173내지 180℃인 2,3-디클로로-4-펜아세틸을 얻는다.a. AlCl 3 (22 g) was added in portions to a stirred solution of phenacetylchloric acid in 150 mL of carbon dioxide over 30 minutes, followed by a 2,3-dichloroanisol solution in 50 mL of carbon dioxide. After stirring for 3 hours at reflux (50 ° C.), the mixture is cooled and AlCl 3 (22 g) is added and the mixture is stirred at reflux for 2 hours. The mixture is cooled, poured into cold 15% HCl solution, stirred for 30 minutes and extracted with ethyl acetate / ethyl ether. The organic extract is washed with water and dried (saturated NaCl, anhydrous MgSO 4 ). After filtration, the solvent is evaporated to give 2,3-dichloro-4-phenacetyl having a melting point of 173 to 180 ° C.

Figure kpo00164
Figure kpo00164

b. 2,3-디클로로-4-펜아세틸페놀을 피리딘중의 하이드록실아민 하이드로클로라이드와 함께 전술된 실시예에 일반적으로 기술된 방법으로 반응시켜 2,3-디클로로-4-펜아세틸페놀 옥심을 얻는다.b. 2,3-dichloro-4-phenacetylphenol is reacted with hydroxylamine hydrochloride in pyridine in the manner generally described in the above examples to give 2,3-dichloro-4-phenacetylphenol oxime.

c. 무수DMF 10㎖ 중의 NaH(2.54g)현탁액에 25㎖ 무수 DMF 중의 2,3-디클로로-4-펜아세틸페놀옥심(6.3g)용액을 가한다. 2시간 동안 80℃에서 교반 후, 혼합물을 냉각하고 10㎖무수 DMF중의 에틸브로모아세테이트(4.2g)용액을 가하고 30분동안 실온에서 교반하고 또 30분동안 60℃에서 교반한다. 냉각 후 혼합물을 물 500㎖에 붓고, 30분동안 교반하고, 에틸아세테이트로 추출한다. 유기층을 물로 세척하고 건조한다(포화 NaCl, 무수 MgSO4).c. To a NaH (2.54 g) suspension in 10 mL of anhydrous DMF is added a 2,3-dichloro-4-phenacetylphenol oxime (6.3 g) solution in 25 mL anhydrous DMF. After stirring at 80 ° C. for 2 hours, the mixture is cooled and a solution of ethyl bromoacetate (4.2 g) in 10 ml anhydrous DMF is added and stirred at room temperature for 30 minutes and at 60 ° C. for 30 minutes. After cooling, the mixture is poured into 500 ml of water, stirred for 30 minutes, and extracted with ethyl acetate. The organic layer is washed with water and dried (saturated NaCl, anhydrous MgSO 4 ).

여과후 용매를 증발시켜 오일을 수득하고 이로부터 융점 120내지 122℃인 에틸{[3-벤질-7-클로로-1,2-벤즈 이소옥사졸-6-일]옥시}아세테이트를 얻는다.After filtration the solvent is evaporated to give an oil from which ethyl {[3-benzyl-7-chloro-1,2-benz isoxoxazol-6-yl] oxy} acetate having a melting point of 120 to 122 ° C.

Figure kpo00165
Figure kpo00165

d. 무수에탄올 650㎖에 에틸{[3-벤질-7-클로로-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트(25.0g)를 가하고 뒤이어 50% NaOH용액(30㎖)을 가한다. 1시간동안 환류(80℃)교반하고, 물 500㎖을 가하고 농염산으로 pH를 1까지 조절하고 1ℓ의 물로 다시 희석한다. 얻은 침전물을 모으고 물로 세척하고 디클로로 메탄에 녹인다. 디클로로메탄 용액을 물로 세척하고 건조한다. (포화 NaCl, 무수 MgSO4).d. Ethyl {[3-benzyl-7-chloro-1,2-benzisoxazol-6-yl] oxy} acetate (25.0 g) was added to 650 mL of anhydrous ethanol followed by 50% NaOH solution (30 mL). The mixture was stirred at reflux (80 ° C) for 1 hour, 500 ml of water was added, the pH was adjusted to 1 with concentrated hydrochloric acid, and diluted again with 1 L of water. The precipitate obtained is collected, washed with water and dissolved in dichloromethane. The dichloromethane solution is washed with water and dried. (Saturated NaCl, anhydrous MgSO 4 ).

여과후, 용매를 증발시켜 융점 147내지 153℃인 {[3-벤질-7-클로로-1,2-벤즈이소옥사졸-6-일)-옥시]}아세트산을 얻는다.After filtration, the solvent is evaporated to yield {[3-benzyl-7-chloro-1,2-benzisoxazol-6-yl) -oxy]} acetic acid having a melting point of 147 to 153 ° C.

Figure kpo00166
Figure kpo00166

[실시예 44]Example 44

a. 실시예 43의 프리델-크레프트 반응을 2,3-디클로로아니졸, -1-나프틸클로라이드 및 AlCl3로 반복하여(2,3-디클로로-4-하이드록시페닐)(1-나프틸)메탄온을 얻는다.a. The Friedel-Craft reaction of Example 43 was repeated with 2,3-dichloroanizol, -1-naphthylchloride and AlCl 3 (2,3-dichloro-4-hydroxyphenyl) (1-naphthyl) methanone Get

b. 피리딘 150㎖중의(2,3-디클로로-4-하이드록시-페닐)-(1-나프틸)메타논 22.48g 용액에 하이드록실아민 하이드로클로라이드 9.87g을 가한다. 혼합물을 약 64시간 동안 환류한다. 추가의 하이드록실아민 HCl(9.87g)을 가하고 반응 혼합물을 18시간 동안 환류한다. 피리딘을 진공중에서 증발하고 잔류물을 5% HCl과 에틸아세테이트에 분배한다. 에틸 아세테이트 추출물을 물로 세척하고 NaSO4상에서 건고하고 증발시켜 반고형 생성물을 얻는다. 이 생성물을 에틸아세테이트 약 100㎖에 녹이고 목탄컬럼에 통과시킨다. 여과물을 증발시키고 헥산-에테르로 처리하여 융점 145내지 160℃인(2,3-디클로로-4-하이드록시페닐 여과물을 증발시키고 헥산-에테르로 처리하여 융점 145내지 160℃인(2,3-디클로로-4-하이드록시페닐-(1-나프틸)메타논옥심을 얻는다.b. 9.87 g of hydroxylamine hydrochloride is added to a 22.48 g solution of (2,3-dichloro-4-hydroxy-phenyl)-(1-naphthyl) methanone in 150 ml of pyridine. The mixture is refluxed for about 64 hours. Additional hydroxylamine HCl (9.87 g) is added and the reaction mixture is refluxed for 18 hours. Pyridine is evaporated in vacuo and the residue is partitioned between 5% HCl and ethyl acetate. The ethyl acetate extract is washed with water, dried over NaSO 4 and evaporated to give a semisolid product. This product is dissolved in about 100 ml of ethyl acetate and passed through a charcoal column. The filtrate was evaporated and treated with hexane-ether to have a melting point of 145 to 160 ° C. (2,3-dichloro-4-hydroxyphenyl the filtrate was evaporated and treated with hexane-ether to have a melting point of 145 to 160 ° C. (2,3 -Dichloro-4-hydroxyphenyl- (1-naphthyl) methanone oxime is obtained.

Figure kpo00167
Figure kpo00167

c. DMF 25㎖중의(2,3-디클로로-4-하이드록시페닐)-(1-나프틸)메타논 옥심 3g용액에 NaH 0.54g을 N2하에서 가한다. 혼합물을 내부온도 100℃때까지 1시간 20분동안 가열한다.c. To a 3 g solution of (2,3-dichloro-4-hydroxyphenyl)-(1-naphthyl) methanone oxime in 25 ml of DMF was added 0.54 g of NaH under N 2 . The mixture is heated for 1 h 20 min until an internal temperature of 100 ° C.

혼합물을 18시간 동안 교반하고, 물을 가하고 생성물을 에틸아세테이트 추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시켜 융점 75내지 85℃ 인 에틸{[7-클로로-3-(1-나프틸)-1,2-벤즈 이소옥사졸-6-일]옥시}-아세테이트를 얻는다.The mixture was stirred for 18 hours, water was added and the product was washed with ethyl acetate extract with water, dried over Na 2 SO 4 and evaporated to ethyl {[7-chloro-3- (1-naphthyl) with a melting point of 75 to 85 ° C. -1,2-benz isoxoxazol-6-yl] oxy} -acetate.

Figure kpo00168
Figure kpo00168

d. 에틸{[7-클로로-3-(1-나프틸)-1,2-벤즈이소옥사졸-6-일]옥시} 아세테이트 1.85g, 에탄올 100㎖과 50% NaOH 2㎖의 현탁액을 1시간 동안 환류한다. 뜨거운 혼합물에 물 100㎖을 가하고 뒤이어 충분한 농 HCl을 가하여 혼합물이 산성화되도록 한다.d. 1.85 g of ethyl {[7-chloro-3- (1-naphthyl) -1,2-benzisoxazol-6-yl] oxy} acetate, 100 ml of ethanol and 2 ml of 50% NaOH were refluxed for 1 hour. do. 100 ml of water is added to the hot mixture followed by sufficient concentrated HCl to allow the mixture to acidify.

반응 혼합물을 교반하고 냉각되면 침전물이 형성된다. 에탄올을 진공중에서 증발시키고 융점 172내지 174℃인 {[7-클로로-3-(1-나프틸)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 여과하여 얻고 진공중에서 건조시킨다.The reaction mixture is stirred and cooled to form a precipitate. Ethanol was evaporated in vacuo and {[7-chloro-3- (1-naphthyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid having a melting point of 172 to 174 ° C. was filtered off and dried in vacuo. Let's do it.

Figure kpo00169
Figure kpo00169

[실시예 45]Example 45

a. 전술된 실시예에 기술된 프리델-크레프트 반응을 2,3-디클로로아니졸, 3-플루오로벤조일 클로라이드 및 AlCl3로 반복하여, 2,3-디클로로-4-하이드록시-3'-플루오로벤조페논을 얻는다.a. The Friedel-Crafts reaction described in the above examples was repeated with 2,3-dichloroanizol, 3-fluorobenzoyl chloride and AlCl 3 , yielding 2,3-dichloro-4-hydroxy-3'-fluorobenzope Get the paddy.

b. 피리딘 50㎖중의 2,3-디클로로-4-하이드록시-3'-플루오로-벤조페논 5g용액에 하이드록실 아민 클로라이드 1.58g을 가한다. 혼합물을 18시간 동안 환류한다. 피리딘을 진공중에서 증발시키고 잔류물을 5%HCl과 에틸아세테이트에 분배한다. 에틸아세테이트를 물로 씻고, Na2SO4상에서 건조하고 증발시켜 융점 178내지 185℃인 2,3-디클로로-4-하이드록시-3-플루오로 벤조페논 옥심을 이성체의 혼합물로서 얻는다.b. 1.58 g of hydroxyl amine chloride is added to a 5 g solution of 2,3-dichloro-4-hydroxy-3'-fluoro-benzophenone in 50 ml of pyridine. The mixture is refluxed for 18 hours. Pyridine is evaporated in vacuo and the residue is partitioned between 5% HCl and ethyl acetate. Ethyl acetate is washed with water, dried over Na 2 SO 4 and evaporated to afford 2,3-dichloro-4-hydroxy-3-fluoro benzophenone oxime having a melting point of 178 to 185 ° C. as a mixture of isomers.

Figure kpo00170
Figure kpo00170

c. DMF 20㎖ 중의 2,3-디클로로-4-하이드록시-3'-플루오로벤조페논 옥심 3g 용액에 NaH 0.25g을 N2기압하에 가한다. 혼합물을 18시간동안 교반한다. 혼합물을 1시간 동안 100℃까지 가열한다. 반응 혼합물을 얼음물에 부어 융점 149내지 150℃인 7-클로로-3-(3-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.c. To a 3 g solution of 2,3-dichloro-4-hydroxy-3'-fluorobenzophenone oxime in 20 ml of DMF was added 0.25 g of NaH under N 2 atmosphere. The mixture is stirred for 18 hours. The mixture is heated to 100 ° C. for 1 hour. The reaction mixture is poured into ice water to give 7-chloro-3- (3-fluorophenyl) -6-methoxy-1,2-benzisoxazole having a melting point of 149 to 150 ° C.

Figure kpo00171
Figure kpo00171

d. 7-클로로-3-(3-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 14.47g과 피리딘 58g의 고체혼합물을 1시간 동안 190내지 200℃에서 가열한다. 뜨거운 혼합물을 강하게 교반하면서 얼음물에 붓고 여과하여 7-클로로-6-하이드록시-3-(3-플루오로페닐)-1,2-벤즈이소옥사졸을 모으고 H2O로 잘 세척한다.d. A solid mixture of 14.47 g of 7-chloro-3- (3-fluorophenyl) -6-methoxy-1,2-benzisooxazole and 58 g of pyridine is heated at 190 to 200 ° C. for 1 hour. The hot mixture is poured into ice-water with vigorous stirring and filtered to collect 7-chloro-6-hydroxy-3- (3-fluorophenyl) -1,2-benzisoxazole and washed well with H 2 O.

Figure kpo00172
Figure kpo00172

e. 7-클로로-6-하이드록시-3-(3-플루오로페닐)-1,2-벤즈이소옥사졸 10.2g 용액을 DMF 25㎖중의 NaH 1.3g 혼합물에 가한다. DMF 25㎖중의 에틸브로모 아세테이트 6.68g용액을 가하고 혼합물을 2시간 30분동안 교반한다. 50% NaOH 10㎖, H2O 175㎖ 및 DMF 30㎖를 반응 혼합물에 가한후 1시간 동안 80내지 85℃에서 가열한다. 혼합물을 농염산으로 산성화하고 물을 가하고 여과하여 융점205내지 209℃인 {[7-클로로-3-(3-플루오르페닐)-1,2-벤즈 이소옥사졸-6-일]옥시}아세트산을 얻는다.e. A 10.2 g solution of 7-chloro-6-hydroxy-3- (3-fluorophenyl) -1,2-benzisoxazole is added to a 1.3 g mixture of NaH in 25 ml of DMF. A solution of 6.68 g of ethylbromo acetate in 25 ml of DMF is added and the mixture is stirred for 2 hours 30 minutes. 10 ml 50% NaOH, 175 ml H 2 O and 30 ml DMF are added to the reaction mixture and then heated at 80-85 ° C. for 1 hour. The mixture was acidified with concentrated hydrochloric acid, water was added and filtered to afford {[7-chloro-3- (3-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid having a melting point of 205 to 209 ° C. Get

Figure kpo00173
Figure kpo00173

[실시예 46]Example 46

a. 50㎖빙초산중의 실시예 42e의 4-클로로-3-(0-플루오로페닐(-6-메토시-1,2-벤즈이소옥사졸 1.0g용액에 염소가스를 가한다(용액을 5분동안 정화시킨다).a. Chlorine gas was added to a solution of 1.0 g of 4-chloro-3- (0-fluorophenyl (-6-methoxy-1,2-benzisoxazole) in Example 42e in 50 ml glacial acetic acid (the solution was added for 5 minutes. Purify).

1시간 동안 실온에서 교반후, 혼합물을 500㎖물에 붓고 15분동안 교반하고 얻은 침전물을 에테르/에틸아세테이트로 추출한다. 유기층을 물로 씻고, 건조하고(포화NaCl, 무수 MgSO4)여과후 용매를 증발시키고 융점 120내지 140℃인 3-(0-플루오로페닐-6-메톡시-4,5,7-트리클로로-1,2-벤즈이소옥사졸을 얻는다.After stirring at room temperature for 1 hour, the mixture is poured into 500 ml water, stirred for 15 minutes and the precipitate obtained is extracted with ether / ethyl acetate. The organic layer was washed with water, dried (saturated NaCl, anhydrous MgSO 4 ), the solvent was evaporated after filtration and 3- (0-fluorophenyl-6-methoxy-4,5,7-trichloro- with a melting point of 120 to 140 ° C. Obtain 1,2-benzisoxazole.

Figure kpo00174
Figure kpo00174

b. 실시예 19d와 e의 방법을 3-(0-플루오로페닐)-6-메톡시-4,5,7-트리클로로-1,2-벤즈이소옥사졸로 실시하여 {[4,5,7-트리클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.b. The process of Examples 19d and e was carried out with 3- (0-fluorophenyl) -6-methoxy-4,5,7-trichloro-1,2-benzisoxazole, where {[4,5,7- Trichloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetic acid is obtained.

[실시예 47]Example 47

실시예 32C의 7-클로로-6-하이드록시-3-(2-플루오로페닐-1,2-벤즈이소옥사졸 10g을 DMF 70㎖에 녹이고 K2CO37.86g을 교반하면서 가한다.10 g of 7-chloro-6-hydroxy-3- (2-fluorophenyl-1,2-benzisoxazole of Example 32C is dissolved in 70 mL of DMF and 7.86 g of K 2 CO 3 is added with stirring.

클로로아세토니트릴 3.6㎖을 가하고 혼합물을 실온에서 0.5시간 동안 교반한후 2시간 동안 55℃까지 상승시킨다. 15시간 동안 실온에서 계속 교반하고 클로로아세토니트릴 1.5㎖을 가하고 반응물을 50℃에서 6시간동안 교반한다. 이것을 다량의 얼음/물에 붓고 침전된{[7-클로로-3-(2-플루오로페닐)-1,2벤즈이소옥사졸-6-일]옥시}-아세토니트릴을 여과하여 얻는다.3.6 ml of chloroacetonitrile are added and the mixture is stirred at room temperature for 0.5 hours and then raised to 55 ° C. for 2 hours. Stirring at room temperature is continued for 15 hours, 1.5 ml of chloroacetonitrile are added and the reaction is stirred at 50 ° C. for 6 hours. This is obtained by pouring a large amount of ice / water and filtering the precipitated {[7-chloro-3- (2-fluorophenyl) -1,2benzisoxazol-6-yl] oxy} -acetonitrile.

Figure kpo00175
Figure kpo00175

[실시예 48]Example 48

DMF 75㎖중의 7-클로로-6-하이드록시-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸을 DMF 75㎖중의 3.0g 현탁액에 가한다.7-Chloro-6-hydroxy-3- (2-fluorophenyl) -1,2-benzisoxazole in 75 ml of DMF is added to a 3.0 g suspension in 75 ml of DMF.

실온에서 1시간 후 에틸 2-브로모이소부틸레이트 16.7㎖를 가한다. 50℃에서 72시간 후 혼합물을 얻음/HCl에 붓고 CH2Cl2로 추출하고 유기층을 5% K2CO3로 세척하고 뒤이어 포화 NaCl로 세척한다. 이것을 MgSO4상에서 건조하고, 여과하고, 갈색오일이 될때까지 증발시킨다. 오일을 감압하에서 증류시켜 미반응의 에틸 2-브로모이소부틸레이트를 제거하고 잔류물을 에테르/석유에테르로 처리하고, 여과하고, 모액을 증발시켜 오일을 수득하고 증류하여(200℃, 1㎜) 에틸-2-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}-2-메틸프로피오네이트를 얻는다.After 1 hour at room temperature 16.7 ml of ethyl 2-bromoisobutylate is added. After 72 h at 50 ° C. the mixture is taken / poured into HCl and extracted with CH 2 Cl 2 and the organic layer is washed with 5% K 2 CO 3 followed by saturated NaCl. It is dried over MgSO 4 , filtered and evaporated to a brown oil. The oil was distilled off under reduced pressure to remove unreacted ethyl 2-bromoisobutylate and the residue was treated with ether / petroleum ether, filtered and the mother liquor was evaporated to yield and distill the oil (200 ° C., 1 mm). ) Ethyl-2-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} -2-methylpropionate.

Figure kpo00176
Figure kpo00176

[실시예 49]Example 49

a. 1,2-디클로로에탄 150㎖중의 4-클로로-2-플루오로벤조일 클로라이드 46g과 디클로로아니졸 38.9g의 혼합물에 AlCl 32g을 서서히 가한다. 혼합물을 강하게 가스를 기화시키면서 40℃까지 가온시킨다. 혼합물을 농 HCl과 얼음에 붓는다. 유기층을 분리하고 수용액층을 추가의 유기용매로 추출한다. 합한 유기추출물을 물로 세척하고 Na2SO4상에서 건조하고 증발시킨다. 조생성물을 헥산으로 처리하여 2,3-디클로로-4-메톡시-4-클로로-2'-플루오로-벤조페논을 얻는다.a. To a mixture of 46 g of 4-chloro-2-fluorobenzoyl chloride and 38.9 g of dichloroanizol in 150 ml of 1,2-dichloroethane was slowly added 32 g of AlCl. The mixture is warmed to 40 ° C. with vigorous gasification. Pour the mixture into concentrated HCl and ice. The organic layer is separated and the aqueous layer is extracted with additional organic solvent. The combined organic extracts are washed with water, dried over Na 2 SO 4 and evaporated. The crude product is treated with hexane to give 2,3-dichloro-4-methoxy-4-chloro-2'-fluoro-benzophenone.

분석시료를 EtOH 재결정한다. 융점 115내지 16℃Re-crystallize the sample from EtOH. Melting Point 115 ~ 16 ℃

Figure kpo00177
Figure kpo00177

b. 실시예 20b와 같은 방법으로 2,3-디클로로-4-메톡시-4'-클로로-2'-플루오로벤조페논을 2,3-디클로로-4-메톡시-4'-클로로-2'-플루오로벤조페논 옥심으로 전환시킨다.b. 2,3-dichloro-4-methoxy-4'-chloro-2'-fluorobenzophenone was replaced with 2,3-dichloro-4-methoxy-4'-chloro-2'- in the same manner as in Example 20b. Convert to fluorobenzophenone oxime.

c. DMF 100㎖중의 NaH 2.24g의 혼합물에 DMF 100㎖중의 2,3-디클로로-4-메톡시-4'-클로로-2'-플루오로벤조페논옥심을 적가한다. 적가 후 혼합물을 1시간 동안 교반하고 반응 혼합물을 얼음물에 붓는다. 침전된 생성물을 여과하고 건조하여 이성체의 혼합물을 얻고 50% 헥산과 50% 톨루엔을 용출제로 사용하여 실리카겔상에서 크로마토그라피하여 융점 193내지 194℃인 7-클로로-3-(4-클로로-2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸을 얻는다.c. To a mixture of 2.24 g of NaH in 100 ml of DMF is added dropwise 2,3-dichloro-4-methoxy-4'-chloro-2'-fluorobenzophenone oxime in 100 ml of DMF. After dropping, the mixture is stirred for 1 hour and the reaction mixture is poured into ice water. The precipitated product was filtered and dried to give a mixture of isomers and chromatographed on silica gel using 50% hexane and 50% toluene as eluent to give 7-chloro-3- (4-chloro-2-fluorine having a melting point of 193 to 194 ° C. Rophenyl) -6-methoxy-1,2-benzisoxazole is obtained.

Figure kpo00178
Figure kpo00178

d. 7-클로로-3-(4-클로로-2-플루오로페닐)-6-메톡시-1,2-벤즈이소옥사졸 5.4g과 피리딘 HCl 22.4g의 고체 혼합물을 2시간동안 200℃에서 가열한다. 반응 혼합물을 강하게 교반하면서 얼음물에 붓고 탈메틸하된 생성물을 얻는다.d. A solid mixture of 5.4 g of 7-chloro-3- (4-chloro-2-fluorophenyl) -6-methoxy-1,2-benzisooxazole and 22.4 g of pyridine HCl is heated at 200 ° C. for 2 hours. The reaction mixture is poured into iced water with vigorous stirring to give the demethylated product.

40㎖중의 탈메틸화된 생성물 3.9g 용액에 K2CO31.9g과 에틸브로모아세테이트 2.3g을 가한다. 반응물을 2시간 동안 60℃로 가온시키고 18시간 방치한다. 반응 혼합물에 물 100㎖와 50% NaOH 10㎖를 가한다. 혼합물 90분동안 90℃에서 가열하고 반응 혼합물을 물에 붓고 산성화하고 에틸아세테이트로 추출하고, 건조하고, 증발하여 융점 226내지 227℃인 {[7-클로로-3-(4-클로로-2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세트산을 얻는다.To a solution of 3.9 g of demethylated product in 40 mL was added 1.9 g of K 2 CO 3 and 2.3 g of ethylbromoacetate. The reaction is warmed to 60 ° C. for 2 hours and left for 18 hours. 100 ml of water and 10 ml of 50% NaOH are added to the reaction mixture. The mixture was heated at 90 ° C. for 90 minutes and the reaction mixture was poured into water, acidified, extracted with ethyl acetate, dried and evaporated to produce {[7-chloro-3- (4-chloro-2-fluoro) having a melting point of 226 to 227 ° C. Lophenyl) -1,2-benzisoxazol-6-yl] oxy} acetic acid.

Figure kpo00179
Figure kpo00179

[실시예 50]Example 50

100㎖ 무수에테르중의 리틀알루미늄하이드리드(90%) 9g의 현탁액에 용액화시키기에 충분한 량의 테트라하이드로푸란을 함유하는 에테르 200㎖중의 실시예 1d의 에틸-2-[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세테이트 10g 용액을 가한다. 반응 혼합물을 실온에서 2시간 동안 교반하고 1시간 동안 환류한다. 반응 혼합물에 0.9㎖ H2O, 0.9㎖ 15% NaOH(및 2.7㎖ H2O를 가한다. 교반한 현탁액을 여과하고 여과물을 농축하여 융점 112℃인 2-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}에탄올을 얻는다.Ethyl-2- [7-chloro-3- in Example 1d in 200 ml of ether containing sufficient amount of tetrahydrofuran to be solution in a suspension of 9 g of little aluminum hydride (90%) in 100 ml anhydrous ether. A 10 g solution of (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetate is added. The reaction mixture is stirred at room temperature for 2 hours and refluxed for 1 hour. And it is a 0.9㎖ H 2 O, 0.9㎖ 15% NaOH ( and 2.7㎖ H 2 O to the reaction mixture in the stirred suspension was filtered and the filtrate was concentrated melting point 112 ℃ 2 -. {[7- Chloro-3 (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} ethanol is obtained.

Figure kpo00180
Figure kpo00180

[실시예 51]Example 51

실시예 51의 에틸-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}-2-메틸프로피오네이트 4.9g을 메탄올 35㎖에 녹이고 여기에 15% NaOH 용액 30㎖를 가한다. 현탁액을 4시간 동안 환류시키고 얼음물에 붓고 산성화하면 유성침전물이 생성된다. 이 침전물을 에테르로 추출하고 에테르 추출물을 10% NaHCO3로 세척한다.4.9 g of ethyl-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} -2-methylpropionate of Example 51 in 35 ml of methanol It is dissolved and 30 ml of 15% NaOH solution is added thereto. The suspension is refluxed for 4 hours, poured into ice water and acidified to form an oily precipitate. This precipitate is extracted with ether and the ether extract is washed with 10% NaHCO 3 .

염기성 추출물을 농 HCl로 산성화하고 냉각한 후 융점108℃인 2-{[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}-2-메틸프로피오닉산을 얻는다.The basic extract was acidified with concentrated HCl and cooled, followed by 2-{[7-chloro-3- (2-fluorophenyl) -1,2-benzisoxazol-6-yl] oxy} -2- Obtain methyl propionic acid.

Figure kpo00181
Figure kpo00181

[실시예 52]Example 52

NaN33.35g과 AlCl32.25g을 0.5시간 동안 환류하면서 50㎖ THF중에서 교반한다. 50㎖ THF중의 실시예 47의 {[7-클로로-3-(2-플루오로페닐)-1,2-벤즈이소옥사졸-6-일]옥시}아세토니트릴 5g 용액을 가하고 반응 혼합물을 약 120시간 동안 환류하면서 교반한다. 반응 혼합물에 물을 가하고 용매를 제거시킨다. 잔류물을 회 HCl로 처리하고 CHCl3로 추출한다. 클로로포름용액을 15% NaOH로 추출하면 침전이 형성되고 이것을 여과하고, 뜨거운 물에 녹이고 산성화하여 융점 198내지 200℃인 7-클로로-3-(2-플루오로페닐)-6-{[5-테트라졸일메틸]옥시}-1,2-벤즈이소옥사졸을 얻는다.3.35 g NaN 3 and 2.25 g AlCl 3 are stirred in 50 mL THF at reflux for 0.5 h. A 5 g solution of {[7-chloro-3- (2-fluorophenyl) -1,2-benzisooxazol-6-yl] oxy} acetonitrile in Example 47 in 50 mL THF was added and the reaction mixture was added for about 120 hours. Stir while refluxing. Water is added to the reaction mixture and the solvent is removed. The residue is treated with ash HCl and extracted with CHCl 3 . Extracting the chloroform solution with 15% NaOH forms a precipitate which is filtered off, dissolved in hot water and acidified to 7-chloro-3- (2-fluorophenyl) -6-{[5-tetra with a melting point of 198 to 200 ° C. Zolylmethyl] oxy} -1,2-benzisoxazole is obtained.

Figure kpo00182
Figure kpo00182

Claims (1)

일반식(a)의 화합물을 일반식(b)의 화합물과 반응시키거나, 이어서 가수분해, 산화,
Figure kpo00183
또는
Figure kpo00184
처리, 디메틸포름아미드중의 HN3처리, 산 또는 염기성 가수분해, 유기 또는 알카리/알카리토금속 염기처리, 빙초산중의 질산처리 또는 탈알킬화시킴을 특징으로 하여 일반식(I)의 화합물을 제조하는 방법.
Reacting a compound of formula (a) with a compound of formula (b), followed by hydrolysis, oxidation,
Figure kpo00183
or
Figure kpo00184
A process for preparing a compound of formula (I) characterized by treatment, HN 3 treatment in dimethylformamide, acid or basic hydrolysis, organic or alkali / alkaline metal base treatment, nitric acid treatment or dealkylation in glacial acetic acid .
Figure kpo00185
Figure kpo00185
상기 일반식에서 R 은 수소, 저급알킬, 저급알케닐, 저급알키닐, 시클로알킬, 시클로알케닐, 비시클로알킬, 트리시클로알킬, 시클로알킬저급알킬, 시클로알케닐저급알킬, 나프틸,In the above formula, R is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, tricycloalkyl, cycloalkyl lower alkyl, cycloalkenyl lower alkyl, naphthyl,
Figure kpo00186
Figure kpo00186
티에닐, 푸릴, 피릴, 피리딜 또는 피리딜 N-옥사이드이고, R1은 탄소수가 1내지 8인 유리 또는 에스테르화된 카복실그룹,
Figure kpo00187
또는
Figure kpo00188
이며, R2, R3및 R4는 동일하거나 상이하고 각각은 수소, 할로겐 또는 저급알킬이 될 수 있고, X는 수소, 할로겐, 저급알킬, 저급알킬티오, 저급알콕시, 히드록시, 트리플루오로메틸, 니트로, 아미노 또는 아실아미노이며, R5,R6,R7,R8및 R9은 동일하거나 상이하고 수소 또는 저급알킬이 될 수 있고; A 및 A'는 동일하거나 상이하고 O 또는 S이며; Z는 염소, 브롬 또는 불소이고; M 및 n은 동일하거나 상이하고 각기 1,2 또는 3의 정수이다.
Thienyl, furyl, pyryl, pyridyl or pyridyl N-oxide, R 1 is a free or esterified carboxyl group having 1 to 8 carbon atoms,
Figure kpo00187
or
Figure kpo00188
R 2 , R 3 and R 4 are the same or different and each can be hydrogen, halogen or lower alkyl, X is hydrogen, halogen, lower alkyl, lower alkylthio, lower alkoxy, hydroxy, trifluoro Methyl, nitro, amino or acylamino, and R 5 , R 6 , R 7 , R 8 and R 9 are the same or different and can be hydrogen or lower alkyl; A and A 'are the same or different and are O or S; Z is chlorine, bromine or fluorine; M and n are the same or different and are integers of 1,2 or 3, respectively.
KR7803502A 1978-11-17 1978-11-17 Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives KR820000476B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR7803502A KR820000476B1 (en) 1978-11-17 1978-11-17 Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives
KR8200779A KR820000562B1 (en) 1978-11-17 1982-02-22 Process for preparing 1,2-benzisoxa - zoloxyacetic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7803502A KR820000476B1 (en) 1978-11-17 1978-11-17 Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR8200779A Division KR820000562B1 (en) 1978-11-17 1982-02-22 Process for preparing 1,2-benzisoxa - zoloxyacetic acid derivatives

Publications (1)

Publication Number Publication Date
KR820000476B1 true KR820000476B1 (en) 1982-04-07

Family

ID=19209237

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7803502A KR820000476B1 (en) 1978-11-17 1978-11-17 Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives

Country Status (1)

Country Link
KR (1) KR820000476B1 (en)

Similar Documents

Publication Publication Date Title
JP3476883B2 (en) Heterocycle-containing carboxylic acid derivatives
JP4482513B2 (en) N2- (substituted arylmethyl) -3- (substituted phenyl) indazole and anti-angiogenic agent containing the same
JP2004532194A (en) Retinoid X receptor modulator
SK40497A3 (en) Ortho substituted phenyl compounds and pharmaceutical compositions on their base
HUT54360A (en) Process for producing new naphthylalkyl-3h-1,2,3,5-oxathiadiazole-2-oxide derivatives and medical compositions comprising such compounds
IE59813B1 (en) Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
JPH04234851A (en) New pyrazole derivative as angiotensin ii receptor antagonist, process for producing same and medicinal composition containing same
WO1999020309A1 (en) Retinoic acid agonists as preventive and therapeutic agents for nephritis
JPH10507754A (en) Di-tert-butyl-phenol compounds having a heterocyclic moiety and useful as anti-inflammatory agents
CA1111853A (en) 1,2-benzisoxazoloxyacetic acids and related compounds
WO2005100303A1 (en) Indene derivatives and process for the preparation thereof
US4927835A (en) Acylphenol derivatives, useful as anti-inflammatory agents and pain suppressants
JP2808460B2 (en) Imidazole derivative
KR820000476B1 (en) Process for preparing 1,2-benzisoxazoloxyacetic acid derivatives
JP2722586B2 (en) Indolyl imidazole derivatives
BG65308B1 (en) 2-phenylpyran-4-one derivatives
US4728662A (en) 1,2-benzisoxazoloxyacetic acids and related compounds
JPS6212214B2 (en)
US4673746A (en) 1,2-benzisoxazoloxyacetic acids and related compounds
FR2493147A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANONES SUBSTITUTED IN POSITION 6
JPH0337549B2 (en)
US4197309A (en) 4-Keto-phenoxyacetic acids
HU204520B (en) Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them
KR820000562B1 (en) Process for preparing 1,2-benzisoxa - zoloxyacetic acid derivatives
JPS6019317B2 (en) Thienothiazine derivative and method for producing the same